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Foot-and-mouth disease (FMD) is a contagious viral disease of cloven-hoofed animals, not 
only of the most important domestic animals i.e. cattle, pigs, sheep, goats and domestic buffalo, 
but also of wildlife species [1]. Outbreaks of FMD are responsible of large socio-economic 
losses [2]. The disease is caused by foot-and-mouth disease virus (FMDV), a virus 25-30 nm 
in size containing a single strand of ribonucleic acid (RNA) inside an icosahedral capsid made 
of protein. FMDV is classified within the genus Aphtovirus, member of the Picornaviridae 
family [3] and consists of seven different serotypes (A, O, C, Asia1, SAT1, SAT2, SAT3) with 
many subtypes [4]. A property of this virus is that it is difficult to stop its transmission [5] 
which makes it difficult to control and eradicate the disease worldwide. Although the virus 
can be rapidly inactivated at pH values of less than 7.0 (below neutral pH) [4], it can withstand 
high temperatures when protected by proteins e.g. from milk [6–9], limiting virus inactivation 
and therefore enhancing virus persistence in the environment. 
history and worLdwide distriBution
FMDV outbreaks have occurred in almost all countries containing FMDV-susceptible 
animals, with the exception of New Zealand [10].
FMDV used to be endemic in Europe, huge epidemics swept through Europe at the end 
of the 19th and the beginning of the 20th century. It was reported that FMDV was introduced 
in the 19th century into South America by imported cattle from Europe [11]. 
Early control strategies for the control of FMDV transmission involved movement 
restrictions, slaughter of infected animals, and disinfection of the environment. Later, the 
use of vaccines was implemented [12]. The first inactivated vaccine against FMDV was 
produced in the 1930’s by Waldmann and collaborators [13]. But it was not until the late 
40’s of the 20th century when Frenkel made the production of vaccines on a larger scale 
[14] possible. The Netherlands was the first country implementing nationwide prophylactic 
vaccination in cattle, which was followed by most countries in mainland Europe. The 
vaccination of cattle only, reduced the number of FMDV outbreaks enormously. The 
vaccination program resulted in cessation of disease outbreaks in 1989. In 1992, a non-
prophylactic vaccination policy was adopted in the EU [15]. The decision was mainly based 
on economic evaluations, resulting in the reduction in cost of prophylactic vaccination 
and increasing the market potential of livestock and livestock products [12]. After the ban 
on prophylactic FMDV vaccination, only minor FMDV outbreaks occurred in Europe 
until the outbreak of 2001 in the United Kingdom [16]. FMDV control strategies such as 
movement restrictions, slaughter of infected animals, and disinfection of the environment 
have remained the basis to control FMD [12, 17]. Also, slaughter of non-infected animals 
from farms neighboring infected farms (pre-emptive culling) is used as a control measure. 
In The Netherlands in the outbreak of 2001, emergency vaccination of all FMDV-susceptible 
animals was used as an additional control measure [18]. However, all vaccinated animals 
were culled (suppressive vaccination) for economic reasons. Slaughtering and vaccination 
remain primary lines of defense for FMDV control [12, 19]. It has been suggested that 
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there is a risk that vaccinated animals can become carriers of the virus after exposure to 
the virus [20]. However to differentiate vaccinated from infected animals (either carriers 
or not), DIVA (Differentiating Infected from Vaccinated Animals) serological tests for 
detecting non-structural proteins (NSP) have been developed [21–23]; If the animals are 
NSP positive they are infected with the virus. Tests for detecting NSPs are highly specific to 
differentiate non-infected from infected vaccinated animals and are even capable to detect 
silent infections in populations of either cattle or sheep [24, 25]. Also complementary 
serological tests for detecting specific immunoglobulin A [26, 27] in infected animals, have 
been developed. However their use is until now questionable [12].
If vaccination would be used as control strategy and tests for detecting NSPs would be 
used for differentiating infected from non-infected vaccinated animals, vaccination should 
be performed with purified vaccines that do not contain NSPs [28, 29]. 
Fmd CLiniCaL siGns
Typical clinical signs and lesions of animals infected with FMDV include fever, excessive 
salivation and/or nasal secretion and development of vesicles on epithelia of the mouth, 
feet and teats. Rupture of vesicles on the hoofs can precede ulcers with secondary bacterial 
infections causing lameness and pain. Loss of affected hoofs can also be expected and 
lesions on the udder can lead to mastitis. Ultimately, an FMDV infection can lead to weight 
loss, decrease in milk production, and loss of draught power [10]. 
In field conditions, the diagnosis of FMDV infection mostly depends on observing 
clinical signs.  FMDV lesions are most apparent in cattle and pigs and therefore clinical 
diagnosis of FMDV infections in these species is mostly straightforward. But in sheep and 
goats, clinical signs are milder and may stay undetected [30] which can make it difficult to 
detect newly infected herds.
PathoGenesis
After the infection with the virus takes place, large amounts of FMDV are released in secretions 
and excretions, before [37] and after [38] the appearance of clinical signs. After FMDV is 
released in secretions and excretions from the infected animals, virus aerosols can be formed 
[39] which may contaminate the environment some distance from their source [40]. 
Secretions are defined as material released from glands (i.e. milk, semen, saliva) whereas 
excretions refer to any other products released from animals (e.g. lesion material, urine, faeces, 
and material released from the respiratory tract). All secretions and excretions from infected 
animals can contain FMDV [31, 41]. FMDV can persist in the secretions and excretions from 
the infected animals in the environment for long periods of time even after the animals have 
died [39] facilitating transmission of FMDV via the indirect route. The factors associated with 
increased secretion and excretions of FMDV by the infected animals are still unknown.
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transmission routes For Fmdv
Pathogen transmission includes any mechanism by which an infectious agent is spread from an 
infected individual to a susceptible host [42]. Even though studies support the idea that FMDV 
transmission does mostly occur when the animals are manifesting clinical signs of the diseases 
[43], others have suggested that the presence of clinical signs is not a determinant for FMDV 
transmission to occur [44]. FMDV in secreted and excreted material can be transmitted either 
directly, e.g. via contact with an infected host [43, 45–52], or indirectly, e.g. via contact with 
a contaminated environment with FMDV infected secretions and excretions [41, 53]. Direct 
(contact) transmission of FMDV occurs when the infected animal(s) and the recipient animal(s) 
are in close vicinity. Indirect (contact) transmission of FMDV, via the environment, occurs when 
the recipient animal(s) are in contact with infected secretions and excretions. For example, 
indirect transmission occurs after feeding animals with contaminated feedstuff and during 
the movement of animals [12] i.e. bringing animals to environments contaminated previously 
by infected animals (e.g. trucks, pens used to hold animals for trade etc.). Contamination of 
the environment and feedstuffs (including concentrates, hay and straw) by saliva, faeces and 
Figure 1. FMD clinical signs in cattle and sheep. Top left figure shows excessive nasal discharge in cattle. Top 
right figure shows a lesion on the coronary band of the hoof from a sheep. Bottom right figure shows a vesicle 
in the interdigital space of the hoof from a sheep.
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urine, was an important cause of transmission of FMDV when Europe was endemic to the virus 
in the 20th century [41]. Even though airborne transmission has been suggested as the cause 
of outbreaks in the 2001 epidemic in Europe [54], its actual contribution to the transmission 
of FMDV is often overestimated. It has been shown that the probability of infection via the 
airborne route is very low [55]. The most important factor in the transmission of FMDV has 
been suggested to be the movement of infected animals [56]. The contribution of secretions 
and excretions from infected animals in the transmission of FMDV has not been quantified 
extensively [41]. It is not yet understood which factors could influence the higher secretion 
and excretion of FMDV by the infected animals. Moreover mathematical quantification of the 
contribution of these infected secretions and excretions to the transmission of FMDV has not 
yet been performed. Filling these gaps in the knowledge of FMD could allow better estimation 
of the contribution of other routes to the transmission of FMDV. 
QuantiFiCation oF transmission 
Epidemic mathematical models can be used to study the transmission of pathogens. It was 
in 1766 when Bernoulli used the first mathematical model to estimate life expectancy in 
individuals infected with smallpox [57]. This was the first mathematical model created 
to study the spread of a disease.  Modern theoretical epidemiology began with Ross 
who described for the first time a “infection rate parameter” (i.e. the rate of occurrence 
of new infection cases in a susceptible population) based on the assumption that an 
infectious individual (re-) infect others in unit of time [58]. Building on the research of 
Ross, Kermack and McKendrick used a mathematical model to describe the transmission 
dynamics of infections [59]. For describing transmission, the individuals in a population 
are often classified according to a simple dynamic system: susceptible (S), infectious (I), 
or recovered (R). The number of individuals S, I and R will vary in time (t). This system 
described by Kermack and McKendrick is called the SIR model. An SIR model can be varied 
to accommodate additional pathways when required [42, 60]. The simplest differential 
equations that describe the SIR transmission dynamics of infections are:
Where β is the transmission rate parameter (i.e. the number of new infections caused 
by a typical infected individual per unit of time) and α is the recovery rate parameter. 
Thus to determine the number of new infections per unit of time, the total number of 
individuals transmitting infection (βI) is multiplied by the probability that the individuals 
are susceptible in the population (S/N). 
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The average number of infections caused by a single typical infectious individual, called 
the reproduction ratio and denoted R0 [61, 62], was first described by Ronald Ross and 
Kermack and McKendrick. But it was George MacDonald who applied it first in modern 
epidemiology to describe transmission of malaria [63]. In epidemics, R0 is useful to 
describe the magnitude of transmission. If R0 is greater than 1, major and minor outbreaks 
are possible, and if R0 is less than 1 only minor outbreaks are possible [64, 65]. By using a 
final size approach the final outcome of a transmission experiment [66, 67] can be used to 
calculate R0. R0 can also be estimated by multiplying the transmission rate parameter β with 
the average infectious period [68]. In heterologous populations (e.g. with different animal 
species or vaccination status) a next generation matrix can be used to calculate R0 [69]. 
To understand the transmission of FMDV and be able to predict FMDV transmission 
dynamics, quantification of FMDV transmission parameters is essential. Deterministic 
models [70, 71] and stochastic models [71, 72] have been used to analyze transmission of 
FMDV. Quantification of R0 for FMDV can be performed either by using field data [73] or 
by using data from animal experiments [48]. 
intrasPeCies and intersPeCies transmission 
oF Fmdv 
All cloven-hoofed mammals are susceptible to FMDV but for economic reasons: cattle, sheep, 
swine, goats and water buffalos have been considered as the epidemiologically most important 
animal species. Many researchers consider cattle as the most susceptible species [74] and 
pigs as the most infectious species [75]. Sheep have a role in the epidemiology of FMDV 
specially because of the difficulty in making a clinical diagnosis in this species and therefore 
the possibility of silent transmission of FMDV [76]. In sheep populations, even in the absence 
of clinical signs, high prevalence of antibodies against FMDV have been identified [77]. 
The reproduction ratio R0 and the transmission rate parameter β have been estimated 
for analyzing intraspecies transmission of FMDV in cattle [51, 78], sheep [50] and pigs [46]. 
In these intraspecies studies, the effect of vaccination has also been quantified. Intraspecies 
transmission of FMDV has also been quantified after the immunization of susceptible 
animals in other studies [45, 46, 49, 52]. 
Whereas pigs are resistant to infection via the airborne route [35], infected pigs will 
rapidly infect other pigs and other animal species in proximity even after vaccination [49]. 
In 2010, a devastating outbreak in Japan showed the high risk of transmission of FMDV 
when pigs and cattle are in close vicinity [79]. It is generally accepted that few infected 
pigs pose a great risk for between herd transmission of FMDV to occur [80]. Moreover, by 
using data from experimental studies, it has been inferred that the transmission from cattle 
to pigs has a low transmission rate whereas the transmission from pigs to cattle has a high 
transmission rate [81, 82]. Interspecies transmission parameters for a mixed population of 
infected sheep and in-contact pigs have been reported: The interspecies transmission rate 
parameter β for a population of sub-clinically infected sheep and in-contact pigs has been 
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reported as β = 0.24 per day [48]. For mixed populations of cattle and sheep, it has been 
suggested that when the cattle are vaccinated but suffer occasional outbreaks, the infection 
in the sheep will be self-limiting (R0<1) [83]. No interspecies transmission parameters for a 
mixed population of cattle and sheep have been reported. 
ControL strateGies 
Efforts to control FMD should be directed at early detection of infection and rapid 
intervention [12, 16, 17]. Intervention strategies in the control of FMD involve stamping-
out of all susceptible animals [5, 12, 17, 84], movement restrictions and vaccination [17]. 
The use of physical barriers between the animals prevents transmission of FMDV [52]. 
Additionally, the use of biosecurity measures such as disinfection of the environment is 
a good strategy to control transmission of FMDV [85], because large amounts of infected 
secretions and excretions from infected animals will be left in the environment [31, 41]. 
During an outbreak, emergency vaccination has shown to control FMDV rapidly [18, 
45, 86]. FMDV vaccination has proved to be a powerful tool to reduce R0 to values < 1 [46, 
51, 78] and vaccinating animals before exposure to the virus occurs can be enough to stop 
manifestation of clinical signs or to reduce virus shedding [87, 88]. Even when control 
measures such as the slaughter of infected animals, movement restriction and disinfection 
of the premises are implemented, transmission of FMDV may continue if no emergency 
vaccination is implemented [84]. The use of physical barriers (i.e. contact restrictions to 
the virus source) and immunological barriers (i.e. by vaccination) should be applied to 
satisfactorily control the disease. Physical barriers prevent contact to infected secretions 
and excretions and therefore the transmission of FMDV can be reduced (R0 <1 in e.g. calves 
and pigs [52, 89]). And vaccination will reduce the susceptibility and infectivity of the 
animals (and virus shedding) reducing R0 (e.g. from ∞ to 2.4 in pigs [49], from ∞ to 0 in 
cows [78] and from 1.14 to 0.22 in lambs [50]).
Although targeted vaccination to control the transmission of FMDV has been used for 
example in South America and in Europe with satisfactory results (i.e. vaccinating cattle 
only) [19, 83, 90], it is until now unclear whether the use of targeted emergency vaccination 
could reduce R0 sufficiently.
sCoPe oF the thesis
During the past decennia, an effort to understand the epidemiology of FMDV and its 
transmission dynamics has been made. This is mainly done because transmission of FMDV 
is difficult to stop, and therefore the economic losses (mainly due to trade restrictions) in 
the countries where outbreaks occur can be dramatic. Despite the efforts made to better 
understand the transmission of FMDV, some of the basic mechanisms via which the virus 
transmits between animals remain unclear. There is still little known on the contribution 
of secretions and excretions from infected animals to the transmission of the infection. 
16
G
e
n
e
r
a
l In
tr
o
d
u
c
tIo
n
I
Also the role of different species on the magnitude of transmission of the virus is limitedly 
understood. Because different species can be differently infectious and susceptible, 
their relative infectivity and susceptibility should be determined to estimate risks of 
transmission of FMDV precisely. Interspecies transmission of FMDV has been limitedly 
quantified. This could be related with the limitations of FMDV research; the biosecurity 
requirements for working with this virus are highly demanding and thus limiting animal 
experimentation. However published data can also be used to determine missing parameters 
in the transmission of FMDV. In this thesis, both published data from animal experiments 
performed previously and data from new animal experiments were used to analyse the 4 
following identified gaps in the transmission of FMDV: 
1. It is known that most of the secretions and excretions of the FMDV infected animals 
can contain virus and thus contamination of the environment with these secretions and 
excretions is feasible. The main goal of chapter 2 of this thesis was to identify which 
factors are associated with higher secretion and excretion of FMDV and consequently 
with a higher contamination of the environment. For this, a multivariate linear regression 
analysis using published data from several animal experiments was performed. Better 
knowledge on quantitative data on FMDV in secretions and excretions is needed to 
identify possible routes of transmission of FMDV and to allow an efficient control 
planning (e.g. of disinfection) during outbreaks. 
2. Since secretions and excretions from FMDV infected animals can contaminate the 
environment, new infections of FMDV can be caused. Another goal of this thesis is to 
quantify the contribution of a contaminated environment in the transmission of the 
infection. In chapter 3 of this thesis, two animal experiments were performed using 
non-vaccinated and vaccinated calves in both direct and indirect transmission studies 
set-ups. Using these experimental data, a modified SIR model in which we included 
an extra compartment for transmission via the environment was used to quantify the 
transmission rate β, and based upon that, the reproduction ratio R0. These results allowed 
estimation of the contribution of a contaminated environment to the transmission of 
FMDV. Understanding how much of the transmission of FMDV occurs via the infected 
secretions and excretions is needed to implement control strategies towards prevention 
of contact of susceptible animals to infectious surfaces.
3. For better understanding of the transmission of FMDV and the improvement of spread 
models, it is necessary to know about the susceptibility and the infectivity of the animal 
species that could be involved during an outbreak of FMDV. There is little known 
about the quantitative role of different species in the transmission of FMDV in a mixed 
population. One other goal of this thesis is to study transmission of FMDV in a mixed 
population (i.e. cattle and sheep) and to identify relative susceptibility and infectivity for 
both animal species. To this aim, in chapter 4 of this thesis, an animal experiment was 
performed using inoculated lambs and in-contact calves. This small-scale transmission 
study allowed quantification of a partial R0 for transmission of FMDV between infected 
sheep and contact cattle. These results allowed definition of relative susceptibility and 
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infectivity for both animal species. Accurate measures of susceptibility and infectivity 
can be used to actualize transmission models of FMDV and to update control strategies 
targeting determined animal species.
4. Control strategies for FMD involve vaccination of animals. In the past it has been shown 
that targeting cattle only to vaccination can be sufficient to control FMD. However it is until 
now unknown if we could extrapolate this strategy to other populations. The last aim of 
this thesis is to analyse the effect of different vaccination strategies to the control of FMD in 
mixed populations of cattle and sheep. For this purpose, in chapter 5 of this thesis, published 
data on intraspecies and interspecies (partial) R estimates were used to determine R for a 
mixed population of cattle and sheep using a next generation matrix. This method allowed 
estimation of the effect of different vaccination strategies in different mixed populations.
The results of this thesis add knowledge on the different mechanisms that are involved 
in the transmission of FMDV. These results can be used to improve FMDV control as for 
example in implementing better biosecurity measures and updating vaccination plans.
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aBstraCt 
We investigated which variables possibly influence the amount of foot-and-mouth disease 
virus (FMDV) shed in secretions and excretions by FMDV infected animals, as it is 
likely that the amount of FMDV shed is related to transmission risk. First, in a separate 
analysis of laboratory data, we showed that the total amount of FMDV in secretions and 
excretions from infected animals is highly correlated with maximum titres of FMDV. 
Next, we collected data from 32 published scientific articles in which FMDV infection 
experiments were described. The maximum titres of FMDV reported in different secretions 
and excretions (the response variable) and the experimental conditions in which they 
occurred (the explanatory variables), were recorded in a database and analysed using 
multivariate regression models with and without random effects. In both types of models, 
maximum titres of FMDV were significantly (p < 0.05) associated with types of secretions 
and excretions, animal species, stage of the disease and days post infection. These results 
can be used to prioritize biosecurity measures in contingency plans. 
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introduCtion 
Foot-and-mouth disease (FMD) is a contagious viral disease of cloven-hoofed animals, 
both domestic (cattle, pigs, sheep, goats and domestic buffalo) and wild [1]. The FMD virus 
(FMDV) can be transmitted by several routes [2, 3], with direct contact between animals 
considered the most important. The virus can also be transmitted by several indirect routes. 
In the European Union, an outbreak of FMD invokes an obligatory stand-still of animal 
transport [4]. During such a stand-still, direct contact between infected animals in one 
farm and non-infected animals in another farm is theoretically impossible, leaving indirect 
transmission via contaminated material the most likely remaining route of transmission. In 
this respect, airborne transmission has been also considered [5]. 
During epidemics, even when there is a complete standstill of animal transport, 
transmission between farms has been shown [6]. That indirect routes play a role in 
such transmission is clear from the observation that veterinarians were involved in the 
transmission of FMDV in outbreaks both in Denmark in 1982, and in Italy in 1993, either 
by using contaminated surgical equipment or by visiting farms after visiting an infected 
farm. Similarly, during the 2001 FMD outbreak in the United Kingdom, it was suggested 
that farmers were involved in the transmission of the virus between sheep flocks [7]. In the 
2001 United Kingdom outbreak, the basic reproduction number remained above 1, that is, 
FMDV transmission continued despite the standstill in animal transport [8]. Thus indirect 
transmission of FMDV can have enormous consequences. 
It can be assumed that the risk of indirect transmission of FMDV is related to the total 
amount of FMDV present in the environment through contamination by secretions and 
excretions from FMDV infected animals. Here, secretions include material released from 
glands (e.g. milk, semen, saliva) whereas excretions refer to any other products released from 
animals (e.g. faeces, material released from the respiratory tract, urine, probang samples, nasal 
discharge and blood). The concentrations of FMDV in infected secretions and excretions 
have been reviewed [9]. However we analysed the quantitative relationship between possible 
explanatory variables and the amount of FMDV in infected secretions and excretions. 
materiaLs and methods 
materials 
Laboratory data 
Laboratory reports from animal studies performed at the Central Veterinary Institute 
(The Netherlands) were mined for all available daily data on virus secretion in milk from 
cattle [10] and on virus secretion and excretion in oropharyngeal fluid (OPF) swabs from 
cattle [11], sheep [12, 13] and pigs [14, 15, 16, 17, 18]. These data were used to identify the 
response variable for our multivariate regression analysis. 
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Literature data 
Data on FMDV in secretions and excretions were collected from 32 scientific articles published 
between 1965 and 2007 (see Annex) found in internal databases and through the electronic 
(external) databases Scopus and PubMed in 2010, all reporting experimental trials involving 
FMDV infection. The electronic databases were explored using the keywords: foot-and-mouth 
disease, virus, infection and excretion. References cited in retrieved articles were reviewed to 
identify additional ones. The articles had to meet two basic criteria for their inclusion in the 
analysis: be written either in English, Spanish or French, and contain data on animal experiments 
with FMDV. They needed to contain information on the maximum titre(s) of FMDV detected 
in secretions and/or excretions, and additional information on one or more of the following: 
the type(s) of secretion or excretion in which the virus was detected, route of infection, animal 
species, FMDV serotype, stage of disease (clinical and non-clinical), dose of infection and/or 
days post infection at which the maxi- mum secretion or excretion occurred. Missing data on 
one or more of these variables were recorded as not available (N.A.). These data were used as the 
response and possible explanatory variables for our multivariate regression analysis. 
Per individual animal, the maximum titre of FMDV (including the experimental 
conditions) was recorded. Virus titres were reported as 10log TCID50/ml. Plaque forming 
units (PFU) were converted to TCID50 [19]. Median doses, such as 50% cattle infection 
dose (CID50), 50% mouse infection dose (MID50) or 50% mouse lethal dose (MID50) per 
ml, were considered equal to 50% tissue culture infective dose (TCID50/ml) [20]. The 
maximum recorded titre was the maximum titre over time for an individual animal. If 
the maximum titre was reported per group of animals, this resulted in one observation 
(from blood in Alexandersen et al. (2003); from airborne excretion in Alexandersen et al. 
(2002), Alexandersen and Donaldson (2002), Donaldson et al. (1970, 1981, 1982), Gloster 
et al. (2007), and Sellers and Parker (1969) [21]; from probang, milk, faeces and blood in 
Burrows (1968); from milk in Burrows (1971); and, from probang and nasal discharge in 
Burrows (1972)). Data on airborne excretion were recorded as 10log TCID50/animal/day. 
The recorded secretion or excretion types were airborne, faeces, milk, probang, semen, 
urine, blood, nasal discharge, oropharyngeal fluid (OPF) swabs, and saliva. The category 
faeces contains data on material collected from the rectum (Burrows et al., 1968) and from 
rectal swabs (Garland, 1974). Probang refers to oropharyngeal samples that were obtained 
after scraping the oropharynx with a sampling cup. 
Routes of infection were recorded as: contact (if an infected donor and a susceptible contact 
animal shared a common experimental unit); intranasal (IN, if the animals were infected via the 
intranasal route) or parenteral (if the animals were infected intravenously (IV), intramuscularly 
(IM), intralingually, intracutaneously (IC), intramammary or intradermally (ID)). 
Animal species were recorded as cattle (bull, steer, ox, cow, calf and heifer), swine (pigs) or 
small ruminants (sheep, lambs and goats). The FMD viruses used for infection were recorded 
based on FMDV serotype, i.e. A, O, C, Asia-1, SAT 1, SAT 2, SAT 3, but no subdivision was 
made to the level of subtypes. The stage of disease was recorded as ‘clinical’ when lesions or 
clinical signs (including fever) were reported; otherwise it was recorded as ‘non-clinical’. 
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Dose of infection (ranging from 0.95 to 10.15 TCID50/ml) was recorded. Days post 
infection was recorded as the day when the maximum titres in the secretion or excretion 
were observed (ranging from 0.33 to 28 dpi). 
methods 
Identifying the response variable for the multivariate regression analysis 
A proxy for the total amount of FMDV secreted and excreted by the infected animals was 
established using available laboratory data from OPF swab samples and milk samples. 
The total amount of secreted and excreted FMDV (per individual animal) was calculated 
by summing the observed viral amounts (without logarithmic trans- formation) from 
consecutive observations (area under the curve, AUC). In a univariate regression analysis, 
the logarithm of the AUC (10log AUC) was used as the response variable. Three explanatory 
variables were analysed: (1) the maximum virus titre (max 10log TCID50/ml), (2) the time 
when the maximum virus titre occurred (10log days post infection) and, (3) their product 
10log (max TCID50/ml × days post infection) which is equal to max 10log TCID50/ml + 10log 
days post infection. For each univariate model, the r2 values were calculated. An F-test (in 
ANOVA) was used to test the significance of each variable. The best explanatory variable 
was used as response variable in the multivariate regression analysis. 
Identifying the explanatory variables for the multivariate regression analysis 
A dataset was built using the information found in the literature. Descriptive statistics of 
the data can be found in Tables 1A–1C. 
Per individual animal, several categorical variables were recorded: type of secretion 
and excretion, route of infection, animal species, FMDV serotype and stage of disease 
and, two continuous variables: dose of infection and days post infection (Table 2). 
Categories in which a limited number of observations were present were combined with 
another category where this made biological sense (e.g. URT secretions and excretions, 
FMDV serotype SAT) [22]. 
Multivariate regression analysis 
Under the assumption that all the included FMDV infection experiments share a common 
true effect size, we used a model in which we did not adjust for variability between data 
sources (a linear model without random effects). Under the assumption that some of the 
FMDV infection experiments from the different data sources differ from each other in ways 
that could impact on the effect in the model, we used a model in which we adjusted for 
variability between the data sources (a linear model with random effects). Three different 
random effects were evaluated: “article” (articles included in the analysis, see Annex), 
“laboratory” (laboratories where the original analyses had been performed) and their 
nested effect. All random effects were assumed to follow a Gaussian distribution [23]. The 
models were compared by computing the AIC (Table 3). 
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Table 1A. Descriptive statistics on data retrieved from the literature on maximum virus excretion from cattle. 
FMDV
Infection variables
Number of 
observations
Maximum titre 
average (range) 
TCID50/ml *
Maximum titre 
Standard deviation 
TCID50/ml*
Total 220 4.51 (0.95,8.65) 1.66
Type of secretion and excretion
Airborne 9 4.33 (3.88, 5.08) 0.36
Blood 47 4.03 (0.95 ,6.20) 1.18
Faeces 5 1.55 (1.50, 1.75) 0.10
Milk 40 4.48 (2.15, 7.35) 1.46
URT (OPF swabs, saliva and nasal discharge) 33 5.70 (1.25, 8.50) 1.66
Nasal discharge only 7 6.09 (2.75, 7.85) 1.61
Probang 68 4.91 (2.20, 8.65) 1.53
Semen 8 4.55 (2.10 , 6.20) 1.33
Urine 10 1.93 (1.00 , 3.80) 0.87
Route of infection
Intranasal 37 4.68 (0.95, 8.65) 1.76
Parenteral 95 4.75 (1.25, 8.50) 1.63
Contact 88 4.17 (1.00, 8.05) 1.57
Undetermined 1 4.60 (NA) NA
FMDV serotype
A 38 3.98 (2.10, 8.05) 1.40
O 140 4.54 (0.95, 8.65) 1.68
Asia-1 4 4.10 (2.80, 5.00) 0.80
C 6 4.6 (2.10, 7.00) 1.80
SAT (1, 2, 3) 12 4.26 (2.10, 6.00) 1.06
Undetermined 20 5.52 (1.25, 8.15) 1.81
Stage of disease
Non-clinical 61 4.52 (0.95, 8.65) 1.66
Clinical 123 4.62 (1.00, 8.50) 1.72
Undetermined 36 4.11 (1.15, 7.15) 1.36
Dose of infection (below/above median: 5.5 TCID50/ml)
0.95 - 5.4 TCID50/ml 51 4.94 (0.95, 8.65) 1.71
5.5 - 10.15 TCID50/ml 59 4.30 (2.10, 7.20) 1.48
Undetermined 110 4.43 (1.00, 8.15) 1.69
Days post infection (dpi; below/above median: 3 dpi)
0.3 to 2.8 dpi 65 4.82 (1.00, 8.50) 1.69
3 to 28 dpi 115 4.07 (0.95, 8.65) 1.49
Undetermined 40 5.28 (1.25, 8.15) 1.67
Total refers to all the maximum titres observations that were encountered.
* TCID50 per animal per day for airborne excretion; dose of infection and days post infection were divided 
as above and below the median of the maximum titre calculated using the maximum titres when either 
the dose of infection or the days post infection were available. 
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Table 1B. Descriptive statistics on maximum virus excretion from swine. 
FMDV
Infection variables
Number of 
observations
Maximum titre average 
(range) TCID50/ml *
Maximum titre standard 
deviation TCID50/ml*
Total 71 5.15 (3.41,8.60) 0.98
Type of secretion and excretion
Airborne 22 6.00 (4.48, 8.60) 0.89
Blood 6 5.18 (3.90, 6.50) 1.07
OPF (swabs and saliva) 43 4.70 (3.41, 6.45) 0.66
Route of infection
Parenteral 39 5.44 (3.85, 8.08) 0.84
Contact 32 4.78 (3.41, 8.60) 1.01
FMDV serotype
A 5 5.65 (4.48, 6.68) 0.70
O 64 5.01 (3.41, 6.54) 0.81
C 2 8.34 (8.08, 8.60) 0.26
Stage of disease
Non-clinical 5 5.80 (5.30, 6.54) 0.50
Clinical 43 5.09 (3.41, 8.60) 1.04
Undetermined 23 5.11 (3.85, 8.08) 0.89
Dose of infection (below/above median: 5.5 TCID50/ml)
0.95 - 5.4 TCID50/ml 19 4.94 (3.85, 6.50) 0.62
5.5 - 10.15 TCID50/ml 18 6.01 (4.48, 8.10) 0.72
Undetermined 34 4.81 (3.41, 8.60) 0.99
Days post infection (dpi; below/above median: 3 dpi)
0.3 to 2.8 dpi 22 5.59 (4.35, 8.60) 0.97
3 to 28 dpi 41 4.76 (3.41, 6.45) 0.77
Undetermined 8 5.95 (5.10, 8.10) 0.93
Total refers to all the maximum titres observations that were encountered.
* TCID50 per animal per day for airborne excretion; dose of infection and days post infection were divided 
as above and below the median of the maximum titre calculated using the maximum titres when either 
the dose of infection or the days post infection were available. 
Due to the small number of identified explanatory variables (Table 2), we used them 
all in the multivariate regression analysis of the models with and without random effects. 
To select the variables that best explained total FMDV secreted and excreted by infected 
animals, a stepwise regression procedure with bidirectional elimination [24] was used in 
multivariate regression analyses. No interaction terms were included in the initial (full) 
models (Table 3). The selection of explanatory variables (or fixed effects) was carried out 
using 2 criteria: the significance level (p < 0.05) and the Akaike Information Criterion 
(AIC). The variable with the highest p-value was removed from the models. In addition, 
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Table 1C. Descriptive statistics on maximum virus excretion from small ruminants (sheep and goats). 
FMDV
Infection variables
Number of
observations
Maximum titre  
TCID50/ml *
Maximum titre standard 
deviation TCID50/ml*
Total 36 3.93 (0.86, 6.28) 1.25
Type of secretion and excretion
Airborne 12 3.75 (2.38, 5.08) 1.00
Blood 8 3.34 (1.50, 5.20) 1.13
OPF (swabs and saliva) 16 4.37 (0.86, 6.28) 1.31
Route of infection
Intranasal 11 4.69 (3.26, 6.28) 0.83
Parenteral 18 3.51 (1.50, 5.20) 1.10
Contact 6 3.70 (0.86, 5.45) 1.64
Undetermined 1 4.60 (NA) NA
FMDV serotype
A 2 2.53 (2.48, 2.58) 0.05
O 23 4.35 (0.86, 6.30) 1.12
C 3 3.28 (2.38, 5.08) 1.27
Undetermined 8 3.34 (1.50, 5.20) 1.13
Stage of disease
Non-clinical 8 3.69 (0.86, 5.08) 1.37
Clinical 13 4.81 (3.26, 6.28) 0.79
Undetermined 15 3.30 (1.50, 5.20) 1.06
Dose of infection (below/above median: 5.5 TCID50/ml)
0.95 - 5.4 TCID50/ml 12 4.69 (3.26, 6.28) 0.79
5.5 - 10.15 TCID50/ml 7 3.33 (2.38, 5.08) 1.05
Undetermined 17 3.65 (0.86, 5.45) 1.33
Days post infection (dpi; below/above median: 3 dpi)
0.3 to 2.8 dpi 20 3.74 (1.50, 5.26) 1.18
3 to 28 dpi 14 4.17 (0.86, 6.28) 1.34
Undetermined 2 4.23 (3.48, 4.98) 0.75
Total refers to all the maximum titres observations that were encountered.
* TCID50 per animal per day for airborne excretion; dose of infection and days post infection were divided 
as above and below the median of the maximum titre calculated using the maximum titres when either 
the dose of infection or the days post infection were available. 
whenever deletion of a variable occurred, we checked for confounding. If the deletion of a 
variable resulted in a change of more than 25% in the regression estimates, this indicated 
confounding [25, 26]. Confounding variables were retained in the models. After deletion 
of those variables with p-values higher than 0.05, we tested whether their inclusion was 
significant (p < 0.05) and whether the inclusion led to significant reduction in AIC (AIC > 
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Table 2. Explanatory variables for the multivariate regression analysis
Variable Type Categories/Specifications
Type of secretion  
and excretion
Categorical Airborne, blood, faeces, milk, URT (OPF swabs, saliva,  
nasal discharge), probang, semen, urine
Route of infection Categorical Intranasal, contact, parenteral (intravenous, intramuscular, 
intralingual, intracutaneous, intramammary or intradermal)
Animal species Categorical Cattle, swine, small ruminants (sheep and goats)
FMDV serotype Categorical A,  Asia-1, C, O, SAT
Stage of disease Categorical Non-clinical, clinical
Dose of infection Continuous From 0.95  to 10.15 TCID50/ml
Days post infection (dpi) Continuous From day 0.33 to 28 post infection
2, [27]). After selecting the explanatory variables of the models, one level interaction terms 
were included one by one in the models. When the interaction term allowed improvement 
of fit (p < 0.05), it remained in the models. 
Both final models (Table 3) were checked for homoscedasticity, normality and outliers by 
residual analysis. Outliers were retained as they were thought to reflect relevant deviations 
in this sort of data. In order to test whether an outlier affected the estimates or the p-values, 
an outlier was excluded from the data and the models were re-fit. When the outlier had no 
influence on the estimates or p-values, it remained in the models. 
All statistical analyses were performed using the R software version 2.11.0 with its 
standard add-on packages stats and lme4 [28]. 
resuLts 
identifying the response variable for the multivariate regression analysis 
The univariate regression analysis between 10log AUC and max 10log TCID50/ml gave a 
correlation coefficient (r2) of 0.98 for OPF swab samples and of 0.99 for milk samples (p-value 
<0.001). The analysis between 10log AUC and 10log days post infection gave correlation 
coefficients of 0.01 for OPF swab samples and 0.09 for milk samples. There was no significant 
association between 10log AUC and 10log days post infection (OPF swab samples, p-value 
0.3; milk samples, p-value 0.2). The addition of 10log days post infection in the model with 
max 10log TCID50/ml did not improve the fit of the model neither for OPF swab samples nor 
for milk samples (p-value 0.3 and 0.4 respectively). The variable max 10log TCID50/ml was 
therefore used as the response variable in the multivariate regression analysis. 
Literature data 
The references of the 32 used scientific articles on FMDV infection experiments are shown 
in the Annex. The FMDV infection experiments reported in the selected scientific articles 
were carried out in 5 FMD reference laboratories: the Pirbright Institute (IAH, Pirbright, 
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United Kingdom), the Plum Island Animal Disease Center (PIADC, Orient Point, New 
York, United States of America), the Central Veterinary Institute (CVI, Lelystad, The 
Netherlands), the Pan American Center for Foot-and-Mouth Disease (PanAftosa, Rio de 
Janeiro, Brazil) and the French Institute for Foot-and-Mouth Disease (Lyon, France). 
In total 327 observations (220 cattle, 71 swine and 36 small ruminants) were retrieved. 
The data retrieved from the reviewed scientific articles are summarized in Table 1A for cattle, 
Table 1B for swine and Table 1C for small ruminants. All the observed maximum titres of 
FMDV in the different types of secretions and excretions per animal species were used to 
calculate the median maximum amounts and are shown in Fig. 1. The highest FMDV median 
amounts (10log TCID50/ml or 10log TCID50/animal/day) were found in URT secretions and 
excretions from cattle (OPF swabs, saliva and nasal discharge samples) followed by airborne 
excretion from swine, probang samples from cattle and blood from swine. 
Identifying the explanatory variables for the multivariate regression 
analysis 
Candidate explanatory variables for the multivariate regression analysis are shown in 
Table 2. Given that (1) OPF swabs and saliva are derived from the oral cavity, and (2) there 
were limited observations in the category nasal discharge (only available for cattle), we 
combined OPF swabs with saliva and with nasal discharge and called this upper respiratory 
Figure 1. Boxplot of FMDV amounts (10log TCID50/ml) in secretions and excretions from cattle (in dark 
blue), swine (in dark red) and small ruminants (in dark green). In airborne excretion (*),10log TCID50 /
animal/day is reported. URT, upper respiratory tract secretions and excretions. When applicable, each 
column contains the extreme of the lower whisker, the lower hinge, the median, the upper hinge and the 
extreme of the upper whisker for one plot.
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tract secretions and excretions (URT). In Table 1A for cattle, we show both URT and nasal 
discharge separately to show that the ranges of the maximum titres of both are similar. 
Due to limited observations in the categories SAT 1, SAT 2 and SAT 3 from the categorical 
variable FMDV serotype, we also combined the categories SAT 1, SAT 2 and SAT 3 into the 
category SAT. 
the final model 
In total, data of 327 observations were used to identify which variables are associated to the 
amount of FMDV that is secreted and excreted by the infected animals. During the analysis, 
first we looked at the inclusion/exclusion of dose of infection because it had the highest 
p-value and because it’s high number of missing data points (161). As the comparison 
of models can only be done between models with the same number of observations, we 
looked at the effect of dose of infection separately. Comparison of the full models (with 118 
observations) with and without dose of infection for the data set where dose of infection 
was not missing revealed that the models without dose of infection had a lower AIC than 
the models with dose of infection. Therefore dose of infection was excluded from both full 
models. Subsequently, all the other variables were looked at (Table 3). 
The final model without random effects is shown in Table 4. This model was fitted using 
204 observations. Using the variables selection criteria (p-values and AIC), 4 explanatory 
variables were identified to be significantly associated with the total amount of FMDV 
secreted and excreted by infected animals: type of secretion and excretion, days post 
infection, stage of disease and FMDV serotype. Even though animal species had a p-value 
of 0.056, its inclusion improved the fit of the model (the AIC decreased), and its biological 
relevant. So, in total we identified 5 explanatory variables associated with the total amount 
of FMDV secreted and excreted by infected animals. No confounding factors were found. 
The explanatory variable route of infection dropped out during the stepwise regression 
procedure. In total 4 interactions terms were significantly associated with the total amount 
of FMDV secreted and excreted by infected animals: “type of secretion and excretion with 
animal species”, “type of secretion and excretion with stage of disease”, “type of secretion 
and excretion with FMDV serotype” and “FMDV serotype with stage of disease”. Note 
that in Table 4 several combinations of categories could not be included in the interaction 
analysis because certain combinations of categories were not present in the used scientific 
articles (e.g. no information on amounts of FMDV in milk from swine could be retrieved 
from the scientific articles). 
Airborne excretion, 0 dpi, cattle, clinical stage of disease and FMDV serotype A were 
chosen as reference categories. Compared to these reference categories, FMDV is found in 
higher quantities in probang samples (2.5 10log TCID50/ml higher, p-value <0.001) and in 
lower quantities in faeces samples (2.3 10log TCID50/ml lower, p-value 0.001). The quantity 
of secreted and excreted FMDV was high if the peak occurred soon after infection and 
decreased with time (0.07 10log TCID50 /ml decrease in time, p-value <0.001). The quantity 
of virus shed into the environment was also determined by animal species (e.g. cattle secrete 
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and excrete FMDV in overall higher amounts than other animal species). Larger quantities 
of FMDV were associated with the presence of clinical signs. They were also associated with 
the FMDV serotype that initiated the infection (Table 4). 
Based on the analysis of the interaction terms, the maximum amount of virus found 
in different secretions and excretions depends on the affected animal species, so a specific 
type of secretion or excretion from a particular animal species would have higher levels of 
FMDV than those from another animal species (e.g. airborne excretion from swine contain 
higher amounts of FMDV than airborne excretion from other species). For all secretions and 
excretions, except milk, the amount of FMDV was lower during the non-clinical stage than 
during the clinical stage. For milk it was about equal in the non-clinical and clinical stages. 
The interaction term between type of secretion and excretion and FMDV serotype 
indicates that infection with some FMDV serotypes is associated with presence of more 
FMDV in a specific secretion or excretion. The interaction term between FMDV serotype 
and stage of disease indicates that during infection with a particular FMDV serotype, 
variations in the total amounts of secreted and excreted FMDV are seen during the non-
clinical and clinical stages. The AIC of the final model without random effects was 584.6, 
the lowest AIC of the examined models (Table 3). 
The final model with random effects is shown in Table 5. This model was fitted using 
204 observations. Inclusion of the random effect “article” improved the fit of the model. In 
the model with random effects, 4 fixed effects (explanatory variables) were identified to be 
significantly associated with the total amount of FMDV released by the infected animals: 
type of secretion and excretion, animal species, stage of disease and days post infection. 
No confounding factors were found. The explanatory variables route of infection and 
FMDV serotype dropped out during the stepwise regression procedure. Because most of 
the possible interactions have to be estimated from comparisons between articles, we were 
only able to analyze the interaction terms in the model without random effects. 
Airborne excretion, cattle, clinical stage of disease and 0dpi were chosen as reference 
categories. Compared to these reference categories, FMDV is found in lower quantities in 
faeces samples (3.5 10log TCID50/ml lower, p-value <0.001) and in urine (3.3 10log TCID50/ml 
lower, p-value <0.001). The amounts of FMDV secreted and excreted into the environment 
are also determined by animal species (e.g. swine excrete higher amounts of FMDV by 
the airborne route than cattle, p-value = 0.002). It is also associated with the presence of 
clinical signs (i.e. in the non-clinical stage of the disease, animals secrete and excrete 0.72 
10log TCID50/ml less virus, p-value = 0.001). Further, the amounts of secreted and excreted 
FMDV are high when they occur early after infection and decrease when the peak occurs 
later in time. The AIC of the final model with random effects was 615.4 (Table 3). 
Normality and homoscedasticity were violated neither in the model without random 
effects nor in the model with random effects, according to the residual analysis. One outlier 
(i.e. 8.1 10log TCID50/ml from a probang sample from cattle; Burrows et al., 1981) was 
identified. The outlier was retained; excluding it from the analysis had no influence on the 
estimates or p-values. 
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Table 4.  Results of the final multivariate regression model. Reference categories: airborne, 0 dpi, cattle, clinical, A. 
Variable Category Estimate Std. Error t-value p-value
Intercept - 4.21 0.45 9.42 < 2e-16
Explanatory variables:
Type of secretion 
and excretion
blood 0.34 0.66 0.51 0.61
faeces -2.29 0.72 -3.19 0.001
milk -0.24 0.53 -0.45 0.65
URT 1.06 1.39 0.77 0.44
probang 2.50 0.73 3.43 <0.001
semen -0.97 1.03 -0.94 0.35
urine -1.90 1.03 -1.85 0.07
Days post infection - -0.07 0.02 -3.42 <0.001
Animal species small ruminants -1.08 0.39 -2.77 0.01
swine -1.58 0.34 -4.60 <0.001
Stage of disease non-clinical -1.74 1.46 -1.19 0.24
FMDV serotype Asia-1 0.70 1.31 0.53 0.59
C 1.11 0.65 1.71 0.09
O -0.02 0.47 -0.05 0.96
SAT 0.81 1.14 0.72 0.47
Interactions:
Type of secretion 
and excretion/
Animal species
airborne : small ruminants 1.08 1.11 0.97 0.33
airborne : swine 3.62 0.58 6.26 <0.001
blood : swine 2.30 0.57 4.03 <0.001
Type of secretion 
and excretion/Stage 
of disease
blood : non-clinical -0.97 1.37 -0.71 0.48
faeces : non-clinical -0.70 1.70 -0.41 0.68
milk : non-clinical 1.83 1.63 1.12 0.26
URT : non-clinical -2.51 1.42 -1.77 0.08
probang : non-clinical -0.64 1.35 -0.47 0.64
Type of secretion 
and excretion/
FMDV serotype
blood : Asia-1 -0.88 1.68 -0.52 0.60
semen : Asia-1 1.27 1.86 0.68 0.49
blood : C -2.45 1.24 -1.98 0.05
URT : C 0.58 1.61 0.36 0.72
semen : C -2.11 1.47 -1.44 0.15
blood : O 0.12 0.71 0.17 0.86
URT : O 1.00 1.42 0.71 0.48
probang : O -0.46 0.77 -0.60 0.55
semen : O 2.81 1.17 2.40 0.02
urine : O -0.55 1.11 -0.49 0.62
blood : SAT -0.91 1.40 -0.65 0.52
semen : SAT 0.35 1.61 0.22 0.83
FMDV serotype/
Stage of disease
C : non-clinical 1.57 1.60 0.98 0.330
O : non-clinical 2.18 0.65 3.35 0.001
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disCussion 
The aim of this study was to determine which variables influence the total amount of 
FMDV that is secreted and excreted by infected animals (expressed as the 10log AUC). This 
study was performed because we assume that the risk of indirect transmission of FMDV is 
related to the total amount of FMDV present in the environment through contamination by 
secretions and excretions from FMDV infected animals. 
The maximum titre of FMDV (max 10log TCID50/ml or, in the case of airborne excretion, 
max 10log TCID50/animal/day) showed a strong relation with the total amount of virus that 
is shed to the environment, expressed as the logarithm of the sum of consecutive daily 
observations on viral amounts (10log AUC). The maximum titres can therefore be used as a 
proxy for the total amount of virus in excretions and secretions. FMDV maximum titres are 
reported in literature differently accordingly to the type of secretion or excretion; FMDV 
titres from airborne excretions are reported in 10log TCID50 per animal per day whereas 
FMDV titres from other types of the secretions and excretions are reported per 1 ml of 
sample (10log TCID50 per ml). In our study, the maximum titres, regardless of denominator 
(i.e. 10 log TCID50 /ml and 10log TCID50 /animal/day) were treated similarly. However, during 
the interpretation of the results, the difference between denominators and the difference 
between the produced amounts of secretions and excretions have to be taken into account 
(note that infected cows can produce several litres of contaminated milk per day). 
The method used in this study allowed estimation of the effect of variables on our 
variable of interest: the maximum virus titre. One of the advantages of this method is its 
ability to bring together lots of information from numerous studies on animal experiments 
Table 5.  Results of the final multivariate regression model with “article” as random effect. Reference 
categories: airborne, cattle, clinical, 0 dpi.
Variable Category Estimate Std. Error t-value p-value
Intercept - 4.94 0.58 8.57 < 2e-16
Explanatory variables:
Type of secretion and excretion blood -0.76 0.63 -1.21 0.23
faeces -3.55 0.79 -4.47 <0.001
milk -1.11 0.71 -1.58 0.12
URT 0.15 0.66 0.23 0.82
probang 1.05 0.64 1.64 0.10
semen -0.91 0.73 -1.25 0.21
urine -3.34 0.69 -4.84 <0.001
Animal species small ruminants 0.25 0.60 0.42 0.67
swine 1.33 0.43 3.13 0.002
Stage of disease non-clinical -0.72 0.21 -3.33 0.001
Days post infection - -0.03 0.03 -1.26 0.21
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with FMDV without the need to perform new animal experiments. During the analysis of 
the model with random effects, we found that the random effect “article”, possibly more 
accurately named “specific experimental conditions”, influences the outcome of the model. 
We therefore report two models, a model without random effects and a model with “article” 
as a random effect. Both models identified the same explanatory variables except for FMDV 
serotype, but the latter could be explained due to the high correlation between FMDV 
serotype and the source of the data (i.e. FMDV serotype O was used in 27 articles and 
most of the analysed articles report the use of only one FMDV serotype). In addition, we 
were unable to analyze the interaction terms in the model with random effects. But because 
the two final models contain almost the same variables, we reported also the results of the 
analysis of the interaction terms of the model without random effects. Moreover, the model 
without random effects including interaction terms had the lowest AIC. Furthermore, we 
consider the interaction terms biologically relevant. 
The interaction between “type of secretion and excretion” and “animal species” shows 
that animal species influences the relation between the maximum titres of FMDV and the 
“type of secretion and excretion”, with types of secretion and excretion linked to particular 
species. For the airborne route, as previous research shows, more FMDV is excreted by 
swine (Donaldson et al., 1970, 1982; Sellers and Parker, 1969). For other routes, as has 
been mentioned, the major secretors and excreters of the virus are cattle [1]. The latter 
has been confirmed by our results; our dataset (Fig. 1) shows that URT secretions and 
excretions from cattle can contain very high amounts of FMDV (virus titres per ml), in 
some cases even higher than the amounts that are contained in airborne excretions from 
swine (virus titres per day). Considering that one of the clinical signs of FMD in cattle 
is profuse salivation, large amounts of saliva with FMDV can be found on the floor of 
an infected farm, making the contamination of different farm appliances (e.g. feedstuff, 
boots, veterinary appliances) feasible and therefore it could be an important vehicle for 
transmission of the virus between farms. In addition, even though milk production drops 
after infection with FMDV, an infected cow still produces 12–16 litres of milk per day [10] 
meaning that the total amount of secreted virus with milk is 4 10log higher than depicted 
in Fig. 1, much higher than the amount in air- borne excretion from swine (Fig. 1). So the 
concern about dispersal of FMDV between farms by the bulk tankers is realistic [1]. 
Beside the interaction between “type of secretion and excretion” and “animal species” 
our analysis showed that also the interaction between “type of secretion and excretion” and 
“stage of disease” was significant. In general, the amounts of FMDV are higher in clinically 
diseased animals but this is not the case in milk, where it is about the same, with high 
amounts of FMDV reported in milk samples when clinical signs were not apparent (see 
Burrows et al., 1968 referring to milk; Hyslop, 1965 referring to saliva [29]). While the risk 
of transmission has been considered [30] low in the early stage of infection before clinical 
signs are apparent, it has also been shown that the basic reproduction number (the average 
number of new infections cause by a typical infectious individual in a totally susceptible 
population) is above 1, meaning that major outbreaks can still occur in pre-clinical dairy 
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cows and pigs [31]. In the study by Charleston et al. [30] it was shown that the calves were 
not infectious until on average 0.5 days after clinical signs appeared, even though FMDV 
was detected in secretions and excretions before the appearance of clinical signs. But, in 
contrast to the study of Orsel, the contact time between calves in the Charleston study 
was limited to only 8h. This could explain why they did not observe transmission between 
calves before clinical signs appeared. Further, one should realize that FMD clinical signs 
are in some cases difficult to detect (see Donaldson and Sellers, 2000 on sheep [32], and 
Kitching and Hughes, 2002 on sheep and goats [33]). 
The last two interactions, i.e. between “type of secretion and excretion” and “FMDV 
serotype” and between “FMDV serotype” and “stage of disease” show that FMDV serotype 
influences both the relation between maximum titre and type of secretion and excretion and 
the relation between maximum titre and stage of disease. Similar FMDV serotype-dependent 
differences have been described for FMDV elsewhere [7]. Moreover, infection with FMDV 
serotype O may also lead to higher secretion and excretion of the virus during the non-clinical 
stage of disease. However, when adjusting for variability between experimental conditions 
(when using “article” as random effect), we found that FMDV serotype is highly correlated 
to the source of the data. Therefore, conclusions on FMDV serotype must be taken carefully. 
Summarizing, we show that the total amount of FMDV secreted and excreted by 
infected animals depends mainly on the maximum titres of FMDV. Secondly, we have 
identified variables related to the maximum amount of secreted and excreted FMDV. To 
relate our findings with the risk of transmission of FMDV, future research will need to 
quantify the FMDV-contaminated material transported between farms and determine the 
infection rates from this contaminated material. The outcome of this analysis shows which 
secretion(s) and/or excretion(s) are of major risk for contaminating the environment with 
FMDV. These results can be used to prioritize biosecurity measures in contingency plans. 
Annex: References of the articles included in the analysis 
1 Alexandersen S., Donaldson A.I., 2002. Further 
studies to quantify the dose of natural aerosols of 
foot-and-mouth disease virus for pigs. Epidemiol. 
Infect. 128, 313–323. 
2 Alexandersen S., Oleksiewicz M.B., Donaldson 
A.I., 2001. The early pathogenesis of foot-and-
mouth disease in pigs infected by contact: a 
quantitative time-course study using TaqMan 
RT-PCR. J. Gen. Virol. 82, 747–755. 
3 Alexandersen S., Zhang Z., Reid S.M., Hutchings 
G.H., Donaldson A.I., 2002. Quantities of 
infectious virus and viral RNA recovered from 
sheep and cattle experimentally infected with 
foot-and-mouth disease virus O UK 2001. J. Gen. 
Virol. 83, 1915–1923. 
4 Alexandersen S., Quan M., Murphy C., Knight J., 
Zhang Z., 2003. Studies of quantitative parameters 
of virus excre- tion and transmission in pigs and 
cattle experimentally infected with foot-and-mouth 
disease virus. J. Comp. Pathol. 129, 268–282. 
5 Augé de Mello P., Sutmoller P., 1977. 
Observaciones preliminares sobre la replicación 
del virus en la faringe y viremia después de 
inoculación intradermolingual en bovinos 
con virus de la fiebre aftosa. Bltn Centro 
Panamericano Fiebre Aftosa 27–28, 13–17. 
6 Blackwell J.H., McKercher P.D., Kosikowski 
F.V., Carmichael L.E., Gorewit R.C., 1982. 
Concentration of foot- and-mouth disease virus 
in milk of cows infected under simulated field 
conditions. J. Dairy Sci. 65, 1624–1631. 
7 Burrows R., 1968a. Excretion of foot-and-mouth 
disease virus prior to the development of lesions. 
Vet Rec, 387–388.
41
Id
e
n
tIfIc
a
tIo
n
 o
f fa
c
to
r
s a
sso
c
Ia
te
d
 w
Ith
 In
c
r
e
a
se
d
 e
x
c
r
e
tIo
n
 o
f fo
o
t-a
n
d
-m
o
u
th
 d
Ise
a
se
 v
Ir
u
s
II
8 Burrows R., 1968b. The persistence of foot-and-
mouth disease virus in sheep. J. Hyg. 66, 633–640. 
9 Burrows R., 1972. Early stages of virus infection: 
studies in vivo and in vitro. In: Symposia of the 
society for general microbiology 22, 303–332.
10 Burrows R., Mann J.A., Greig A., Chapman W.G., 
Goodridge D., 1971. The growth and persistence 
of foot-and-mouth disease virus in the bovine 
mammary gland. J. Hyg. 69, 307–321. 
11 Burrows R., Mann J.A., Garland A.J., Greig A., 
Goodridge D., 1981. The pathogenesis of natural 
and simulated natural foot-and-mouth disease 
infection in cattle. J Comp Pathol. 91, 599–609. 
12 Cottral, P.G., 1971. Experimental multiple infection 
of animals with foot-and-mouth disease viruses. In: 
Proc. Annu. Meet. US Anim. Health Assoc., 441–
465.
13 Cottral G.E., Bachrach H.L., 1968. Food-and-
mouth disease viremia. In: Proc. Annu. Meet. US 
Anim. Health Assoc. 72, 383–399. 
14 Cottral G.E., Gailiunas P., Cox B.F., 1968. Foot-
and- mouth disease virus in semen of bulls and its 
transmission by artificial insemination. Archiv. 
für die gesamte Virus- forschung 23, 362–377. 
15 Cunliffe H.R., Blackwell J.H., 1977. Survival of 
foot- and-mouth disease virus in casein and 
sodium caseinate produced from the milk of 
infected cows. J. Food Prot. 40, 389–392. 
16 de Leeuw P.W., van Bekkum J.G., Tiessink J.W., 
1978. Excretion of foot-and-mouth disease virus 
in oesophageal–pharyngeal fluid and milk of cattle 
after intranasal infection. J. Hyg. 81, 415–425. 
17 Donaldson A.I., Herniman K.A., Parker J., Sellers 
R.F., 1970. Further investigations on the airborne 
excretion of foot-and-mouth disease virus. J. 
Hyg. 68, 557–564. 
18 Donaldson A.I., Garland A.J., Ferris N.P., Collen T., 
1981. The 1975 Foot-and-Mouth disease epidemic 
in Malta. I: Experimental studies with the causal 
virus strain O1 Malta. Br. Vet. J. 137, 300–307. 
19 Donaldson A.I., Ferris N.P., Gloster J., 1982. Air 
sampling of pigs infected with foot-and-mouth 
disease virus: comparison of Litton and cyclone 
samplers. Res. Vet. Sci. 33, 384–385. 
20 Eblé P.L., Bouma A., de Bruin M.G., van Hemert- 
Kluitenberg F., van Oirschot J.T., Dekker A., 2004. 
Vaccination of pigs two weeks before infection 
significantly reduces transmission of foot-and-
mouth disease virus. Vaccine 22, 1372–1378. 
21 Eblé P.L., Bouma A., Weerdmeester K., Stegeman 
J.A., Dekker A., 2007. Serological and mucosal 
immune responses after vaccination and infection 
with FMDV in pigs. Vaccine 25, 1043–1054. 
22 Fontaine J., Bornarel P., Dubouclard C., Stellmann 
C., Lang R., 1969. Anti-aphthous vaccination of 
sheep. Bull. Off. Int. Epizoot. 71, 421–442.
23 Garland A.J., 1974. The inhibitory activity of 
secretions in cattle against FMDV (PhD thesis). 
London School of Tropical Hygiene. University of 
London and The Virus Animal Research Institute. 
Pirbright, Surrey, United Kingdom.
24 Gloster J., Williams P., Doel C., Esteves I., Coe 
H., Valarcher J.F., 2007. Foot-and-mouth disease 
quantification and size distribution of airborne 
particles emitted by healthy and infected pigs. 
Vet. J. 174, 42–53. 
25 Hyslop N., 1965. Secretion of foot-and-mouth 
disease virus and antibody in the saliva of 
infected and immunized cattle. J. Comp. Pathol. 
75, 111–117.
26 McVicar J.W., Sutmoller P., 1976. Growth of 
foot- and-mouth disease virus in the upper 
respiratory tract of non-immunized, vaccinated, 
and recovered cattle after intranasal inoculation. 
J. Hyg. 76, 467–481. 
27 Orsel K., de Jong M.C., Bouma A., Stegeman 
J.A., Dekker A., 2007a. Foot-and-mouth disease 
virus transmission among vaccinated pigs after 
exposure to virus shedding pigs. Vaccine 25, 
6381–6391. 
28 Orsel K., de Jong M.C., Bouma A., Stegeman 
J.A., Dekker A., 2007b. The effect of vaccination 
on foot-and-mouth disease virus transmission 
among dairy cows. Vaccine 25, 327–335. 
29 Orsel K., Dekker A., Bouma A., Stegeman J.A., 
de Jong M.C., 2007c. Quantification of foot-and-
mouth disease virus excretion and transmission 
within groups of lambs with and without 
vaccination. Vaccine 25, 2673–2679.
30 Scott F.W., Cottral. G.E., Gailiunas., P., 1966. 
Persistence of foot-and-mouth disease virus in 
external lesions and saliva of experimentally 
infected cattle. Am. J. Vet. Res. 27, 1531–1536. 
31 Sellers R., Burrows R., Mann J., Dawe P., 1968. 
Recovery of virus from bulls affected with foot-
and-mouth disease. Vet. Rec. 83, 303.
32 Sellers R.F., Parker J., 1969. Airborne excretion of 
foot- and-mouth disease virus. J. Hyg. 67, 671–677. 
42
Id
e
n
tIfIc
a
tIo
n
 o
f fa
c
to
r
s a
sso
c
Ia
te
d
 w
Ith
 In
c
r
e
a
se
d
 e
x
c
r
e
tIo
n
 o
f fo
o
t-a
n
d
-m
o
u
th
 d
Ise
a
se
 v
Ir
u
s
II
List of RefeRences 
1 Thomson GR: Foot-and-mouth disease. In: 
Coetzer, J.A.W., Thomson, G.R., Tustin, R.C. (Eds.) 
1994, Infectious Diseases of Livestock with Special 
Reference to Southern Africa. Oxford University 
Press Southern Africa, Capetown, pp. 825–851.
2 Sellers RF: Quantitative aspects of the spread 
of foot-and-mouth disease. Veterinary Bulletin 
1971, 41: 431–439. 
3 Hyslop N: The epizootiology and epidemiology 
of foot-and-mouth disease. Advances in 
Veterinary Sciences 1970, 14: 261–307. 
4 OIE: World Organization for Animal Health, 
2012. Foot-and-Mouth Disease, Available from: 
http://www.oie.int/eng/A FMD2012/ docs/en 
chapitre 1.8.5.pdf (accessed 13.06.13). 
5 Henderson RJ: The outbreak of foot-and-mouth 
disease in Worcestershire. An epidemiological 
study with special reference to spread of disease 
by wind carriage of the virus. Journal of Hygiene 
Cambridge 1969, 67: 21. 
6 Bouma A, Elbers AR, Dekker A, de Koeijer A, 
Bartels C, Vellema P, van der Wal P, van Rooij,EM, 
Pluimers FH, de Jong MC: The foot-and-mouth 
disease epidemic in The Netherlands in 2001. 
Preventive Veterinary Medicine 2003, 57: 155–166. 
7 Kitching RP: Global epidemiology and prospects 
for control of foot-and-mouth disease. Current 
Topics in Microbiology and Immunology 2005, 
288: 133–148.
8 Woolhouse M, Chase Topping M, Haydon D, 
Friar J, Matthews L, Hughes G, Shaw D. Wilesmith 
J, Donaldson A, Cornell S, Keeling M, Grenfell B: 
Epidemiology foot-and-mouth disease under 
control in the UK. Nature 2001, 411: 258–259. 
9 Pharo HJ.: Foot-and-mouth disease: an 
assessment of the risks facing New Zealand. New 
Zealand Veterinary Journal 2002, 50: 46–55. 
10 Orsel K, De Jong MCM, Bouma A, Stegeman JA, 
Dekker A: The effect of vaccination on foot-and-
mouth disease virus transmission among dairy 
cows. Vaccine 2007a, 25: 327–335. 
11 Orsel K, Dekker A, Bouma A, Stegeman JA, 
De Jong MCM: Vaccination against foot-and-
mouth disease reduces virus transmission in 
groups of calves. Vaccine 2005, 23: 4887–4894. 
12 Eblé PL, Orsel K, Dekker A: Quantification of 
transmission of FMDV strain Asia-1 Turkey 
among vaccinated and non-vaccinated lambs. 
In: Session of the Research Group of the European 
Commission for the Control of Foot-and-Mouth 
Disease 2008, Erice, Sicily, Italy. 
13 Orsel K, Dekker A, Bouma A, Stegeman JA, De 
Jong MCM: Quantification of foot-and-mouth 
disease virus excretion and transmission within 
groups of lambs with and without vaccination. 
Vaccine 2007b, 25: 2673–2679. 
14 Eblé PL, Bouma A, De Bruin MG, van Hemert-
Kluitenberg F, van Oirschot JT, Dekker A: 
Vaccination of pigs two weeks before infection 
significantly reduces transmission of foot-and-
mouth disease virus. Vaccine 2004, 22: 1372–1378. 
15 Eblé P, de Koeijer A, Bouma A, Stegeman A, Dekker 
A: Quantification of within- and between-pen 
transmission of Foot-and-Mouth disease virus in 
pigs. Veterinary Research 2006a, 37: 647–654. 
16 Eblé PL, De Bruin MG, Bouma A, Van Hemert-
Kluitenberg F, Dekker A: Comparison of 
immune responses after intratypic heterologous 
and homologous vaccination against foot-and-
mouth disease virus infection in pigs. Vaccine 
2006b, 24: 1274–1281.
17 Eblé PL, Bouma A, Weerdmeester K, Stegeman 
JA, Dekker A: Serological and mucosal immune 
responses after vaccination and infection with 
FMDV in pigs. Vaccine 2007, 25: 1043–1054.
18 Orsel K, De Jong MCM, Bouma A, Stegeman 
JA, Dekker A: Foot-and-mouth disease virus 
transmission among vaccinated pigs after 
exposure to virus shedding pigs. Vaccine 2007c, 
25: 6381–6391. 
19 Horzinek MC (Ed.), 1985. Het virus als deeltje: 
Methodiek van het virusonderzoek. Algemene 
Virology: een compendium. Wetenschappelijke 
Uitgeverij Bunge, Utrecht, The Netherlands. 
20 House JA, Yedloutschnig RJ: Sensitivity of seven 
different types of cell cultures to three serotypes of 
foot-and-mouth disease virus. Canadian Journal of 
Comparative Medicine 1982, 46: 186–189. 
21 Sellers RF, Parker J: Airborne excretion of foot-
and-mouth disease virus. Journal of Hygiene 
1969, 67: 671–677. 
22 Dohoo I, Martin W, Stryhn H (Eds.) 2009. 
Veterinary Epidemiologic Research. VER Inc., 
Canada. 
23 Ott RL, Longnecker M, 2010. An Introduction to 
Statistical Methods and Data Analysis, sixth ed. 
Brooks/Cole, Cengage Learning, Canada, pp. 1044. 
24 Faraway JJ, 2002. Practical Regression and ANOVA 
using R (online) http://cran.r-project.org/doc/
contrib/Faraway-PRA.pdf (consulted 2011). 
25 Hosmer D, Lemeshow S (Eds.) 1989. Applied 
Logistic Regression. Wiley, New York. 
43
Id
e
n
tIfIc
a
tIo
n
 o
f fa
c
to
r
s a
sso
c
Ia
te
d
 w
Ith
 In
c
r
e
a
se
d
 e
x
c
r
e
tIo
n
 o
f fo
o
t-a
n
d
-m
o
u
th
 d
Ise
a
se
 v
Ir
u
s
II
26 Noordhuizen JPTM, Frankena K, Thrusfield 
MV, Graat EAM (Eds.) 2001. Application 
of Quantitative Methods in Veterinary 
Epidemiology. Wageningen Pers Publ, 
Wageningen, The Netherlands.
27 Burnham KP, Anderson DR: Multimodel 
inference: understanding AIC and BIC in model 
selection. Sociological Methods and Research 
2004, 33: 261–304. 
28 R Development Core Team 2012. R: A Language 
and Environment for Statistical Computing. R 
Foundation for Statistical Computing, Vienna, 
Austria, ISBN 3-900051-07-0, URL: http://
www.R-project.org/ 
29 Hyslop N: Secretion of foot-and-mouth disease 
virus and antibody in the saliva of infected 
and immunized cattle. Journal of Comparative 
Pathology 1965, 75: 111–117. 
30 Charleston B, Bankowski BM, Gubbins S, Chase-
Topping ME, Schley D, Howey R, Barnett PV, 
Gibson D, Juleff ND, Woolhouse ME: Relationship 
between clinical signs and transmission of an 
infectious disease and the implications for 
control. Science 2011, 332: 726–729.
31 Orsel K, Bouma A, Dekker A, Stegeman JA, 
De Jong MC: Foot-and-mouth disease virus 
transmission during the incubation period of 
the disease in piglets, lambs, calves, and dairy 
cows. Preventive Veterinary Medicine 2009, 88: 
158–163. 
32 Donaldson AI, Sellers RF (Eds.) 2000. Foot-and-
Mouth Disease. Blackwell Science, Oxford. 
33 Kitching RP, Hughes GJ: Clinical variation in 
foot-and-mouth disease: sheep and goats. Revue 
scientifique et technique 2002, 21: 505–512. 
44

III
IIIQuantif ication of transmission  of foot-and-mouth disease virus  caused by an environment contaminated with secretions and excretions  from infected calves
Carla Bravo de Rueda, Aldo Dekker, Phaedra L. Eblé, Mart C.M. de Jong
Veterinary Research 2015 (in press)
 Q
u
a
n
tific
a
tio
n
 o
f tr
a
n
sm
issio
n
 o
f fm
D
V
 c
a
u
se
D
 b
y a
 c
o
n
ta
m
in
a
te
D
 e
n
V
ir
o
n
m
e
n
t 
III
aBstraCt 
Foot-and-mouth disease virus (FMDV) infected animals can contaminate the environment 
with their secretions and excretions. To quantify the contribution of a contaminated 
environment to the transmission of FMDV, this study used calves that were not vaccinated 
and calves that were vaccinated 1 week prior to inoculation with the virus in direct and 
indirect contact experiments. In direct contact experiments, contact calves were exposed 
to inoculated calves in the same room. In indirect contact experiments, contact calves were 
housed in rooms that previously had held inoculated calves for three days (either from 0 
to 3 or from 3 to 6 days post inoculation). Secretions and excretions from all calves were 
tested for the presence of FMDV by virus isolation; the results were used to quantify FMDV 
transmission. This was done using a generalized linear model based on a 2 route (2R, i.e. 
direct contact and environment) SIR model that included information on FMDV survival 
in the environment. The study shows that roughly 44% of transmission occurs via the 
environment, as indicated by the reproduction ratio Rˆ02Renvironment that equalled 2.0, whereas the 
sum of Rˆ02Rcontact and Rˆ02Renvironment equalled 4.6. Because vaccination 1 week prior to inoculation 
of the calves conferred protective immunity against FMDV infection, no transmission rate 
parameters could be estimated from the experiments with vaccinated calves. We conclude 
that a contaminated environment contributes considerably to the transmission of FMDV 
therefore that hygiene measures can play a crucial role in FMD control. 
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introduCtion 
Foot-and-mouth disease virus (FMDV) is the causative agent of foot-and-mouth disease (FMD), 
a highly contagious disease of livestock. Outbreaks of FMD cause vast sums of money to be 
spent, to reduce its incidence to low levels [1]. Control measures to restrict the spread of FMDV 
include movement restrictions, but even when movement restrictions are applied, these do not 
always prevent new outbreaks (for example in the 2001 FMD epidemic in United Kingdom 
[2]). Since these restrictions mean that livestock are not allowed to move between farms, direct 
contact cannot be the (major) cause of transmission, so other, indirect, routes must play a role. 
Because most of the secretions and excretions of FMDV infected animals contain virus 
[3], environmental contamination with secretions and excretions containing FMDV was 
considered to be one of the causes of FMDV spread [4]. This conclusion was supported 
by the fact that FMDV remains in the environment, for at least 24h, after infected animals 
are killed [5]. Moreover, as studies on survival of FMDV in secretions and excretions have 
shown, detectable amounts of FMDV persist in the environment (for example, in manure) 
for up to 14 weeks due to the thermal stability of the virus [6,7]. The suspicion that an 
environment contaminated with secretions and excretions from FMDV infected animals 
contributes to the transmission of FMDV has likewise persisted.  
SIR (susceptible-infected-recovered) models have been used to model the role of the 
environment in the transmission of different pathogens [8-12]. Although transmission of 
FMDV has been quantified in animal experiments [13,14] using a stochastic SIR model [15] 
and a transient-state algorithm [16], such studies have neither modeled nor quantified the 
contribution of the environment. In addition, FMDV transmission is known to be reduced 
through vaccination [17], and that vaccinating 2 weeks before inoculation with the virus 
reduces the reproduction ratio R0 to a value below 1 [18]. However, it is unknown whether 
this could be accomplished through earlier vaccination. Thus, the aim of the present 
study is twofold: to utilize a 2 route-SIR model i.e. with both direct contact and indirect 
(environment) routes, to quantify the contribution of a contaminated environment to the 
transmission of FMDV, and to examine whether vaccination one week before inoculation 
with the virus could reduce FMDV transmission through either direct contact or via the 
environment. As this article shows, a contaminated environment contributes considerably 
to the transmission of FMDV, and vaccination of cattle 1 week prior to inoculation with the 
virus does confer protective immunity against FMDV infection. 
materiaLs and methods 
experimental design 
We used 46 female calves, aged between 6 and 7 months, born and raised in The Netherlands 
on conventional dairy farms. Our experiments were performed in rooms approximately 10 
m2 inside the biosecurity facilities of the Central Veterinary Institute (CVI, Lelystad, The 
Netherlands). The settings for temperature and humidity in the stables were 20 – 24 °C and 
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40 – 70% relative humidity respectively. The experiments received ethical approval from the 
animal experiment committee of the CVI in accordance with Dutch law. The experiments 
with non- vaccinated calves and the experiments with vaccinated calves were performed 
sequentially. During the experiments, all calves were inspected daily for clinical signs of 
FMD. In these inspections, rectal temperature above 39.5 °C was considered fever [19] and 
the calves were checked for the presence of FMD lesions i.e. vesicles. During inspection 
and/or sampling, animal caretakers changed coveralls and gloves between animal rooms. 
The animal rooms in which the indirect transmission experiments were performed were 
not cleaned with water; instead, animal waste was swept daily with a broom to the drainage. 
Challenge virus and vaccine 
Virus inoculation was performed intranasally using FMDV Asia-1 TUR/11/2000. The 
inoculum contained 106.1 plaque forming units (pfu)/mL (titrated on primary lamb kidney 
cells). Each inoculated calf received 1.5 mL of inoculum per nostril. The vaccine used was a 
freshly prepared inactivated FMDV Asia-1 Shamir vaccine, prepared in a double water-in-
oil emulsion. The potency of a similarly prepared vaccine was previously determined at > 6 
PD50 (at 28 days post vaccination). 
direct contact experiments
In both vaccinated and unvaccinated scenarios, 10 calves were randomly assigned to 5 animal 
rooms in pairs i.e. 2 calves per room. On the day of inoculation i.e. 0 days post inoculation 
(dpi), 1 calf from each pair was moved to a separate animal room and inoculated with FMDV. 
Eight hours after inoculation, these calves were reunited with their original roommates. In the 
experiment in which vaccinated calves were used, all 10 calves were vaccinated intramuscularly 
with 2 mL of vaccine one week before inoculation (−7 dpi). The direct contact experiments 
ended at 14 dpi, assuming this duration could allow transmission to occur. 
indirect contact experiments 
This experimental design is shown in Figure 1. In both vaccinated and unvaccinated 
scenarios, 4 calves were inoculated with FMDV at 0 dpi (2 pairs of inoculated calves, IA 
and IB). Eight hours after inoculation, they were moved into 2 animal rooms to which they 
had been randomly assigned, 2 calves per room. At 3 dpi, the inoculated calves were moved 
to 2 new animal rooms. Subsequently, 1 pair of non-vaccinated contact calves (contacts 1, 
C1A and C1B) was moved into each of the animal rooms that had been contaminated by the 
inoculated calves. The inoculated calves stayed in their new rooms from 3 to 6 dpi; at 6 dpi, 
they were removed from the animal rooms and euthanized. On the same day, each of these 
now contaminated rooms was allocated to a pair of non-vaccinated contact calves (contacts 
2, C2A and C2B). In the experiment in which vaccinated calves were used, at −7 dpi the 
4 inoculated calves were vaccinated intramuscularly with 2 mL of vaccine. The 8 contact 
calves were not vaccinated. The indirect contact experiments ended at 20 dpi. 
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Figure 1 Indirect contact experiment design. IA and IB, calves inoculated at 0 days post infection (dpi); 
C1A and C1B, contact exposed calves to contaminated environment from 0 to 3 dpi; C2A and C2B, contact 
exposed calves to contaminated environment from 3 to 6 dpi. Grey arrows indicate movement of animals to 
an (− other) animal room. Black arrows indicate movement of animals for euthanasia. 
vaccine controls 
During the experiment with vaccinated calves, 2 additional calves were vaccinated and used 
as vaccine control group to evaluate the serological response of the calves in the absence of 
infection; these controls were housed together in a separate animal room. 
sampling 
Oropharyngeal fluid (OPF) swabs, heparinised blood, urine and faeces samples were 
collected daily from each calf from 0 dpi until the end of the experiment. OPF was collected 
by inserting a cotton gauze with a 25 cm long forceps into the mouth of the calves and by 
rubbing the surface of the oropharyngeal cavity. In the laboratory, the pieces of cotton gauze 
were immersed in 4 mL of Eagle’s minimum essential medium (EMEM) containing 2% fetal 
calf serum (FCS) and 10% antibiotics solution (ABII: 1000 U/mL of penicillin, 1 mg/mL of 
streptomycin, 20 μg/mL of amphotericin B, 500 μg/mL of polymixin B, and 10 mg/mL of 
kanamycin). After 20 min of incubation at environmental temperature, the samples were 
centrifuged (2500 rpm for 15 min). Samples were stored at −70 °C until virus isolation and 
real-time reverse transcriptase polymerase chain reaction (RT-PCR) analysis. 
Heparinised blood samples (10 mL per calf) for virus isolation were taken daily, while 
clotted blood samples (10 mL per calf) for serology were taken twice per week. Blood 
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samples were centrifuged at 2500 rpm for 15 min. Plasma was stored at −70 °C until virus 
isolation analysis and serum was stored at −20 °C until serological analysis. Urine samples 
were collected, as calves were stimulated to urinate spontaneously by rubbing the skin next 
to the vulva. Urine samples were collected into sterile plastic containers. In the laboratory, 
800 μL of urine was mixed with 200 μL of a 50% FCS, 50% ABII solution and stored at −70 
°C until virus isolation analysis. Faeces samples were collected from the rectum. In the 
laboratory, the faeces were suspended 1:10 (w/v) in EMEM containing 10% FCS and 10% 
ABII solution, and vortexed with glass beads. After 20 min of incubation at environmental 
temperature, the suspension was vortexed and centrifuged (3000 rpm for 15 min). The 
supernatants were stored at −70 °C until virus isolation analysis. 
virus detection 
All OPF, heparinised blood, urine and faeces suspension samples were tested for presence 
of FMDV by plaque count on monolayers of secondary lamb kidney cells (virus isolation, 
VI). Samples were tested in 2 wells of a six-well plate using 200 μL per well, as previously 
described [20]. All OPF samples were also tested for presence of FMDV by RT-PCR. RNA 
isolation was performed using the Magna Pure LC total Nucleid Acid Isolation kit®  (Roche) 
and the MagNa Pure 96 system® (Roche). Isolated RNA was tested in a LightCycler 480 
Real-Time PCR System® (Roche) using a QuantiFast Probe RT-PCR kit®  (Qiagen), all in 
accordance with the manufacturers’ instructions. The primers, probes and test protocol 
used have been previously described [21]. 
statistical analysis of virus secretions and excretions 
Using data from both the direct and the indirect contact experiments, we calculated, for 
individual animals, the area under the curve (AUC) of the virus titres. The AUC represents 
the total amount of FMDV that was secreted and excreted by the infected calves during the 
experiment. The AUCs were calculated for each calf using the non-logarithm transformed 
virus titres observed in its OPF swabs, urine and faeces samples. In the statistical analysis, 
the logarithm of the AUC was used (log AUC). The maximum FMDV log titres found in 
OPF swabs, urine and faeces samples from each calf were also calculated. The duration 
(in days) of FMDV secretion and excretion in OPF swabs, urine and faeces samples was 
calculated for each calf, counting from the first day until the last day the calf tested positive 
in the virus isolation assay (in either OPF swabs, urine or faeces samples). A Kruskal 
Wallis test was used to test whether differences existed between the experimental groups 
(i.e. inoculated calves, direct contacts, indirect contacts C1 and indirect contacts C2) for 
either the log AUC, the maximum FMDV log titres or the duration of FMDV secretion and 
excretion. The log AUC and the maximum FMDV log titres were tested for each type of 
sample (OPF swabs, urine and faeces). The duration of FMDV secretion and excretion was 
tested using data from OPF swabs, urine and faeces samples combined. 
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antibody detection 
A commercially available ELISA (PrioCHECK® FMDV NS, Prionics) was used to detect 
antibodies against non- structural proteins of FMDV. The test was performed in accordance 
to the manufacturer’s instructions. This test detects antibodies against the non-structural 
protein 3B of FMDV and differentiates infected from non-infected animals in both non-
vaccinated and vaccinated animals. Samples were considered to be positive when the 
percentage of inhibition was ≥ 50%. 
The virus neutralization test (VNT) was performed as previously described [22] but 
using BHK-21 cells instead of porcine kidney cells. Titres were determined against both 
the vaccine strain (Asia-1 Shamir) and the challenge strain (Asia-1 TUR/11/2000). Samples 
were considered to be positive when the titres were above 1.2 10log (cut-off of validated 
diagnostic test) using the Asia-1 Shamir strain and 0.6 10log (cut-off based on the score of 
control samples) using the Asia-1 TUR/11/2000 strain. 
Quantification of the Fmdv survival rate 
The FMDV survival rate (σ day), needed for the calculation of the contribution of 
the environment (Et) to the transmission of FMDV, was calculated using published 
data on FMDV thermal inactivation combined with own laboratory data. Because the 
temperature in the animal rooms was approximately 20 °C during the experiments, the 
survival rate σ was estimated at 20 °C. The lowest, middle and highest estimates of the 
time needed for a 10-fold reduction in FMDV titres at 20 °C was used to calculate the 
FMDV survival rate σ. An additional file shows the calculation of the FMDV survival 
rate σ in more detail (Additional file 1). 
Quantification of Fmdv transmission 
Transmission rate parameters: β, βcontact and βenvironment 
The transmission rate parameter β is defined as the average number of new infections 
caused by one typical infectious individual per day in a totally “susceptible” (not infected) 
population [16, 23] (Additional file 2: equations 1 and 2). For the analysis, as described 
previously [23], it was assumed that the calves were infectious (I) when one of their samples 
(OPF swabs, urine or faeces) tested positive in the virus isolation assay at the start of the 
time interval. Contact animals were considered cases (C) when one of their samples (OPF 
swabs, urine or faeces) tested positive, for the first time, in the virus isolation assay at the 
end of the time interval. The number of new cases (C) during that time interval is binomially 
distributed with probability p (which is a function of the transmission rate parameter β, the 
number of infected animals (It) and the total number of animals (N)) and with binomial 
total St, the number of susceptible animals. Thus, the probability of a single susceptible 
animal becoming infected during a period Δt is, 
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where eco is the transmission rate parameter β. To quantify β, the data from the direct contact 
experiment were analysed using a generalized linear model (GLM) [24]. The GLM is based on 
the binomial distribution and the above-mentioned expression for p, using a complementary 
log-log link function, S as binomial total, a binomial error function and with  as 
offset [16, 23]. This model will be hereinafter referred to as the 1 route-SIR (1R-SIR) model. To 
quantify the contribution of the environment to the transmission of FMDV, as an extra route to 
the 1R-SIR model (Figure 2), we included the environment (E). In the new 2 route-SIR model 
(2R-SIR) we additionally assumed that the amount of FMDV present in the environment on 
a specific day (Et) depends on the secretion and excretion of FMDV by infectious individuals 
(either I or C) on the previous days, as well as on the remaining FMDV in the environment 
(E(t-1)), both weighted (discounted) by the FMDV survival rate (σ). Et is represented by the 
following equation: Et = σI(t − 1) + σC(t − 1)→ t + σE(t − 1) with starting condition E0=0 (Additional 
file 2: equation 3). We performed a sensitivity analysis in which we multiplied the new cases 
(C) in the equation above either by 0 or by 0.5, instead of 1 as it is in the above equation for Et, 
to check whether this affected the outcome. Additionally, we performed a sensitivity analysis 
in which we considered a latent period (counting the inoculated calves as infected but not 
yet infectious, (1, 2 and 3 days before virus shedding was detected), to check whether the use 
of an SEIR (susceptible-exposed-infected-recovered) instead of an SIR model would lead to 
different results for the estimated β and R values (i.e. if β is underestimated) and whether this 
affected the estimation of the environmental component. 
In the 2R-SIR model, there are 2 ways by which the susceptible calves (St) can become 
infected: (1) because they have been in direct contact with an infectious calf (It) i.e. being 
in the same room at the same day as an infectious calf and/or (2) because they have been 
in contact with a contaminated environment (Et) i.e. being in an animal room that housed 
previously one or more infectious individuals (Figure 2). By using the 2R-SIR model, we 
quantified the transmission rate parameters βcontact and βenvironment. As in the definition of β 
the transmission rate parameter βcontact is defined as the average number of new infections 
per day caused by direct contact to one typical infectious individual in a fully susceptible 
population. The transmission rate parameter βenvironment is defined as the average number of 
new infections per day caused by virus in the environment, where the unit of infectivity is 
equal to the amount of virus secreted and excreted during one day by an infectious animal. 
An additional file shows the 2R-SIR model in more detail (Additional file 2: equations 4 
to 6). In the 2R-SIR model, the number of new cases (Ct→ (t + 1)), whether caused by It and/
or Et, is binomially distributed with parameter p as before (see also below) but now β = 
eco+c1×fe where fe =  is the fraction of transmission by the environment and therefore 
its regression coefficient measures the extra infectivity contributed by the environment. 
When only direct contact can occur, fe is 0 and thus βcontact = eco. When only environmental 
exposure can occur fe is 1 and βenvironment = eco+c1 (Additional file 2). The latter expression 
contains c0+c1 and thus c1 is the extra transmission for each unit of infectivity through the 
environment as compared to one unit through direct contact. Thus the probability of a 
susceptible animal becoming infected during a period Δt is 
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Figure 2 The 2R- SIR model. The combined transmission rate parameter (βcontact+environment) depends on 
the number of infectious calves (It) and/or on the amount of virus in the environment (Et). Et depends on 
FMDV secretion and excretion by the infected calves on previous days (t-1) and on the remaining amount of 
FMDV in the environment weighted by σ. 
(Additional file 2: equation 6). To quantify βcontact and βenvironment we analysed the combined data 
from both the direct contact experiment and the indirect contact experiment using a GLM. 
The GLM was based on the binomial distribution and the above mentioned expression for p 
using a complementary log-log link function, S as binomial total, a binomial error function, 
fe as the explanatory variable [23] and with  as offset (Additional file 2: equations 
7 and 8). To test whether βcontact and βenvironment were significantly different from each other, we 
used the Wald test on the regression coefficient of fe. Both analyses (of the 1R-SIR and of the 
2R-SIR models) were performed using the statistical program R [25] and the package stats. 
Infectious periods: T and τ 
The infectious period T was defined as the average infectious period of the inoculated 
calves that caused transmission from the direct contact experiment. The infectious period 
of each inoculated calf was defined as the time between the first and the last day on which 
FMDV was detected (by virus isolation) in OPF swabs, urine, or faeces samples. The 95% 
confidence intervals (CI) of Tˆ were calculated using the logarithm of T (log T) and the 
variance of log T i.e. . The infectious period τ represents the infectious 
period of the contaminated environment. The calculation of τ was based on the amount of 
infectious material present in the environment (Et, used in the 2R-SIR model). 
Considering the loss of infectiousness due to inactivation at environmental temperature, 
τ was calculated by taking the sum of geometric series:  where σ is the 
survival rate of FMDV and Tˆ is the estimated average infectious period of the inoculated 
calves in the direct contact experiment. The method allowed us to obtain an average period 
over which one infectious animal contributes to the contamination of the environment, 
weighted for the amount of infectious material relative to the amount secreted and excreted 
by an infectious animal on one day. The 95% CI of τˆ was calculated using the 95% CI of Tˆ. 
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reproduction ratio r0 
Using the 1R-SIR model: R0 
1R 
The reproduction ratio R01R is defined as the average number of new infections caused by 
one typical infectious individual in a population made up entirely of susceptible individuals 
[26]. R01R was estimated by multiplying the transmission rate parameter βˆ by the infectious 
period Tˆ. The 95% CI of Rˆ01R was calculated using the variance and the regression constant 
of the GLM result (log β) and the variance and the logarithm of the average infectious 
period T, i.e. . 
Using the 2R-SIR model: R0 
2R
contact, R0
2R
environment and R0
2R
The reproduction ratio R02R  is defined as the average number of new infections caused by 
both direct contact to one typical infectious individual in a population made up entirely of 
susceptible individuals and the virus left in the environment by that one typical infectious 
individual on the previous days. Both R02Rcontact and R02Renvironment were estimated using the 
results from the 2R-SIR model, i.e. estimated transmission rate parameter βˆ contact and 
βˆ environment. The R02Rcontact was estimated by multiplying βˆ contact by the infectious period Tˆ. The 
R02Renvironment was estimated by multiplying βˆ environment by the infectious period τˆ. Subsequently 
R02R was estimated by summing Rˆ02Rcontact and Rˆ02Renvironment. The Rˆ02R contact is the contribution 
to Rˆ02R by direct contact to virus from an infectious individual (on the day virus secretion 
and excretion is detected by virus isolation). The Rˆ02Renvironment is the contribution to Rˆ02R by 
the virus left in the environment by infectious individuals on previous days. The 95% CI of 
Rˆ02R contact, Rˆ02Renvironment and of Rˆ02R were calculated. For this purpose, we used the variances and 
the regression constants (see above c0 and c1 in equation for p) of the GLM results (log β contact 
or log β environment) and the variances and the logarithm of the average infectious periods 
(log T or log τ). Thus, the 95% CI of the Rˆ02Rcontact is  
and, the 95% CI of the Rˆ02Renvironment is  
where a is . As Rˆ02R is the sum of Rˆ02Rcontact and Rˆ02Renvironment,  its variance is 
 and although this is not a linear 
function we calculated the 95% CI of the Rˆ02R using: 
Using the final size model: R0
FS 
The transmission parameter R0 can also be estimated based only on the final outcome (the final 
size of the experiment, FS) [27]. We estimated the R0FS based on the total number of infected 
calves at the end of the direct contact experiment under the assumption that the epidemic 
process ended before the experiment stopped [28]. The animals were considered infected when 
one or more of their samples tested positive in the virus isolation assay. Because in the direct 
contact experiment we got all contacts infected in the 4 pairs in which the inoculated calf was 
considered to be infectious, we used continuity correction, i.e. 3.5 infections in 4 experiments, 
to avoid an infinite estimate for R0FS. The 95% confidence intervals (CI) of Rˆ0FS were estimated 
under the FS assumption by using the binomial distribution for the infected fraction [27,29]. 
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resuLts 
experiments with non-vaccinated calves 
Table 1 summarizes the results from the direct and indirect contact experiments with the non-
vaccinated calves. FMDV transmission to the contact calves occurred in both experiments. 
direct contact experiment 
Inoculated calves
FMD clinical signs were observed in 4 of the 5 inoculated calves. Three of these calves 
(calves 3643, 3645 and 3649) showed fever and had FMD lesions on the tongue. One of 
these 3 calves (calf 3643) also had hoof lesions, and another (calf 3651) showed FMD 
lesions on the nose. Three of the clinically infected calves (calves 3643, 3645 and 3649) 
shed FMDV in OPF, blood and urine (Table 1). One of these 3 calves (calf 3645) also shed 
FMDV in faeces. The fourth clinically infected calf (calf 3651) shed FMDV in OPF only. All 
the inoculated calves were positive in OPF by RT-PCR. Antibodies against non-structural 
proteins and neutralizing antibodies against FMDV were detected in serum samples from 
all the inoculated calves. Inoculated calf 3647 became subclinically infected, but shed 
FMDV in urine, was positive for FMDV in OPF by RT-PCR and developed antibodies 
against non-structural proteins and neutralizing antibodies against FMDV. 
Contact calves 
Clinical signs were observed in the 3 contact calves (calves 3644, 3646 and 3650) that were 
housed together with inoculated calves 3643, 3645 and 3649. The 3 contact calves showed 
fever and had FMD lesions on the tongue (calf 3646) and hooves (calves 3644 and 3650); 
they shed FMDV in OPF, blood and urine (Table 1). One of these 3 calves (calf 3650) also 
shed FMDV in faeces. Another contact calf (calf 3652) became subclinically infected; it shed 
FMDV in its OPF. Calves 3644, 3646 and3650 were positive for FMDV in OPF by RT-PCR. 
All 4 contact calves in which the virus was detected showed antibodies against non-structural 
proteins and neutralizing antibodies against FMDV. Calf 3648, in contact with inoculated 
calf 3647, showed no FMD clinical signs and tested negative for FMDV and for antibodies 
against FMDV. Thus transmission occurred in 4 of the 5 animal rooms in the direct contact 
experiment. The only moment infectious virus was recovered from inoculated calf 3647 (from 
urine) was at 14 dpi, at the day of the end of the experiment. Thus, occurrence of transmission 
was not possible anymore and this pair of calves (calves 3647 and 3648) was excluded from 
the estimation of the transmission rate parameters and the reproduction ratio. 
indirect contact experiment 
Inoculated calves 
Clinical signs were observed in 2 out of 4 inoculated calves (number 3653 and 3654; both in 
pair IA). These 2 inoculated calves showed fever and 1 of them had lesions on the tongue. 
The other 2 calves (calves 3655 and 3656; pair IB) showed no FMD specific clinical signs. 
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Table 1 Results of virus isolation, RT-PCR (OPF swabs only), antibody detection and detection of FMD 
clinical signs
Ex
pe
ri
m
en
t
C
al
f I
D
I: 
In
oc
ul
at
ed
 
C:
 C
on
ta
ct
 
G
ro
up
FMDV detection by virus isolation in OPF swabs (in log10 titres), blood, urine 
and faeces samples and by RT-PCR (OPF swabs only, shaded in grey) days post 
infection of the inoculated calves
FMDV detection by virus isolation in OPF swabs (in log10 titres), blood, 
urine and faeces samples and by RT-PCR (OPF swabs only, shaded in grey) 
days post infection of the inoculated calves
Antibody 
detection 
C
lin
ic
al
 si
gn
s
In
fe
ct
io
us
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
NS- 
ELISA VNT
D
ire
ct
 C
on
ta
ct
3643 I ≡e 2.2f  ≡,vg 2.6,v,uh 3.8,v,u 2.0,u - - - - - - - - + + Yes Yes
3644 C - - - - 1.5 -,v,u 2.1,v 1.4,v ≡ 1.7,u - - 1.2 ≡ + + Yes Yes
3645 I - - ≡,v 2.5,v,fi 2.6,v 0.9,u 1.2,u 0.7 0.7 - - - - - + + Yes Yes
3646 C - - - - - ≡ 3.8 4.3,v 3.0,v,u 3.0,u -,u 0.4 - - + + Yes Yes
3647 I - ≡ - - - - - - - - - - - -,u + + No No
3648 C - - - - - - - - - - - - - - - - No No
3649 I - - 0.7,v 2.3,v,u 3.4,v 0.9,u -,u -,u - - - - - - + + Yes Yes
3650 C - - - - - 2.3,v,u 1.6,v,u,f 0.4,u,f ≡,u 0.9 0.4 -,u - - + + Yes Yes
3651 I - - 1.4 ≡ 4.2 1.7 0.4 - - - - - - - + + Yes Yes
3652 C   - - - - - - - 0.4 - - - - - -             + + No Yes
In
di
re
ct
 C
on
ta
ct
3653 I A - - n.tj 1.7,v,u 3.4,v 2.1,u - - Yes Yes
3654 I A - ≡ 6.0,v 4.6,v 3.7,v,f 1.7 - - Yes Yes
3657 C1 A - - - - - - - - - - - - - - - - - - - - No No
3658 C1 A - - - - - - - - - - - - - - - - - - - - No No
3661 C2 A - - - - - 3.7,v ≡,v,u ≡,v,u 2.4 ≡,u ≡ ≡ - - - + + Yes Yes
3662 C2 A - - - - 2.0 ≡ ≡ ≡,v 1.3,v 3.8,v,u 3.5,v,u 3.6,u ≡ - ≡ + + Yes Yes
3655 I B - - 2.1 5.2,v 4.9,v,u 2.6,u - - No Yes
3656 I B - 0.4 ≡,v 3.2,v,u 5.0,v,u,f 3.5,u - - No Yes
3659 C1 B - - 1.9 2.0 3.6,v,f 4.9,v,u 4.1,v,u 3.4,u - 1.2 - - - - - - - - + + Yes Yes
3660 C1 B - - - - 0.9 1.3,u 0.7 1.0 - - - - - - - - - - - - Yes Yes
3663 C2 B - - - - - - - 2.4 0.7 1.6 3.3,u 2.3,u ≡ - - + + Yes Yes
3664 C2 B           - 0.4 1.0 1.9 3.0,v 5.2,v ≡,v 2.6 0.4 ≡ - - - - - + + Yes Yes
aExp=experiment: DC=direct contact, IC=indirect contact ; bI=inoculated, C=contact animal ; 
cClin=clinical signs ; dInf=infectious ; eresults of virus isolation (VI) and RT-PCR of oral swab sample: - = 
VI and RT-PCR negative, ≡ = VI negative and RT-PCR positive; 
foral swab sample scored positive for FMDV by VI (log10 pfu/mL), RT-PCR positive samples are indicated 
in bold ; gv=viraemia: blood sample scored positive for FMDV by VI ; hu=urine sample scored positive for 
FMDV by VI ; if=faeces sample scored positive for FMDV by VI ; jn.t.=not tested
In all 4 inoculated calves, virus was detected in the OPF (IA and IB). All four secreted 
and excreted FMDV in their blood, urine and/or faeces (Table 1). They all were positive 
for FMDV in OPF by RT-PCR. Thus, inoculated calves 3655 and 3656 were subclinically 
infected. Serum samples from all 4 inoculated calves were obtained only at 0 dpi and 3 
dpi; in these samples neither antibodies against non-structural proteins nor neutralizing 
antibodies against FMDV were detected as expected. 
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Table 1 Results of virus isolation, RT-PCR (OPF swabs only), antibody detection and detection of FMD 
clinical signs
Ex
pe
ri
m
en
t
C
al
f I
D
I: 
In
oc
ul
at
ed
 
C:
 C
on
ta
ct
 
G
ro
up
FMDV detection by virus isolation in OPF swabs (in log10 titres), blood, urine 
and faeces samples and by RT-PCR (OPF swabs only, shaded in grey) days post 
infection of the inoculated calves
FMDV detection by virus isolation in OPF swabs (in log10 titres), blood, 
urine and faeces samples and by RT-PCR (OPF swabs only, shaded in grey) 
days post infection of the inoculated calves
Antibody 
detection 
C
lin
ic
al
 si
gn
s
In
fe
ct
io
us
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
NS- 
ELISA VNT
D
ire
ct
 C
on
ta
ct
3643 I ≡e 2.2f  ≡,vg 2.6,v,uh 3.8,v,u 2.0,u - - - - - - - - + + Yes Yes
3644 C - - - - 1.5 -,v,u 2.1,v 1.4,v ≡ 1.7,u - - 1.2 ≡ + + Yes Yes
3645 I - - ≡,v 2.5,v,fi 2.6,v 0.9,u 1.2,u 0.7 0.7 - - - - - + + Yes Yes
3646 C - - - - - ≡ 3.8 4.3,v 3.0,v,u 3.0,u -,u 0.4 - - + + Yes Yes
3647 I - ≡ - - - - - - - - - - - -,u + + No No
3648 C - - - - - - - - - - - - - - - - No No
3649 I - - 0.7,v 2.3,v,u 3.4,v 0.9,u -,u -,u - - - - - - + + Yes Yes
3650 C - - - - - 2.3,v,u 1.6,v,u,f 0.4,u,f ≡,u 0.9 0.4 -,u - - + + Yes Yes
3651 I - - 1.4 ≡ 4.2 1.7 0.4 - - - - - - - + + Yes Yes
3652 C   - - - - - - - 0.4 - - - - - -             + + No Yes
In
di
re
ct
 C
on
ta
ct
3653 I A - - n.tj 1.7,v,u 3.4,v 2.1,u - - Yes Yes
3654 I A - ≡ 6.0,v 4.6,v 3.7,v,f 1.7 - - Yes Yes
3657 C1 A - - - - - - - - - - - - - - - - - - - - No No
3658 C1 A - - - - - - - - - - - - - - - - - - - - No No
3661 C2 A - - - - - 3.7,v ≡,v,u ≡,v,u 2.4 ≡,u ≡ ≡ - - - + + Yes Yes
3662 C2 A - - - - 2.0 ≡ ≡ ≡,v 1.3,v 3.8,v,u 3.5,v,u 3.6,u ≡ - ≡ + + Yes Yes
3655 I B - - 2.1 5.2,v 4.9,v,u 2.6,u - - No Yes
3656 I B - 0.4 ≡,v 3.2,v,u 5.0,v,u,f 3.5,u - - No Yes
3659 C1 B - - 1.9 2.0 3.6,v,f 4.9,v,u 4.1,v,u 3.4,u - 1.2 - - - - - - - - + + Yes Yes
3660 C1 B - - - - 0.9 1.3,u 0.7 1.0 - - - - - - - - - - - - Yes Yes
3663 C2 B - - - - - - - 2.4 0.7 1.6 3.3,u 2.3,u ≡ - - + + Yes Yes
3664 C2 B           - 0.4 1.0 1.9 3.0,v 5.2,v ≡,v 2.6 0.4 ≡ - - - - - + + Yes Yes
aExp=experiment: DC=direct contact, IC=indirect contact ; bI=inoculated, C=contact animal ; 
cClin=clinical signs ; dInf=infectious ; eresults of virus isolation (VI) and RT-PCR of oral swab sample: - = 
VI and RT-PCR negative, ≡ = VI negative and RT-PCR positive; 
foral swab sample scored positive for FMDV by VI (log10 pfu/mL), RT-PCR positive samples are indicated 
in bold ; gv=viraemia: blood sample scored positive for FMDV by VI ; hu=urine sample scored positive for 
FMDV by VI ; if=faeces sample scored positive for FMDV by VI ; jn.t.=not tested
Contact calves C1 
Contact calves C1 were exposed to the animal rooms that were contaminated by the inoculated 
calves from 0 to 3 dpi. The contact calves of group C1A (calves 3657 and 3658) did not get 
infected; no FMD specific clinical signs were seen and both calves tested negative by virus 
isolation, by RT-PCR and, for antibodies against FMDV. The contact calves of group C1B 
(calves 3659 and 3660) showed fever and one had FMD lesions on the mouth, tongue, nose and 
hooves. Both C1B calves had virus detected in their OPF; one of them secreted and excreted 
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virus in blood, urine and faeces, the other one excreted virus in urine. They tested positive for 
FMDV in OPF by RT-PCR. One C1B calf showed antibodies against non-structural proteins 
in serum (calf 3660). Both C1B calves showed neutralizing antibodies in serum. 
Contact calves C2 
Contact calves C2 were exposed to the animal rooms that were contaminated by the 
inoculated calves from 3 to 6 dpi. All the contact calves of groups C2A and C2B showed 
clinical signs. Three of them showed fever, and all of them showed FMD lesions on the 
nose and in the mouth. In all 4 calves, virus was detected in their OPF (Table 1); the calves 
secreted and/or excreted FMDV in  the blood (calves 3661, 3662 and 3664) and in urine 
(calves 3661, 3662 and 3663). They all were positive for FMDV in OPF by RT-PCR. All 
developed antibodies against non-structural proteins as well as neutralising antibodies. 
Thus transmission occurred in the indirect  contact experiment in 1 of the 2 animal 
rooms that were contaminated from 0 to 3 dpi and, in both of the animal  rooms that were 
contaminated from 3 to 6 dpi. 
statistical analysis of virus secretion and excretion
The mean values for the AUC’s, peak of virus shedding and duration of virus shedding 
(and their ranges) for OPF swabs, urine samples, faeces samples and blood  samples for the 
inoculated group, the direct contact  group and the indirect contact groups C1 and C2 are 
shown in Additional file 3. 
No significant difference in log AUC could be determined between the different 
experimental groups i.e. inoculated, direct contacts, indirect contacts C1 and indirect 
contacts C2, neither for OPF swabs nor for urine nor for faeces (p > 0.05). No significant 
difference in the maximum FMDV log titres was found between the different experimental 
groups neither for OPF swabs nor for urine nor for faeces (p > 0.05). No significant 
difference in the duration of FMDV secretion and excretion could be determined between 
the different experimental groups (p> 0.05) (Additional file 3). 
experiments with vaccinated calves
At day of challenge (0 dpi, 7 days post vaccination), the average virus neutralisation test 
(VNT) titre against the vaccine strain FMDV Asia-1 Shamir for all the vaccinated calves 
(including the vaccine controls) was 2.210log. The average virus neutralisation test (VNT) 
titre  against the challenge strain FMDV Asia-1 TUR/11/2000  was 1.2 10log. 
direct contact experiment
After challenge, neither the vaccinated inoculated calves nor the vaccinated contact 
calves showed clinical signs of FMD and all calves tested negative by virus isolation and 
RT-PCR. Only 2 inoculated calves (calves 3972 and 3976) developed antibodies against 
non-structural proteins. 
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indirect contact experiment 
After challenge, neither the vaccinated inoculated calves nor the non-vaccinated contact 
calves showed clinical signs of FMD. All calves tested negative by virus isolation and 
RT-PCR. Neither the vaccinated inoculated nor the non-vaccinated contact calves showed 
detectable antibodies against non-structural protein. 
Fmdv survival rate (σ)
From the combined published and own experimental data, it was estimated that at 20°C a 
10-fold reduction in FMDV titres occurs in 2.4 days (95% CI: 1.7, 3.3). We calculated the FMDV 
survival rate (σ) using the lowest  (in spiked urine), middle (in spiked faeces) and highest (in 
spiked buffered solution) estimates obtained at 20°C. An additional file shows these estimates 
inside a dashed pointed rectangle (Additional file 4). The estimated time needed for 10-fold 
reduction in FMDV titres in spiked urine (lowest value) was 0.5 days, indicating an FMDV 
survival rate (σ) of 0.014 day−1. The estimated time needed for 10-fold reduction in FMDV titres 
in spiked faecal material (middle value) was 2.8 day indicating an FMDV survival rate (σ) of 
0.44 day−1. The estimated time needed for 10-fold reduction in FMDV titres in spiked buffered 
solution (highest value) was 8.2 days, indicating an FMDV survival rate (σ) of 0.75 day−1. For the 
quantification of FMDV transmission, we used the middle estimate i.e. σ = 0.44 day−1. 
Quantification of Fmdv transmission 
Results of the 1R-SIR model 
The transmission rate parameter βˆ was 0.67 per day (95% CI: 0.26, 1.8). The average 
infectious period from the inoculated calves Tˆ was 5.5 days (95% CI: 4.5, 6.7). Therefore the 
estimated reproduction ratio Rˆ01R was 3.7 (95% CI: 1.3, 10.), significantly above 1. 
Results of the 2R- SIR model 
The regression coefficient of fe, the extra infectivity contributed by the environment, was 
not significantly different from 0 which means that βcontact and βenvironment are not significantly 
different. Because βenvironment /βcontact equalled 1.4 (95% CI 0.14, 14), there is contribution of 
the environment. Using the most parsimonious model βcontact and βenvironment were estimated 
both to be 0.45 per day (95% CI: 0.24, 0.85). Because Tˆ was 5.5 days (95% CI: 4.5, 6.7), 
Rˆ02Rcontact equalled 2.5 (95% CI: 1.3, 5.0). 
The average infectious period from the contaminated environment τˆ was 4.3 days (95% 
CI: 3.6, 5.2), which leads to a Rˆ02Renvironment of 1.9 (95% CI: 1.007, 3.8). Combination of the two 
estimates (Rˆ02Rcontact + Rˆ02Renvironment) resulted in Rˆ02R equalled to 4.4 (95% CI: 1.5, 7.4), which is 
significantly above 1. Rˆ02R was not significantly different from Rˆ01R as can be seen from their 
overlapping confidence intervals. The contribution of the environmental transmission to 
the total transmission of FMDV was 44% (Rˆ02Renvironment / Rˆ02R).
The sensitivity analysis, i.e. multiplication of the new infections or cases (C) in Et 
by either 0 or 0.5, resulted in the same contribution of the environmental transmission 
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(44%). When the lowest and the highest values of σ were used, the contribution of the 
environmental transmission to the total transmission was estimated to be 31% (when 
σ=0.014 day−1) and 75% (when σ = 0.75 day). The sensitivity analysis in which we included 
a latent period of 1, 2 or 3 days, resulted in higher estimates for β (Additional file 5) and R0 
(Additional file 6) for the models with a latent period, but the estimated contribution of the 
environment stayed  the same (Additional file 6). 
Results of the final size model 
The Rˆ0FS equalled 14 (95% CI: 1.3, infinite), which is significantly above 1. Based on the comparison 
of the confidence intervals, Rˆ0FS seems to be not significantly different from Rˆ01R nor from Rˆ02R.
experiments with vaccinated calves
After challenge, none of the inoculated or contact calves became infectious; therefore 
transmission parameters could not be estimated. 
disCussion 
In this study, we quantified the contribution of a contaminated environment to the 
transmission of FMDV and analysed whether vaccination one week prior to inoculation 
of the calves could block FMDV transmission. We show that using a 2R-SIR model allows 
FMDV transmission to be quantified in two parts: the direct contact component and the 
indirect i.e. via the environment component. Our results show that roughly 44% of the 
transmission of FMDV occurs via the environment, in the days after the calves started 
secreting and excreting the virus. The contribution of the environment to the transmission 
of FMDV depends on the FMDV survival rate; if the survival rate is high, the contribution 
of the environment is higher. An environment that has previously housed infectious animals 
can contain FMDV if it is not properly disinfected after the removal of the infectious animals 
[5] and our study shows that this virus accumulation can cause new infections. 
As we show, environmental transmission of FMDV plays a role in the total transmission 
of FMDV also in groups of animals that do have direct contact. Transmission of FMDV has 
been quantified before in several studies by using a 1R- SIR model [14,18,30-35]. We believe 
that in all of these studies, transmission occurred through both routes: via direct contact to 
an infected animal and via indirect contact to a contaminated environment. However within 
the experimental design of those studies, the role of the environment could not be separated 
from the role of direct contact on the transmission of FMDV. By using both direct and 
indirect contact experiments we could employ a 2R-SIR model (that included accumulation 
of FMDV in the environment) to quantify the contribution of the environment (Rˆ02Renvironment) 
to the total transmission of FMDV. As expected, the estimated Rˆ01R, Rˆ02R and Rˆ0FS are very 
similar to each other and moreover, they are similar to the Rˆ0 (by using a 1R-SIR model) 
estimated in other direct contact experiments with cattle infected with FMDV O/NET/2001 
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[18,35]. The consistency of these results indicates that our 2R-SIR model is valid for the 
estimation of the reproduction ratio and that it is very useful to separate both components 
i.e. the environment and direct contact transmission, for the quantification of their separate 
contribution to the transmission of FMDV. Moreover based on the statistical analysis of 
virus secretion and excretion, the results obtained with the 2R-SIR model are not biased by 
the route of infection i.e. inoculated and contact infected calves. 
In our models, we used an SIR model and we did not incorporate a latent period (then 
we would have a SEIR i.e. susceptible, exposed, infectious, recovered model), although the 
data from the virus excretion of the inoculated animals suggest that for this group there 
is a latent period of approximately 2 days. The main reason why we did not incorporate a 
latent period in our study is because we did not want to introduce more complexity in the 
model. Also, incorporation of a latent period affects the estimates for the direct and indirect 
transmission more or less equally and thus the estimation of the role of the environment 
(the main interest of this research) was not been affected. 
Our sensitivity analysis showed that, when a latent period is incorporated in the models, 
the estimates of the transmission parameters are still “equal” i.e. not significantly different 
(Additional files 5 and 6). The transmission parameters we provide in Additional files 5 and 
6, where a latent period was used, could be useful when the transmission parameters are 
applied for modelling disease outbreaks and the effect of control measures. 
The temporal separation used in our indirect contact experiment allowed us to observe 
the occurrence of transmission through the environment by taking into consideration virus 
accumulation in 2 different periods i.e. 0–3 and 3–6 dpi. Temporal separation was also used 
by Charleston et al.   [36] to study FMDV transmission, although they exposed   “donor” 
calves to “recipient” calves by direct contact for  8 hours in separate environments that had 
been previously   disinfected, and thus with no accumulation of virus in the  environment. 
This would, based on our results, reduce  transmission of FMDV. They conclude in their 
study that the occurrence of FMDV transmission is correlated with the presence of clinical 
signs. However, it has been previously shown that FMDV transmission also can occur before 
clinical signs are seen [33]. In our study as well, transmission through the environment was 
caused by one group of calves that contaminated the environment from 0 to 3 dpi but showed 
no clinical disease. This supports the conclusion that the correlation of FMDV transmission 
with the presence of clinical signs cannot be generalized to populations, if animals have 
direct contact to each other for a longer period and/or are present where accumulation of 
FMDV in the environment is plausible. FMDV transmission may not occur, however, when 
animals are separated by  fences or wooden walls (in pigs [37]; in calves: Charleston et al. 
(personal communication), [36]), indicating that either  exposure to virus secreting and/or 
excreting animals or exposure to virus contaminated surfaces is important for the occurrence 
of transmission. Vaccination can be used as a tool to reduce transmission of FMDV [17]. 
In our study the calves vaccinated one week prior to inoculation with FMDV did not shed 
virus. Previously, vaccinating animals 2 weeks prior inoculation with FMDV was reported 
[18] to reduce FMDV transmission; our results indicate that vaccination reduces FMDV 
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transmission even earlier. As others have demonstrated, vaccination rapidly protects cattle 
from clinical disease, and reduces virus shedding by infected cattle [38-40]. As our results 
indicate, vaccination as early as one week before challenge cannot only protect calves against 
infection but also, can avoid contamination of the environment and so prevent new infections. 
In summary, our study shows that the environment is a relevant mechanism in the 
transmission of FMDV. The quantification of the magnitude of the contribution of 
transmission via the environment emphasizes again that hygiene is an extremely important 
control measure for FMDV. And that, as already recommended by veterinary authorities, 
good disinfection of e.g. vehicles, walls and floors previously contaminated by infected 
animals is necessary to reduce the accumulation of the virus in the environment and 
therefore FMDV transmission. Also, the data from our experiment give some insight in 
which secretions and excretions contain FMDV at different times post infection and also 
this knowledge could be to improve control measures. The accumulation of FMDV in the 
environment should be taken into account when studying FMDV transmission. Further, 
the environmental aspect in the transmission of FMDV should be considered during the 
planning and implementation of measures to control FMD during an outbreak. 
additionaL FiLes
Additional file 1: On the FMDV survival rate σ. Detailed calculation of the FMDV survival 
rate σ, which was calculated using published data on FMDV thermal inactivation combined 
with own laboratory data. 
on the Fmdv survival rate σ
Published data on FMDV titres of serum samples [42], medium [7, 42], buffer [43], milk 
[44, 45], slurry [7], bone marrow [46], lymph nodes [46] and hemal nodes [46] after being 
exposed to different temperatures, were collected and put in a database. 
Further, in a laboratory experiment, we contaminated water, Eagle’s Minimum Essential 
Medium (EMEM), faeces (from calves) and urine (from calves) samples at the starting time 
(0h) with an inoculum that contained 10 6.8 pfu/ml of FMDV Asia-1 TUR/11/2000 (all in 
Duplo). All samples were exposed to 4 ºC and 20 ºC for 0 h, 8 h, 24 h, 48 h, 96 h, 168 h, 
336 h, or 504 h. Water and urine, mixed previously with 10% ABII (by volume, v/v), were 
contaminated with 10% of the FMDV inoculum (v/v). After the required incubation, 800 µl 
of water or urine was mixed with 200 µl of a 50% FCS, 40% ABII solution and stored at -70 
°C until virus isolation analysis. EMEM (containing 10% ABII and 2% FCS) was mixed with 
10% ABII (v/v) and contaminated with 10% of the FMDV inoculum (v/v). After the required 
incubation, samples were stored at -70 °C until virus isolation analysis. Using a sonicator, we 
mixed and homogenized 50% of faeces with 50% of the FMDV inoculum (w/v). 10% ABII 
(v/v) was added to the mix. After the required incubation, the faecal mix was suspended 
1:10 (by weight, w/v) in EMEM containing 10% FCS, and vortexed with glass beads. After 
20 minutes of incubation at environmental temperature, the suspension was vortexed and 
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centrifuged (3000 x g for 15 min). The supernatants were stored at -70 °C until virus isolation 
analysis. Virus isolation and titration were performed as described before [20]. 
The FMDV titres from serum, medium, buffer, milk, slurry, bone marrow, lymph nodes 
and hemal nodes exposed to 2.5 ºC, 4 ºC, 20 ºC, 37 ºC, 43 ºC, 49 ºC, 50 ºC, 55 ºC, 56 ºC, 60 ºC, 
61 ºC, 65 ºC, 67 ºC, 70 ºC, 72 ºC and/or 80 ºC for different intervals of time (from published 
data), and the obtained FMDV titres from water, medium, faeces and urine exposed to 4 ºC 
and 20 ºC for different intervals of time (from laboratory data), were recorded. Using the 
recorded FMDV titres per time of exposure, we calculated how much time is needed to have 
a 10-fold reduction in FMDV titres by dividing 1 (the logarithmic reduction of interest) by 
the slope of FMDV titres on time (per sample and per temperature). The obtained times 
that are needed to have a 10-fold reduction in FMDV titres (in hours) per sample and per 
temperature, were transformed in logarithmic scale and plotted against temperature (ºC) to 
obtain a regression line. An additional file shows this in more detail [see Additional file 4]. 
Then the estimated time that is needed to have a 10-fold reduction in FMDV titres (in 
days) at 20 °C was used to calculate the FMDV survival rate σ as: 0.1 to the exponential of 1 
divided by the necessary days to have a 10-fold reduction in FMDV titres at 20 °C.
Additional file 2: The 2R-SIR model. Detailed information on the quantification of transmission 
rate parameters. The transmission rate parameters were calculated using a Generalized Linear 
Model (GLM) based on an stochastic SIR model. In this additional file we describe the SIR 
model parameters, the inclusion of an extra route i.e. E to the 1 route SIR-model to calculate 
the contribution of the environment to the transmission of the infection and, the methodology 
to quantify the transmission parameters using the GLM model [41,23,24]. 
the 2r-sir model
In the 1R-SIR model we use only the data from the direct contact experiment with non-
vaccinated calves. The model is: 
Where susceptible animals (St) are infected with a rate:
Equation 1
β is the average number of new infections caused by a typical infectious individual per unit of time 
(day) in a fully susceptible population; St is the number of susceptible animals; It is the number 
of infectious animals; and Nt is the total number of animals present at time (t). Division by Nt is 
done based on the assumption of constant density after comparison of different group sizes [41]
Per susceptible animal the number of contacts that lead to infection during a period 
with the length ∆t, is:
Equation 2
The 1R-SIR model is analysed as in previously reported studies [23, 24].
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In the 2R-SIR model we use data from both the direct contact experiment and the 
indirect contact experiment. In this model we included an extra route to the 1R-SIR model: 
E. The model is: 
In this case calves are exposed to both infectious animals (It) and/or to virus coming from 
infectious animals via the environment (Et) (see Figure 2 in manuscript). Et is based on the 
secretion and excretion of FMDV by the infectious animals on previous days as well as on 
the remaining virus in the environment. We therefore include the FMDV survival rate (σ), 
described in Additional file 2, to correct for the decrease of FMDV in time, thus:
Equation 3
Thus the rate of infection per susceptible individual during a period with the length 
becomes:
Equation 4
βcontact+environment is a combined transmission rate parameter for contact exposure to an infected 
animal and for contact exposure to a contaminated environment (for its calculation we used 
data from both direct contact and indirect contact experiments).
By replacing βcontact+environment by  this can be rewritten as:
Equation 5
Where fe is the fraction of transmission by the environment and its regression coefficient measures 
the extra infectivity contributed by the environment. If the contribution of the environment is 
zero, then fe becomes zero (because Et is zero) and βcontact+environment = βcontact equal to eco. If there are 
no infectious animals present, then fe is 1 and βcontact+environment = βenvironment equal to eco+c1.
The probability that a single susceptible animal becomes infected is then binomial 
distributed with:
Equation 6
The data are analysed with a Generalised Linear Model (GLM) with a complementary 
log-log link, thus we take the log(-log(1-p)). The expected value of C/S when applying the 
link function is:
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Equation 7
So this is a GLM with offset:
Equation 8
With S as binomial total, a binomial error function, and with explanatory variable fe (the 
infectivity contributed by the environment):
 
Additional file 3: Mean values (plus range) and the Kruskal-Wallis statistics of virus present 
in secretions, excretions and blood samples, for the inoculated, direct contact and indirect 
contact groups. H is the Kruskal-Wallis test statistic and df the degrees of freedom.
Measured 
variables
Mean values (range)
Kruskal-Wallis statisticsInoculated 
group
Direct contact 
group
Indirect contact groups
C1 C2 H df P-value
AUC (log10 titres)
OPF swabs 8.8 (0, 15) 5.7 (0, 15) 6.2 (0, 21) 6.1 (2.6, 14) 2.32 3 0.51
Urine 2.3 (0, 5.1) 2.1 (0, 6.2) 1.8 (0, 5.3) 1.0 (0, 4.0) 1.60 3 0.66
Faeces 0.3 (0, 1.2) 0.4 (0, 2.1) 0.2 (0, 0.2) 0 1.54 3 0.67
Blood 5.8 (0,9.5) 4.0 (0, 8.7) 2.1 (0, 8.3) 4.6 (0, 9.8) 2.35 3 0.50
Maximum FMDV excretion (log10 titres)
OPF swabs 3.7 (0, 6.0) 1.8 (0, 4.3) 1.6 (0, 4.9) 4.0 (3.3, 5.2) 5.53 3 0.14
Urine 1.2 (0, 2.6) 0.7 (0, 1.9) 1.1 (0, 2.7) 1.7 (0, 2.5) 1.81 3 0.61
Faeces 0.3 (0, 1.2) 0.3 (0, 1.7) 0.2 (0, 0.9) 0 1.54 3 0.67
Blood 2.5 (0, 3.6) 1.9 (0, 3.3) 0.9 (0, 3.7) 2.2 (0, 3.4) 1.65 3 0.65
Duration of FMDV excretion (days)
OPF swabs 4.0 (0, 6) 4.4 (0, 9) 3.0 (0, 8) 6.3 (4, 8) 3.01 3 0.39
Urine 2.1 (0, 5) 3.0 (0, 7) 1.0 (0, 3) 2.3 (0, 4) 1.68 3 0.64
Faeces 0.3 (0, 1) 0.4 (0, 2) 0.3 (0, 1) 0 1.52 3 0.68
Blood 2.1 (0, 3) 1.4 (0, 3) 0.8 (0, 3) 2.5 (0, 4) 4.03 3 0.26
Additional file 4: Plotted linear regression estimates of the log time (hours) needed for a 
10-fold reduction in FMDV titres. In this additional file we show the obtained times (log 
hours) that are needed to have a 10-fold reduction in FMDV titres per sample and per 
temperature. Light blue points correspond to estimates from water; green from buffers; grey 
from hemal and lymph nodes and bone marrow; black from faeces; red from urine; pink 
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from milk; blue from slurry. Inside the dashed pointed rectangles, only obtained estimates 
at 20 °C. Red dashed lines, regression lines at 95% CI. 
Latent 
period 
(days) βcontact βenvironment Ratio1 βoverall
 2 N3
Number of contact infections  
for each number of latent days
0 1 2 3
0 0.373 0.523 1.404 0.453 47 10
1 0.459 0.753 1.640 0.625 40 1 9
2 0.868 0.928 1.071 0.909 33 1 1 8
3 1.280 1.258 0.983 1.265 29 1 1 3 5
1Ratio = βenvironment/βcontact
2 This is the beta estimate for contact and environment when the two are not significantly different which 
is the case here for all latent periods.
3  N = number of rows in the dataset used in the GLM analysis
Additional file 5: Sensitivity analysis considering latent periods. In this additional file we 
show results of the estimation of transmission parameters for latent periods of 0 (as used in 
the paper), 1, 2 and 3 days. We show the effect of different latent periods on transmission 
parameters βcontact and βenvironment from the model assuming that both are not the same and, 
on the βoverall, the overall estimate for both, under the assumption that both are the same. 
Additional file 6: Sensitivity analysis considering latent periods. In this additional file we 
show results of the estimation of R0’s for latent periods of 0 (as used in the paper), 1, 2 
and 3 days. We show the effect of different latent periods on the different estimates for R0 
(including 95% confidence interval) and on the estimated contribution of the environment 
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Latent 
period 
(days) Rˆ01R Rˆ02Rcontact Rˆ02Renvironment Rˆ02R
Environmental 
contribution to 
transmission (%)
0 3.7 <1.3, 10> 2.5 <1.3, 4.8> 1.9 <1.0, 3.8> 4.4 <1.5, 7.4> 44
1 5.6 <2.0, 15> 3.4 <1.8, 6.7> 2.7 <1.4, 5.2> 6.1 <3.2, 9.1> 44
2 12 <4.2, 34> 5.0 <2.5, 9.8> 3.9 <2.0, 7.7> 8.9 <5.9, 12> 44
3 17 <5.8, 53> 6.9 <3.5, 14> 5.4 <2.8, 11> 5.4 <2.8, 11> 44
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aBstraCt
The quantitative role of sheep in the transmission of foot-and-mouth disease virus (FMDV) 
is not well known. To estimate the role of sheep in the transmission of FMDV, a direct 
contact transmission experiment with 10 groups of animals each consisting of 2 infected 
lambs and 1 contact calf was performed. Secretions and excretions (oral swabs, blood, 
urine, faeces and probang samples) from all animals were tested for the presence of FMDV 
by virus isolation (VI) and/or RT-PCR. Serum was tested for the presence of antibodies 
against FMDV. To estimate FMDV transmission, the VI, RT-PCR and serology results were 
used. The partial reproduction ratio R0p i.e. the average number of new infections caused by 
one infected sheep introduced into a population of susceptible cattle, was estimated using 
either data of the whole infection chain of the experimental epidemics (the transient state 
method) or the final sizes of the experimental epidemics (the final size method). Using the 
transient state method, R0p was estimated as 1.0 (95% CI 0.2 - 6.0) using virus isolation 
results and 1.4 (95% CI 0.3 - 8.0) using RT-PCR results. Using the final size method, R0p 
was estimated as 0.9 (95% CI 0.2 - 3.0). Finally, R0p was compared to the R0’s obtained 
in previous transmission studies with sheep or cattle only. This comparison showed that 
the infectivity of sheep is lower than that of cattle and that sheep and cattle are similarly 
susceptible to FMD. These results indicate that in a mixed population of sheep and cattle, 
sheep play a more limited role in the transmission of FMDV than cattle.
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introduCtion
Foot-and-mouth disease (FMD) is a contagious viral disease in cloven-hoofed animals 
caused by foot-and-mouth disease virus (FMDV). Clinical signs of FMD in sheep are 
frequently mild or not apparent [1]. But while sheep may not manifest clear clinical signs of 
FMD, they can secrete and excrete considerable amounts of FMDV [2-4] and therefore may 
play a significant role in FMDV transmission. Transmission of FMDV between sheep [5-8] 
and between cattle [9-11] has been studied previously. Transmission of FMDV from sheep 
to cattle may have occurred during the 1994 type O epidemic in Greece [12], during the 
1999 type O epidemics in Morocco [13] and during the 2001 type O epidemics in UK [14]. 
However, transmission of FMDV from sheep to cattle has not yet been quantified.
In epidemiology, the reproduction ratio (R0) is an important quantitative parameter of 
transmission. R0 is defined as the average number of new infections caused by one typical 
infectious individual, during its entire infectious period, introduced into a population 
made up entirely of susceptible individuals [15]. Major outbreaks of FMDV can occur only 
if R0 is above 1. In the previously mentioned studies, R0 was estimated within species i.e. 
intraspecies transmission either in sheep or in cattle. When different species are mixed, 
the R0 for a mixed population of cattle and sheep not only depends on the occurrence of 
intraspecies (cattle-to-cattle and sheep-to-sheep) transmission but also on the occurrence 
of interspecies (sheep-to-cattle and cattle-to-sheep) transmission. To estimate R0 for a 
mixed population of cattle and sheep, all 4 (2 intraspecies and 2 interspecies) transmission 
parameters have to be known. The 2 interspecies transmission parameters will be called 
partial R0’s to emphasise that these parameters are strictly speaking not reproduction 
ratios. On the interspecies transmission of FMDV between sheep and cattle no quantitative 
information is available yet.
Moreover, with estimates for the intraspecies and interspecies (partial) R0’s, relative 
infectivity and susceptibility of sheep and cattle can be determined. Because for FMDV, 
relative infectivity and susceptibility have not extensively been quantified, modellers have 
had to rely on educated guesses about the relative infectivity and susceptibility of cattle, 
sheep and pigs herds [16]. Knowledge on relative infectivity and susceptibility of different 
species would improve modelling of FMDV transmission and more importantly could be 
used to implement tailored control measures in accordance to the animal species.
This study fills part of the gap on quantitative information on interspecies transmission 
of FMD. We estimated interspecies transmission of FMDV from infected sheep to contact 
cattle by estimating a partial R0 (R0p) for sheep to cattle transmission. Further, comparison 
of our results to those obtained in intraspecific transmission studies allowed us to define the 
relative infectivity and susceptibility of sheep and cattle.
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materiaLs and methods
experimental design
Twenty conventionally reared lambs (crossbred Texelaar-Noordhollander) aged between 6 and 
7 months and 10 conventionally reared calves (pure- or crossbred (87%) Holstein-Frisian) aged 
between 6 and 8 months were used in this study. The study was performed in 10 separate animal 
rooms within the biosecurity facilities of the Central Veterinary Institute (CVI, Lelystad, The 
Netherlands). Each animal room was between 9 and 11 m2 in size. In each animal room, 2 
infected lambs and 1 contact calf were housed together for 31 days. The study received ethical 
approval from the animal experiment committee of the CVI in accordance with Dutch law.
On the day of infection (0 days post infection (dpi)), all the lambs were moved to a separate 
animal room and inoculated with FMDV. Eight hours after inoculation, the lambs were 
reunited with their original roommates. The lambs were inoculated with FMDV strain Asia-1 
TUR/11/2000 by intranasal instillation. The virus was obtained from the World Reference 
Laboratory for Foot-and-Mouth Disease (Pirbright, United Kingdom); it was passaged once 
in cattle before its use. The inoculum contained 105.8 plaque forming units (pfu)/mL (tested on 
primary lamb kidney cells). Each lamb received 1.5 mL of inoculum per nostril.
sampling procedures
During animal inspection and/or sampling, animal caretakers changed coveralls and gloves 
between animal rooms. All the animals were inspected daily for clinical signs of FMD. In 
these inspections, rectal temperature above 39.5 °C in calves and above 40 °C in lambs was 
considered fever [17], and the animals were checked for the presence of vesicles and/or 
lameness. Oral swab samples were collected daily from each animal from 0 dpi until the 
end of the experiment (31 dpi). They were collected and processed as described previously 
[11], with the exception that we used medium containing 2% foetal bovine serum. The 
oral swab samples were stored at −70 °C until analysis by virus isolation (VI) and real time 
RT-PCR. Probang samples were collected from each animal at 29, 30 and 31 dpi. These 
were stored at -70 °C until analysis by real time RT-PCR. Heparinized blood samples were 
collected daily from each animal from 0 dpi until 11 dpi. The heparinized blood samples 
were centrifuged at 2500 RPM for 15 min; plasma was stored at −70 °C until analysis by VI. 
Samples for serum (clotted blood) were collected twice per week from 0 dpi till the end of 
the experiment (31 dpi). Serum was stored at −20 °C until serological analysis.
From the calves urine samples were collected daily during the first two weeks of the 
experiment and then twice per week until the end of the experiment. Urine samples were 
collected, as calves were stimulated to urinate spontaneously by rubbing the skin next to 
the vulva. In the laboratory, 800 μL of urine was mixed with 100 μL of foetal bovine serum 
and 100 μL of antibiotics (1000 U/mL of penicillin, 1 mg/mL of streptomycin, 20 μg/mL of 
amphotericin B, 500 μg/mL of polymixin B, and 10 mg/mL of kanamycin). Urine samples 
were stored at −70 °C until analysis by VI. From both animal species, faeces samples were 
collected from the rectum daily during the first two weeks of the experiment and then 
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twice per week until the end of the experiment. Faeces samples were processed as described 
previously [18] with the exception that the samples were centrifuged at 3000 RPM for 15 
min. The supernatants were stored at −70 °C until analysis by VI.
virus detection
All oral swab, heparinised blood, urine, and faeces samples were tested for the presence of FMDV 
as described previously [11], using plaque titration on monolayers of secondary lamb kidney cells 
(VI, i.e. detection of infectious virus particles). In addition all oral swab and probang samples were 
tested for the presence of FMDV using real time RT-PCR because in these samples neutralising 
antibodies, that could influence the virus isolation results, were expected to be present. RNA 
isolation was performed using the Magna Pure LC total Nucleid Acid Isolation kit (03 038 505) in 
the MagNa Pure 96 system (Roche®, Mannheim, Germany). Isolated RNA was tested as described 
previously [19] using a LightCycler 480 Real-Time PCR System (Roche®) with the exception that 
we used a Quantifast Probe RT-PCR Kit (Qiagen®, Venlo, The Netherlands).
serological analysis
The serum samples were tested for the presence of antibodies against both non-structural 
and structural proteins of FMDV. To detect antibodies against non-structural proteins, a 
PrioCHECK FMDV NS ELISA (Prionics®, Lelystad, The Netherlands) was performed in 
accordance to the manufacturers’ instructions. To detect antibodies against structural 
proteins, a virus neutralisation test (VNT) was performed as described previously [20], 
using the FMDV isolate Asia-1 TUR/11/2000 and Baby Hamster Kidney cells (BHK-21). 
Samples were considered to be positive when the VNT titres were above 100.6 (VNT cut-off).
estimation of transmission parameters
Interspecies transmission rate
To estimate the transmission rate parameter β, which is the average number of new 
infections in a fully susceptible population caused by one typical infectious individual 
per unit of time [21], i.e. in our case the number of cattle (in a population of only cattle) 
that will become infected from one infectious lamb per day, we used a generalized linear 
model (GLM) [22]. The GLM was based on a stochastic SIR model [23] (in which infection 
dynamics are described by the change in number of susceptible (S), infectious (I), recovered 
(R) and total number (N) of animals). The GLM uses the number of new cases (of cattle 
in this case) as dependent variable and the total number of cattle as binomial total. The 
analysis is done with a complementary log-log (cloglog) link function, a binomial error 
term, and an offset as explained below [24].
The expression for the GLM is:
cloglogE(Ct/St) = ln(β) + ln(ItΔt /Nt)
where ln(β) is the regression coefficient and ln(ItΔt /Nt) is the offset variable.
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E(Ct/St) = the expected number of cases (Ct) during the interval (t, t + Δt) divided by the 
number of susceptible individuals (St) at the start of the time interval (i.e. at t).
β = the transmission rate parameter.
It = the number of infectious animals at the start of time interval (t).
Δt = the duration of the time interval.
Nt = the total number of animals at the start of the time interval (t).
Note that because of the experimental design i.e. with all sheep infectious and all susceptible 
animals being cattle, the estimated β is an interspecies transmission rate parameter of sheep 
to cattle.
We assumed that the lambs were infectious from the first day until the last day FMDV 
was detected in their oral swab samples (by either VI or RT-PCR). Calves were considered 
infected if FMDV or antibodies against FMDV were detected in their samples. Because no 
virus was detected in 2 of the 4 contact calves that seroconverted, we assumed that both 
calves became infected 7 days before they scored positive in the VNT (which corresponded 
to the results from the calves that tested positive in VI and/or RT-PCR).
The data were analysed using the statistical program R [25]. The 95% confidence 
intervals (CI) of the estimated interspecies β were calculated using the standard error of 
the mean of log β.
Infectious period: T
We calculated the infectious period (T) based on the presence of virus in the oral swab 
samples from the individual lambs. Also for this purpose, both VI and RT-PCR results 
were used separately. The first moment at which an individual lamb tested positive in 
virus detection was considered as day 1 of its infectious period. The last day on which an 
individual lamb tested positive in virus detection (even if at one or more days in between no 
virus was detected), was considered as the last day of its infectious period.
Because some lambs still scored positive in virus detection at the end of the experiment, 
the mean duration of the infectious period T was calculated using a parametric (exponential) 
survival analysis [26]. To that end the time series of the lambs that scored positive in virus 
detection at the last day of the observational period were treated as censored data. The 
survival analysis was performed using the statistical program R [25] with the package 
“survival” [27]. The 95% confidence intervals (CI) of the estimated infectious period T were 
calculated using the standard error of the mean of log T.
Partial reproduction ratio: R0 
p
The partial reproduction ratio R0p i.e. the average number of new infections caused by one 
infectious sheep, during its entire infectious period, when introduced into a population of 
susceptible cattle, was estimated using two different methods.
78
E
stim
a
tio
n
 o
f th
E
 tr
a
n
sm
issio
n
 o
f fo
o
t-a
n
d
-m
o
u
th
 d
isE
a
sE
 v
ir
u
s fr
o
m
 in
fE
c
tE
d
 sh
E
E
p to
 c
a
ttlE
IV
the transient state method
The transient state method takes the time course of the epidemic process into account [21]. 
We estimated the R0p by multiplying interspecies β with the mean infectious period T, both 
estimated using VI and RT-PCR results. The 95% confidence intervals (CI) of the estimated 
reproduction ratio were calculated using exp (log β + log T ± 1.96 · √ (var log β + var log T) 
based on the assumption that the log transformed parameters follow a normal distribution 
and are independent.
the final size method
The final size method is based on the total number of infected calves at the end of the direct 
contact experiment, under the assumption that the epidemic process has ended before the 
experiment is stopped [21]. Even though some sheep (in contact to calves that did not 
become infected) were still shedding virus at the end of the experiment, we assumed that 
the epidemic process had ended at the end of the experiment. This assumption was based on 
the fact that FMDV transmission, leading to virus detection in the contact calves, occurred 
during the first week of the experiment (calf nr 5457 and calf nr 5463) at the moment when 
virus titres in oral swabs of sheep were high.
In a one-to-one experimental transmission design, the maximum likelihood estimate 
(MLE) of R0 (RMLE) can be derived analytically [21,28]. Because we used a two-to-one 
experimental transmission design, we derived the maximum likelihood estimate of
 
where p is the total number of infection events divided by the number of independent 
replications. In the Additional files 1 and 2 the derivation of RMLE is shown in more detail. 
The confidence intervals for p were derived from the binomial distribution. Consequently 
the confidence intervals for the final size R0p could be calculated.
relative infectivities and susceptibilities of sheep and cattle
The relative infectivities and susceptibilities of sheep and cattle were determined by comparing 
the final size R0p estimate obtained in this interspecies transmission study with the final 
size R0 estimates obtained in intraspecies transmission studies performed previously. The 
(intraspecies) final size R0 estimates used were: R0 sheep-to-sheep = 1.1 [5, 6] and R0 cattle-to-cattle = ∞ 
[9], 2.52 [10], 14 (Bravo de Rueda et al., in press). By comparing R0p sheep-to-cattle with R0 sheep-to-sheep, 
we could determine the relative susceptibility of sheep and cattle. By comparing R0p sheep-to-cattle 
with R0 cattle-to-cattle, we could determine the relative infectivity of sheep and cattle.
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resuLts
Fmd clinical signs
In total 15 of the 20 inoculated lambs developed clinical signs of FMD (fever, vesicles and/or 
lameness). In lambs, fever (n = 13) was most frequently observed followed by vesicle formation 
(n = 11) and lameness (n = 10) (Table 1). Only one of the 10 contact calves (nr 5457) developed 
fever and had vesicles on the feet; the other 9 calves did not show clinical signs of FMD.
vi and rt-PCr
All the lambs tested positive for FMDV in oral swabs by VI. FMDV was first detected at 
1–3 dpi. Higher levels of FMDV in oral swabs were detected in the first week after infection 
(Table 2). At the end of the experiment, oral swabs of 3 lambs (nr 5452, 5456 and 5458) still 
contained the virus. In total, 16 lambs tested positive by VI in their blood. Only 1 lamb (nr 
5458) tested VI positive in its faecal sample. Only 1 calf (nr 5457) tested positive for FMDV 
in its oral swabs by VI (at 7–11 dpi). Virus was also isolated from blood and urine samples 
of this calf. No virus was isolated from faeces samples from any of the calves.
All the lambs tested positive for FMDV RNA in oral swabs by means of RT-PCR (Table 3). 
FMDV RNA in oral swabs was first detected at 1–2 dpi. At the end of the experiment, 8 lambs 
(nr 5446, 5447, 5452, 5455, 5456, 5458, 5461 and 5464) still tested positive for FMDV RNA 
in oral swabs. In total 9 lambs tested positive for FMDV RNA in their probang samples. Two 
of the 10 contact calves (nr 5457 and nr 5463) tested positive for FMDV RNA in oral swabs. 
Another contact calf (nr 5442) tested positive for FMDV RNA in one of its probang samples.
serological results
Neutralising antibodies (by VNT) (Figure 1) were developed by all lambs, as were antibodies 
against non-structural proteins (by NS-ELISA) (Table 1). Neutralising antibodies were 
developed by four of the ten contact calves (Figure 1), these four calves also developed 
antibodies against non-structural proteins (Table 1) (calves nr 5442, 5457, 5463 and 5466). 
Calf 5457 became VNT positive at 14 dpi; 7 days after becoming positive in VI and RT-PCR. 
Calf 5463 became VNT positive at 17 dpi; 7 days after becoming positive in RT-PCR. Calf 
5442 became VNT positive at 10 dpi and calf 5466 became VNT positive at 17 dpi. Figure 
1 shows the averages of the VNT titres from the VNT positive lambs, the averages of the 
VNT titres from the VNT negative calves and the individual VNT titres from the 4 VNT 
positive contact calves.
estimation of transmission parameters
FMDV transmission occurred in 4 of the 10 groups. Calves 5457 and 5463 were detected 
infectious at 7 dpi and at 10 dpi respectively. Calves 5442 and 5466 did not test positive in any 
of the virus detection methods but they developed neutralizing antibodies at 10 and 17 dpi 
respectively. For the estimation of the transmission parameters, these calves were assumed 
becoming infected at 3 dpi and at 10 dpi respectively, 7 days prior to the detection of neutralizing 
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Figure 1. Results of VNT titres. The black line with solid boxes ( ■ ) represents the average VNT titres (log10) of 
the 20 inoculated sheep and the black line with solid triangles ( ▲ ) the average VNT titres of the 6 VNT negative 
contact calves. For the 4 VNT positive contact calves (in grey lines) the individual VNT titres are shown. The grey 
dashed line (--) indicates the VNT cut-off (100.6). Error bars represent the standard error of the mean.
antibodies. The interspecies transmission rate parameter β, the infectious period T and the 
partial reproduction ratio R0p were calculated using the results given in Tables 2 and 3.
Using the VI results, the interspecies β was estimated at 0.037 per day (95% CI: 0.014 
- 0.076) and the infectious period T (of the sheep) was estimated at 28 days (95% CI 19. - 
42.). Using the RT-PCR results, the interspecies β was estimated at 0.031 per day (95% CI: 
0.012 - 0.065) and the infectious period T (of the sheep) was estimated at 46 days (95% CI 
28. - 73.). By using the transient state method and the VI results, the R0p was estimated to 
be 1.0 (95% CI: 0.20 - 6.0). By using the transient state method and the RT-PCR results, 
the R0p was estimated to be 1.4 (95% CI: 0.30 - 8.0). By using the final size method, R0p was 
estimated to be 0.90 (95% CI: 0.20 - 3.0). The estimated transmission parameters using the 
results from the VI and the RT-PCR analysis are shown in Table 4.
relative infectivities and susceptibilities of sheep and cattle
The estimated R0p sheep-to-cattle is very similar to the R0 sheep-to-sheep estimated previously (final size 
R0 = 1.1) in two intraspecies transmission studies with sheep [5,6], indicating that cattle and 
sheep are similarly susceptible to FMD.
The estimated R0p sheep-to-cattle is lower than the R0 cattle-to-cattle estimated previously in three 
intraspecific transmission studies with cattle (final size R0 = ∞ [9], final size R0 = 2.52 [10] 
and final size R0 = 14 in Bravo de Rueda et al., in press), indicating that cattle are more 
infectious than sheep.
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Table 1 Results of the virus isolation, RT-PCR, serology and clinical inspection.
Animal Virus isolation RT-PCR Serology FMD clinical signs
Contact infectionRoom Species Nr Oral swabs Blood Oral swabs Probang NS- ELISA VNT Fevera Vesicles Lameness
1 Calf 5439 - - - - - - - - - No
Lamb 5440 + + + + + + + + +
Lamb 5441 + + + - + + + + +
2 Calf 5442 - - - + + + - - - Yes
Lamb 5443 + + + - + + + - -
Lamb 5444 + - + + + + - - -
3 Calf 5445 - - - - - - - - - No
Lamb 5446 + - + - + + - - -
Lamb 5447 + - + - + + - - -
4 Calf 5448 - - - - - - - - - No
Lamb 5449 + + + + + + + + -
Lamb 5450 + + + - + + + - -
5 Calf 5451 - - - - - - - - - No
Lamb 5452 + + + + + + - - -
Lamb 5453 + + + + + + - + -
6 Calf 5454 - - - - - - - - - No
Lamb 5455 + + + - + + + + +
Lamb 5456 + + + + + + + + +
7 Calf 5457 + + + - + + + + - Yes
Lamb 5458 + + + - + + + + +
Lamb 5459 + + + - + + - + +
8 Calf 5460 - - - - - - - - - No
Lamb 5461 + + + - + + + - +
Lamb 5462 + + + - + + + - +
9 Calf 5463 - - + - + + - - - Yes
Lamb 5464 + + + + + + + + -
Lamb 5465 + - + + + + - - -
10 Calf 5466 - - - - + + - - - Yes
Lamb 5467 + + + - + + + + +
Lamb 5468 + + + + + + + + +
+/−, positive /negative in one or more of the tested samples. a fever in sheep: body temperature above 40 °C; fever in cattle: body temperature above 39.5 °C.
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Table 1 Results of the virus isolation, RT-PCR, serology and clinical inspection.
Animal Virus isolation RT-PCR Serology FMD clinical signs
Contact infectionRoom Species Nr Oral swabs Blood Oral swabs Probang NS- ELISA VNT Fevera Vesicles Lameness
1 Calf 5439 - - - - - - - - - No
Lamb 5440 + + + + + + + + +
Lamb 5441 + + + - + + + + +
2 Calf 5442 - - - + + + - - - Yes
Lamb 5443 + + + - + + + - -
Lamb 5444 + - + + + + - - -
3 Calf 5445 - - - - - - - - - No
Lamb 5446 + - + - + + - - -
Lamb 5447 + - + - + + - - -
4 Calf 5448 - - - - - - - - - No
Lamb 5449 + + + + + + + + -
Lamb 5450 + + + - + + + - -
5 Calf 5451 - - - - - - - - - No
Lamb 5452 + + + + + + - - -
Lamb 5453 + + + + + + - + -
6 Calf 5454 - - - - - - - - - No
Lamb 5455 + + + - + + + + +
Lamb 5456 + + + + + + + + +
7 Calf 5457 + + + - + + + + - Yes
Lamb 5458 + + + - + + + + +
Lamb 5459 + + + - + + - + +
8 Calf 5460 - - - - - - - - - No
Lamb 5461 + + + - + + + - +
Lamb 5462 + + + - + + + - +
9 Calf 5463 - - + - + + - - - Yes
Lamb 5464 + + + + + + + + -
Lamb 5465 + - + + + + - - -
10 Calf 5466 - - - - + + - - - Yes
Lamb 5467 + + + - + + + + +
Lamb 5468 + + + + + + + + +
+/−, positive /negative in one or more of the tested samples. a fever in sheep: body temperature above 40 °C; fever in cattle: body temperature above 39.5 °C.
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Table 2 FMDV virus titres in oral swab, blood, urine and faeces samples.
Animal Nr
Days post infection Days post infection
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
Calf 5439 -a - toxb - - - - - - - - N.A.c - - - - - - - - - - - - - - - - - - - -
Lamb 5440 - 2.6d tox 3.8/
Vd
1.6 - 0.9 - - - 0.7 N.A. - - - 1.1 - - 1.7 1.1 0.7 - 1.0 - - 1.2 - 1.4 - - - -
Lamb 5441 - 1.3 tox 2.1/V 1.3 1.4 - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Calf 5442 - - tox -*e - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5443 - - tox/V 2.8/V -/V 1.0 0.4 - - - - N.A. - - - - - - - - 0.4 - - - 1.2 - 0.4 - - - - -
Lamb 5444 - 2.2 tox - 0.4 1.0 0.9 - - - 1.0 N.A. 1.5 - 0.4 1.8 - 1.5 2.1 1.2 0.9 - 1.1 - 1.7 - 1.0 0.4 - - - -
Calf 5445 - - tox - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5446 - 0.4 tox 4.0 3.3 2.2 0.4 - 0.4 - - N.A. - - 1.0 1.1 - 2.5 N.A. 0.4 - - - - - - 1.3 - - - - -
Lamb 5447 - 2.7 tox 0.4 2.4 2.4 - - - - - N.A. - - 2.1 1.3 0.7 0.4 - 0.7 0.4 - - - - - 0.4 - - - - -
Calf 5448 - - tox - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5449 - 2.1/V tox/V 4.2/V - 0.9 - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5450 - 3.7 tox/V 2.3/V 1.4 1.5 - - - - - N.A. - - - 1.7 - 1.2 0.4 - 1.7 - - - 2.1 - 1.0 - - - - -
Calf 5451 - - tox - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5452 - -/V tox/V 4.0 1.6 - 0.4 - - - - N.A. - - - - - 2.2 2.0 1.7 0.4 1.8 1.9 - - 0.9 1.3 1.3 1.6 - - 1.0
Lamb 5453 - 0.4/V tox/V 2.3/V 1.9 1.4 1.1 - - - 0.7 N.A. - - 1.9 1.5 0.7 0.4 - - - - - - - - 1.5 - - - - -
Calf 5454 - - tox - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5455 - - tox 0.7/V 0.7/V 1.9 0.4 - - - - N.A. - - 1.4 0.9 1.4 1.5 1.4 - - - 0.9 - - - - 1.4 - - 1.2 -
Lamb 5456 - 1.6 tox 2.7/V 2.1/V 1.0 0.4 - - - - N.A. - - 1.0 0.4 - 0.9 1.4 1.5 - - 0.4 - - - 0.9 - - 1.7 - 0.7
Calf 5457 - - tox - - - - 3.1/V* 3.4 4.3/Vf 4.3f N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5458 - 0.7 tox 3.9/V 0.9 0.9 1.2 - - -g - N.A. - - 1.3 1.9 2.5 2.8 2.5 0.4 2.1 2.6 2.4 1.5 1.6 - 1.7 - 2.3 - 0.4 2.4
Lamb 5459 - 1.6 tox 2.8/V 2.2 0.4 - - - - 2.3 N.A. - 0.9 2.6 - 1.2 1.2 1.8 1.9 - 1.5 2.3 - 1.2 1.7 1.4 - 0.7 - 1.6 -
Calf 5460 - - tox - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5461 - 0.4/V tox/V 2.7/V 1.2 0.7 - - - - - N.A. - - 0.4 1.4 - 0.9 - - - 1.2 1.7 - - - - - - - - -
Lamb 5462 - 2.1/V tox/V 4.0/V 1.7 1.9 - - - - - N.A. - - - - - - 0.9 - - - 1.1 - - - - - 1.6 - - -
Calf 5463 - - - - - - - - - - -* N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5464 - 1.7 2.5 3.7 2.1/V 0.9/V - - - - - N.A. - 1.7 1.5 1.2 2.6 0.9 1.2 2.3 - - 1.8 - 1.2 2.2 2.5 1.7 0.4 - - -
Lamb 5465 - - 2.1 - 0.4 2.2 - - - 1.5 - N.A. - 2.1 1.1 1.3 2.7 1.2 2.0 1.2 - - 1.2 - - - 0.7 - - - - -
Calf 5466 - - - - - - - - - - -* N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5467 - -/V 3.0/V 2.7/V 2.8 1.8 - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5468 - 4.0/V 3.0/V -/V 1.4/V 1.0 - - - - - N.A. - - 1.0 0.9 0.4 1.2 0.4 - - 1.8 2.0 2.1 - - - - - - - -
aoral swab sample that scored positive for FMDV by virus isolation (VI) (log10 pfu/mL); −: no virus was 
detected.
btox: toxic oral swab sample, no VI result available. 
cN.A.: results not-available for oral swab samples. 
dV = viraemia: blood sample that scored positive for FMDV by VI.
e* indicates the (estimated) day of infection of the contact calves 5442, 5457, 5463 and 5466.
furine sample that scored positive for FMDV by VI.
gfaeces sample that scored positive for FMDV by VI.
84
E
stim
a
tio
n
 o
f th
E
 tr
a
n
sm
issio
n
 o
f fo
o
t-a
n
d
-m
o
u
th
 d
isE
a
sE
 v
ir
u
s fr
o
m
 in
fE
c
tE
d
 sh
E
E
p to
 c
a
ttlE
IV
Table 2 FMDV virus titres in oral swab, blood, urine and faeces samples.
Animal Nr
Days post infection Days post infection
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
Calf 5439 -a - toxb - - - - - - - - N.A.c - - - - - - - - - - - - - - - - - - - -
Lamb 5440 - 2.6d tox 3.8/
Vd
1.6 - 0.9 - - - 0.7 N.A. - - - 1.1 - - 1.7 1.1 0.7 - 1.0 - - 1.2 - 1.4 - - - -
Lamb 5441 - 1.3 tox 2.1/V 1.3 1.4 - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Calf 5442 - - tox -*e - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5443 - - tox/V 2.8/V -/V 1.0 0.4 - - - - N.A. - - - - - - - - 0.4 - - - 1.2 - 0.4 - - - - -
Lamb 5444 - 2.2 tox - 0.4 1.0 0.9 - - - 1.0 N.A. 1.5 - 0.4 1.8 - 1.5 2.1 1.2 0.9 - 1.1 - 1.7 - 1.0 0.4 - - - -
Calf 5445 - - tox - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5446 - 0.4 tox 4.0 3.3 2.2 0.4 - 0.4 - - N.A. - - 1.0 1.1 - 2.5 N.A. 0.4 - - - - - - 1.3 - - - - -
Lamb 5447 - 2.7 tox 0.4 2.4 2.4 - - - - - N.A. - - 2.1 1.3 0.7 0.4 - 0.7 0.4 - - - - - 0.4 - - - - -
Calf 5448 - - tox - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5449 - 2.1/V tox/V 4.2/V - 0.9 - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5450 - 3.7 tox/V 2.3/V 1.4 1.5 - - - - - N.A. - - - 1.7 - 1.2 0.4 - 1.7 - - - 2.1 - 1.0 - - - - -
Calf 5451 - - tox - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5452 - -/V tox/V 4.0 1.6 - 0.4 - - - - N.A. - - - - - 2.2 2.0 1.7 0.4 1.8 1.9 - - 0.9 1.3 1.3 1.6 - - 1.0
Lamb 5453 - 0.4/V tox/V 2.3/V 1.9 1.4 1.1 - - - 0.7 N.A. - - 1.9 1.5 0.7 0.4 - - - - - - - - 1.5 - - - - -
Calf 5454 - - tox - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5455 - - tox 0.7/V 0.7/V 1.9 0.4 - - - - N.A. - - 1.4 0.9 1.4 1.5 1.4 - - - 0.9 - - - - 1.4 - - 1.2 -
Lamb 5456 - 1.6 tox 2.7/V 2.1/V 1.0 0.4 - - - - N.A. - - 1.0 0.4 - 0.9 1.4 1.5 - - 0.4 - - - 0.9 - - 1.7 - 0.7
Calf 5457 - - tox - - - - 3.1/V* 3.4 4.3/Vf 4.3f N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5458 - 0.7 tox 3.9/V 0.9 0.9 1.2 - - -g - N.A. - - 1.3 1.9 2.5 2.8 2.5 0.4 2.1 2.6 2.4 1.5 1.6 - 1.7 - 2.3 - 0.4 2.4
Lamb 5459 - 1.6 tox 2.8/V 2.2 0.4 - - - - 2.3 N.A. - 0.9 2.6 - 1.2 1.2 1.8 1.9 - 1.5 2.3 - 1.2 1.7 1.4 - 0.7 - 1.6 -
Calf 5460 - - tox - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5461 - 0.4/V tox/V 2.7/V 1.2 0.7 - - - - - N.A. - - 0.4 1.4 - 0.9 - - - 1.2 1.7 - - - - - - - - -
Lamb 5462 - 2.1/V tox/V 4.0/V 1.7 1.9 - - - - - N.A. - - - - - - 0.9 - - - 1.1 - - - - - 1.6 - - -
Calf 5463 - - - - - - - - - - -* N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5464 - 1.7 2.5 3.7 2.1/V 0.9/V - - - - - N.A. - 1.7 1.5 1.2 2.6 0.9 1.2 2.3 - - 1.8 - 1.2 2.2 2.5 1.7 0.4 - - -
Lamb 5465 - - 2.1 - 0.4 2.2 - - - 1.5 - N.A. - 2.1 1.1 1.3 2.7 1.2 2.0 1.2 - - 1.2 - - - 0.7 - - - - -
Calf 5466 - - - - - - - - - - -* N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5467 - -/V 3.0/V 2.7/V 2.8 1.8 - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5468 - 4.0/V 3.0/V -/V 1.4/V 1.0 - - - - - N.A. - - 1.0 0.9 0.4 1.2 0.4 - - 1.8 2.0 2.1 - - - - - - - -
aoral swab sample that scored positive for FMDV by virus isolation (VI) (log10 pfu/mL); −: no virus was 
detected.
btox: toxic oral swab sample, no VI result available. 
cN.A.: results not-available for oral swab samples. 
dV = viraemia: blood sample that scored positive for FMDV by VI.
e* indicates the (estimated) day of infection of the contact calves 5442, 5457, 5463 and 5466.
furine sample that scored positive for FMDV by VI.
gfaeces sample that scored positive for FMDV by VI.
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Table 3 FMDV RT-PCR results in oral swab samples.
Days post infection Days post infection
Animal Nr 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
Calf 5439 -a - - - - - - - - - - N.A.b - - - - - - - - - - - - - - - - - - - -
Lamb 5440 - + + + + + + - - - - N.A. - + + + + + + + + + + + + + + + - - + -
Lamb 5441 - + - + + + + - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Calf 5442 - - - - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5443 - + - + + + - - - + + N.A. - + - + - - - - + - - + + - + - - - + -
Lamb 5444 - + + - + + + - - + + N.A. + - + + - + + + + + + + + - + + + - - -
Calf 5445 - - - - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5446 - + - + + + + + + + + N.A. + - + + + + N.A. + + + + + + - + + + - - +
Lamb 5447 - + + - + + + - - - - N.A. - - + + + + + + + + - + - - - - - - - +
Calf 5448 - - - - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5449 - + + + + + + - - - - N.A. - - - - - + - + + + + - + + + - - - - -
Lamb 5450 - + - + + + + + - - - N.A. + - + + - + + - + + + - + + + - - - - -
Calf 5451 - - - - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5452 - - + + + - + - - - - N.A. - + + + + + + + + + + + + + + + + - + +
Lamb 5453 - - + + + + + + - + + N.A. + + + + + + + - + - + + + + + + + - + -
Calf 5454 - - - - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5455 - + + + + + - - - - - N.A. - + + + + + + + + + + + + - + + - - + +
Lamb 5456 - + + + + + + + - + + N.A. + + + + + + + + - + + + + + + - + + - +
Calf 5457 - - - - - - - + + + + N.A. + + - - - - - - - - - - - - - - - - - -
Lamb 5458 - + - + + + + - - - + N.A. - + + + + + + + + + + + + - + - + - + +
Lamb 5459 - + + + + + + - - + + N.A. + + + + + + + + + + + + + + + - + - + -
Calf 5460 - - - - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5461 - + - + + + - - - - - N.A. - + + + - + + + - + + + - + + + - + + +
Lamb 5462 - + + + + + - - - - - N.A. - - + - + + + - - - - - + - - - + - - -
Calf 5463 - - - - - - - - - - + N.A. + - - - - - - - - - - - - - - - - - - -
Lamb 5464 - + + + + + - - - + + N.A. + + + + + + + + + + + + + + + + + + + +
Lamb 5465 - + + - + + - - - + - N.A. + + + + + + + + + - + + + - - - - - + -
Calf 5466 - - - - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5467 - + + + + + - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5468 - + + + + + + + + + + N.A. + + + + + + + + + + + + + + + - + + + -
aoral swab sample that scored positive for FMDV by RT-PCR; −: no virus was detected and +: virus detected. bN.A.: results not-available for oral swab samples.
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Table 3 FMDV RT-PCR results in oral swab samples.
Days post infection Days post infection
Animal Nr 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
Calf 5439 -a - - - - - - - - - - N.A.b - - - - - - - - - - - - - - - - - - - -
Lamb 5440 - + + + + + + - - - - N.A. - + + + + + + + + + + + + + + + - - + -
Lamb 5441 - + - + + + + - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Calf 5442 - - - - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5443 - + - + + + - - - + + N.A. - + - + - - - - + - - + + - + - - - + -
Lamb 5444 - + + - + + + - - + + N.A. + - + + - + + + + + + + + - + + + - - -
Calf 5445 - - - - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5446 - + - + + + + + + + + N.A. + - + + + + N.A. + + + + + + - + + + - - +
Lamb 5447 - + + - + + + - - - - N.A. - - + + + + + + + + - + - - - - - - - +
Calf 5448 - - - - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5449 - + + + + + + - - - - N.A. - - - - - + - + + + + - + + + - - - - -
Lamb 5450 - + - + + + + + - - - N.A. + - + + - + + - + + + - + + + - - - - -
Calf 5451 - - - - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5452 - - + + + - + - - - - N.A. - + + + + + + + + + + + + + + + + - + +
Lamb 5453 - - + + + + + + - + + N.A. + + + + + + + - + - + + + + + + + - + -
Calf 5454 - - - - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5455 - + + + + + - - - - - N.A. - + + + + + + + + + + + + - + + - - + +
Lamb 5456 - + + + + + + + - + + N.A. + + + + + + + + - + + + + + + - + + - +
Calf 5457 - - - - - - - + + + + N.A. + + - - - - - - - - - - - - - - - - - -
Lamb 5458 - + - + + + + - - - + N.A. - + + + + + + + + + + + + - + - + - + +
Lamb 5459 - + + + + + + - - + + N.A. + + + + + + + + + + + + + + + - + - + -
Calf 5460 - - - - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5461 - + - + + + - - - - - N.A. - + + + - + + + - + + + - + + + - + + +
Lamb 5462 - + + + + + - - - - - N.A. - - + - + + + - - - - - + - - - + - - -
Calf 5463 - - - - - - - - - - + N.A. + - - - - - - - - - - - - - - - - - - -
Lamb 5464 - + + + + + - - - + + N.A. + + + + + + + + + + + + + + + + + + + +
Lamb 5465 - + + - + + - - - + - N.A. + + + + + + + + + - + + + - - - - - + -
Calf 5466 - - - - - - - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5467 - + + + + + - - - - - N.A. - - - - - - - - - - - - - - - - - - - -
Lamb 5468 - + + + + + + + + + + N.A. + + + + + + + + + + + + + + + - + + + -
aoral swab sample that scored positive for FMDV by RT-PCR; −: no virus was detected and +: virus detected. bN.A.: results not-available for oral swab samples.
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disCussion
The purpose of this study was to estimate transmission of FMDV from infected sheep to 
contact cattle and, together with results from previous studies, to identify differences in 
either susceptibility to FMD or infectivity of FMD infected sheep and cattle. Our study 
shows that FMDV transmission from sheep to cattle occurs, but the estimated partial 
reproduction ratio (R0p) indicates that the expected number of secondary cases in calves, 
caused by infected lambs, is relatively low. Moreover, the susceptibility of sheep to FMD 
seems to be similar to the susceptibility of cattle to FMD. This finding is supported by French 
et al. [29] who found overlapping distributions when analysing dose–response relationships 
in cattle and sheep exposed to FMDV in aerosols. The fact that cattle and sheep have a 
similar susceptibility to FMD and the fact that the transmission (R0) from cattle to cattle 
is higher than the transmission (R0p) from sheep to cattle, indicate that cattle are more 
infectious than sheep. Thus, cattle play the major role in the transmission of FMDV in a 
mixed population with sheep and cattle. These relative infectivities and susceptibilities are 
useful for modelling FMD spread such as for example in Backer et al. [16]. In their model 
they assumed that the susceptibility of cattle herds is twice the susceptibility of sheep herds. 
Our results can be used to update such FMD spread models, and more importantly, could 
be a reason to implement different control strategies for both animal species.
We estimated a partial reproduction ratio for sheep-to-cattle transmission. This 
estimate alone does not reflect transmission for an entire mixed population consisting of 
sheep and cattle. In such a population, cattle-to-cattle, sheep-to-sheep, sheep-to-cattle and 
cattle-to-sheep transmission can take place. For the estimation of transmission in a mixed 
population, more information and/or other mathematical techniques are required [15]. 
Even though sheep play a more limited role in transmitting FMDV as compared to cattle, 
the reproduction ratio in a mixed population of sheep and cattle can still be larger than 1, 
meaning that major outbreaks can occur. Probably, the R0 for a mixed population of cattle 
and sheep will be higher if a higher proportion of cattle are present.
Previously, we studied transmission of FMDV between cattle [9-11] and between sheep [6] 
using FMDV strain O/NET/2001. However, different strains of FMDV might affect different 
species and might have different transmission characteristics. In more recent studies, we therefore 
Table 4 Estimated transmission parameters using the results from the Virus isolation (VI) and the RT-PCR 
analysis.
Transmission rate 
parameter (interspecies β) Infectious period (T)
Partial reproduction ratio (R0p)
Transient state method Final size method
β (day−1) 95% CI T (days) 95% CI R0p 95% CI R0p 95%CI
VI 0.037 0.014 - 0.076 28. 19. - 42. 1.0 0.20 - 6.0
RT-PCR 0.031 0.012 - 0.065 46. 28. - 73. 1.4 0.30 - 8.0
0.90 0.20 -3.0
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used another serotype of FMDV to study transmission of FMDV. We chose FMDV Asia-1 because 
this serotype spread towards mainland Europe [30,31]. We observed transmission of FMDV 
Asia-1 between sheep [5] and between cattle (Bravo de Rueda et al., in press), and now studied 
transmission between sheep and cattle. The R0 values obtained in the studies using serotype O 
and Asia-1 are not significantly different. Still, differences might exist for other serotypes.
In this study, we investigated within pen transmission. The animals in this study were 
in close proximity. Extrapolation of experimental data to field conditions should always be 
done with care. However, the relative infectivity and susceptibility will not change under 
field conditions. In field conditions, the estimated R0p will probably be lower because it 
is known that between-pen transmission is lower than within-pen transmission [32-34]. 
Additionally, between-herd transmission will most likely be even lower [35].
The relative low R0p in the transmission of FMDV from sheep to cattle can have 
implications for control measures implemented during an outbreak, e.g. whether or not 
to use vaccination in sheep, given the fact that vaccination against FMD is very effective in 
cattle [9,10]. If all cattle were vaccinated and thus became less infectious, then vaccination 
of sheep would not have an additional contribution to FMD control, especially when other 
control measures are implemented e.g. movement restrictions.
The observed relatively low infectivity of sheep is remarkable if we take into consideration 
that the duration of the secretion and excretion of FMDV in sheep (specifically in oral swabs) 
is much longer than in cattle. The mean duration of secretion and excretion of FMDV in 
sheep, in this study, was 28 days (VI results from oral swab samples). A similarly long period 
was shown by Eblé et al. [5], who showed that sheep secrete and excrete FMDV for longer 
than 30 days. In contrast, calves infected with the same strain of FMDV, secrete and excrete 
FMDV for on average 5.0 days (VI results from oral swab samples in Bravo de Rueda et al., 
in press). It was already known that sheep are long- term secretors and excretors of FMDV 
[3,36]. Nevertheless the results reported here show that this long-term secretion and excretion 
of FMDV in sheep does not enhance transmission of the infection from sheep to cattle. In our 
study, transmission events took place mainly during the first week after infection. This is in 
accordance with what others have observed in sheep [5-8] and in cattle [9,10].
In our study as well as in the above-mentioned studies, it was observed that FMDV is 
secreted and excreted in higher quantities during the first week post infection. Previous 
research showed that virus titres in upper respiratory tract samples from sheep are lower 
than those in cattle [4]. The ability of cattle to shed more virus than sheep could (partially) 
explain the observed difference in the infectivity of sheep and cattle. Moreover, in FMDV 
infected cattle, profuse salivation and nasal discharge are often observed [37]. Compared to 
cattle, salivation and nasal discharge after FMDV infection in sheep is less profuse i.e. sheep 
show less severe clinical signs [1,38,39]. Therefore it can be assumed that profuse secretion 
and excretion of the virus contributes to a higher contamination of the environment with 
FMDV. A recent analysis showed that FMDV transmission occurs for a large part through 
the environment (Bravo de Rueda et al., in press), and thus more new cases of FMD will 
take place if animals would shed more infected secretions and excretions.
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We conclude that despite the ability of sheep to secrete and excrete FMDV for a relatively 
long period of time, sheep are less infectious than cattle. The observed differences in the 
relative susceptibility and infectivity of sheep and cattle could be a reason to implement 
different control strategies for both animal species.
additionaL FiLes
Additional file 1 Calculating reproduction ratio R0 in two-to-one transmission experiments. 
This additional file shows the analytical derivation of the maximum likelihood estimate 
(MLE) of R0 (RMLE) in a two-to-one experimental transmission design.
introduction
In disease transmission, quantifying the average number of newly infected individuals 
caused by an infectious individual during its entire infectious period (Reproduction ratio, 
R0) is important. When several infectious and susceptible individuals are mixed in an 
experiment, both infectious and susceptible individuals should have a similar status e.g. both 
be vaccinated, or e.g. be the same species. To avoid this problem transmission experiments 
can also be performed in a one-to-one transmission experiment set up [21,24]. In one-to-
one transmission experiments, the expression for R0 has been derived analytically, R0 = 2 p/
(1-p) where p is the total number of infection events divided by the number of independent 
replications. Given the rates of infection and recovery (see Additional file 2), R0 is β times 
the infectious period (1/α) [21,28]. Similarly to a one-to-one transmission experiment, in 
this paper we derive R0 for a two-to-one transmission experiment.
maximum Likelihood estimate for r0 in a transmission experiment 
using 2 infectious and 1 susceptible individuals
The two-to-one transmission experiment can graphically be represented as an SI (susceptible-
infected) plane. An additional file shows this graphical SI plane (see Additional file 2). 
The probability that both infected individuals recover and the susceptible individual 
escapes infection (St = 1 and Nt = 3) is:
So the probability that the susceptible individual becomes infected is:
and .
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Where pˆ is the MLE of p, the total number of infection events divided by the number of 
independent replications and Rˆ0 is the MLE of R0.
Note that in this case the estimated R0 is a partial reproduction ratio (R0p) as infectious 
animals are all sheep and susceptible animals are all cattle.
Additional file 2 The two-to-one transmission experiment is graphically represented as an SI 
(susceptible-infected) plane. This additional file is part of Additional file 1. This graph shows 
how a two-to-one transmission experiment can be represented using an infectious-susceptible 
plane. β is the transmission rate parameter, St is the number of susceptible animals, It is the 
number of infectious animals, Nt is the total number of animals and, α the recovery rate.
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Vvaccination of cattle only is sufficient to stop Fmdv transmission in mixed populations of sheep and cattle
Carla Bravo de Rueda, Aldo Dekker, Phaedra L. Eblé, Mart C.M. de Jong
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We quantify the transmission of foot-and-mouth disease virus in mixed cattle-sheep 
populations and the effect of different vaccination strategies. The (partial) reproduction 
ratios (R) in groups of non-vaccinated and vaccinated cattle and/or sheep were estimated 
from (published) transmission experiments. A 4 × 4 next-generation matrix (NGM) was 
constructed using these estimates. The dominant eigenvalue of the NGM, the R for a mixed 
population, was determined for populations with different proportions of cattle and sheep 
and for three different vaccination strategies. The higher the proportion of cattle in a mixed 
cattle-sheep population, the higher the R for the mixed population. Therefore the impact 
of vaccination of the cattle is higher. After vaccination of all animals R = 0.1 independent 
of population composition. In mixed cattle-sheep populations with at least 14% of cattle, 
vaccination of cattle only is sufficient to reduce R to < 1. 
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introduCtion
Foot-and-mouth disease (FMD) is a viral disease in cloven-hoofed animals caused by 
foot-and-mouth disease virus (FMDV). Transmission of FMDV is difficult to control. The 
magnitude of transmission of any infection is assessed using the reproduction ratio R [1, 2]. 
R is defined as the average number of new cases arising from a typical infected individual 
during its whole infectious period in a fully susceptible population. An infectious agent is 
able to cause major outbreaks only if R is > 1 [3]. For FMDV, R has been quantified using field 
data [4] and experimental data [5–12]. Using experimental data, R has been quantified for 
both vaccinated and non-vaccinated sheep-to-sheep transmission [7, 11] and for vaccinated 
and non-vaccinated cattle-to-cattle transmission [9, 10] (and in Bravo de Rueda et al., in 
press). In addition, a partial R for non-vaccinated sheep to non-vaccinated cattle [13] has 
been quantified; however, this estimate alone is not sufficient to assess the magnitude of 
transmission of FMDV in a mixed population of cattle and sheep. In order to understand the 
transmission of FMDV in field conditions where different species co-exist, it is necessary to 
quantify R for heterogeneous populations (i.e. consisting of sheep and cattle). 
Vaccination against FMDV has been recognized as an important tool for the control of 
FMDV. Vaccination against FMDV can prevent transmission of the virus both in field conditions 
[14–16] and experimentally [5, 7, 9–11, 17, 18]. In mainland Europe, FMDV was eradicated by 
prophylactic vaccination of cattle only [15]. In parts of South America, FMDV was successfully 
eradicated by vaccination of cattle only [16]. For example, in Uruguay, where cattle and sheep, 
mingle freely and where (before 2002) the proportion of sheep in the population was slightly 
higher than that of cattle, vaccination of cattle only was sufficient to eradicate FMDV [16, 19]. 
In the European Union, emergency vaccination of (all) susceptible species is an option during 
an FMDV outbreak (EU directive 2003/85). The Netherlands used emergency vaccination in 
the 2001 outbreak with vaccination of all FMDV susceptible animals. However, it is unclear 
whether emergency vaccination of all susceptible species is necessary to control an epidemic or 
if targeting vaccination to certain species (e.g. only cattle) could be sufficient. 
In the current study we developed a method to determine R for mixed populations 
consisting of cattle and sheep by using experimental transmission data and a technique 
known as the next-generation matrix (NGM) [20]. The method allows analysis of different 
vaccination strategies in different mixed populations consisting of cattle and sheep. 
methods
data source from experimental studies 
Data available from direct contact transmission studies [7, 9–11, 13] (and in Bravo de Rueda 
et al. in press) were used. These data were collected from three cattle-to-cattle transmission 
studies (26 experimental groups), two sheep-to-sheep transmission studies (24 experimental 
groups) and one sheep-to-cattle transmission study (10 experimental groups). These 
transmission studies were selected because the raw data on the number of susceptible, 
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infectious, and recovered animals were readily available, and because comparable methods 
were used in the experiments. The donors in all these studies were inoculated via the 
intranasal route using either FMDV O/NET/2001 or Asia-1 TUR/11/2000. Five of these six 
studies also contained data on transmission of FMDV after vaccination, using either FMDV 
O Manisa or FMDV Asia-1 Shamir as vaccine strains. 
Quantification of (partial) r values by using experimental data 
The SIR model [21] was used for the quantification of R cattle to cattle (Rc–c), sheep to sheep 
(Rs–s), and partial R sheep to cattle (partial Rs–c) for non- vaccinated animals and of Rc-cvac and 
Rs-svac for vaccinated animals. The animals from the direct contact transmission studies [7, 
9–11, 13] (and in Bravo de Rueda et al., in press) were classified as susceptible, infectious, or 
recovered (S-I-R, respectively), at the start (S0, I0) and at the end (St, Rt) of the experiment. 
It was assumed that the animals were infectious if they tested positive by virus isolation (on 
secondary lamb kidney cells) or if they developed infection specific antibodies (detected by 
NS-ELISA). Contact animals were considered infected if they tested positive for FMDV or 
FMDV specific antibodies during the experiment. Animals that were infectious during the 
experiment were considered as recovered at the end of the experiment (Rt). Data originating 
from experiments with the same donor species and same contact animal species were pooled 
for the calculation of the reproduction ratio R.  The recorded data as S0, I0, St and Rt and the 
frequencies at which they occurred (see Tables 1 and 2), were used to estimate the reproduction 
ratio R [22] for non-vaccinated and/or vaccinated groups by using the final size method [23, 
24]. The Rc–c, Rc-cvac, Rs–s, Rs-svac  and partial Rs–c, and their 95% confidence intervals (CI) were 
calculated from the final sizes using the maximum likelihood estimation and exact confidence 
bounds [25] in Mathematica® (http://www.wolfram.com/mathematica/). 
The null hypothesis that no difference existed between the estimates of Rc–c and Rs–s, 
Rs–s and partial Rs–c, and Rc–c and partial Rs–c was tested by using a two-sided test with a 
significance level of 0.05 [25]. 
estimation of relative infectivities, susceptibilities and the unknown 
(partial) r values by using the separable mixing assumption 
We built a 4 × 4 table using the (partial) R’s between non-vaccinated/ vaccinated cattle and 
non-vaccinated/ vaccinated sheep. In this 4 × 4 table only five out of the possible 16 values 
were quantified using the experimental data. By assuming separable mixing, i.e. assuming 
that the (partial) R’s are the product of a relative infectivity fi [where i is either non-vaccinated 
cattle (nc), vaccinated cattle (vc), non-vaccinated sheep (ns), or vaccinated sheep (vs)] and a 
relative susceptibility gi [where i is either non-vaccinated cattle (nc), vaccinated cattle (vc), non-
vaccinated sheep (ns), or vaccinated sheep (vs)], we calculated the missing values in the table. 
Without loss of generality we chose non-vaccinated cattle to have a susceptibility of 1. Further, 
we assumed the relative susceptibility of vaccinated animals also to be 1, the same as the relative 
susceptibility of non-vaccinated animals. This assumption might seem counterintuitive, but 
local virus replication is often detected in vaccinated animals after challenge [26], indicating 
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Table 1 Final outcome from the transmission experiments with non-vaccinated animals. 
Experiment
FMDV 
serotype Animals
No. of 
animals/group S0   I0 St Rt Frequency Reference
a Asia-1 Calves 2 1 1 0 2 4 (Bravo de Rueda 
et al., in press)
a Asia-1 Calves 2 2 0 2 0 1 (Bravo de Rueda 
et al., in press)
b O Calves 4 2 2 0 4 4 (10)
b O Calves 4 2 2 1 3 2 (10)
c O Cows 10 5 5 0 10 2 (9)
d Asia-1 Lambs 4 2 2 0 4 2 (7)
d Asia-1 Lambs 4 2 2 1 3 1 (7)
d Asia-1 Lambs 4 2 2 2 2 3 (7)
e O Lambs 4 2 2 0 4 2 (11)
e O Lambs 4 2 2 1 3 1 (11)
e O Lambs 4 2 2 2 2 3 (11)
f Asia-1 Lambs -calf 3 1 2 0 3 4 (13)
f Asia-1 Lambs -calf 3 1 2 1 2 6 (13)
S0 and St represent the number of susceptible animals at the start and at the end of the experiment; I0 
represents the number of infectious animals at the start of the experiment; and Rt represents the number 
of recovered animals at the end of the experiment. Frequency represents the number of experimental 
groups with the same outcome. Dashed lines separate the experimental groups of animals.
that vaccinated animals are still susceptible. In our calculations, the value is only necessary for 
filling the table. It does not influence the results on the diagonal, which are the only numbers 
that will be used (as will be explained below) in the calculation of the R values for the different 
strategies. Note that the reduction in transmission due to vaccination is now assumed to be due 
to the lower infectivity of the vaccinated and then infected animals (Table 3). 
Construction of a nGm 
A NGM allows the analysis of the effect of different categories of individuals on the overall 
transmission, i.e. in a mixed population [27]. In our case, R for a mixed population of cattle 
and sheep depends on the proportion of each animal species in the population. In the matrix 
pc is the proportion of cattle (i.e. the total number of cattle divided by the total number of cattle 
and sheep in a population) and 1 – pc is the proportion of sheep in the same population. In the 
matrix the proportion of vaccinated animals per species are indicated by pvc and pvs, where 
pvc and pvs represent the proportion of vaccinated cattle and the proportion of vaccinated 
sheep, respectively. The relative infectivity fi and relative susceptibility gi from the above 4 × 4 
table were added to the NGM. Thus, the elements of our matrix are functions of the relative 
infectivity (fi), relative susceptibility (gi), the proportion of cattle (pc), and the proportion of 
vaccinated cattle and that of sheep (pvc or pvs). 
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evaluation of the influence of different proportions of cattle (pc)  
and sheep (1 – pc) 
We studied the influence of different proportions of cattle and sheep on the transmission of 
FMDV in our NGM. To illustrate this we used five different populations: (1) a population 
consisting of cattle only, (2) a population with a higher number of cattle than sheep, (3) 
a population with a relatively similar number of cattle and sheep, (4) a population with 
a higher number of sheep than cattle, and (5) a population consisting of sheep only. For 
defining the different mixed populations consisting of cattle and sheep we used proportions 
of known livestock populations from the FAOSTAT database [28]. In 2011 these pc values 
were: 0.78 in The Netherlands (for population 2), 0.61 in Uruguay (for population 3), and 
0.24 in New Zealand (for population 4). The proportions of the population of cattle (pc per 
population) were included in the NGM. Finally, the dominant eigenvalue of the NGM, i.e. 
the reproduction ratio for the mixed populations, was determined for all five populations. 
evaluation of the effect of different vaccination strategies 
We used the five above-mentioned populations to evaluate the effect of three different 
vaccination strategies for the control of FMD transmission. These strategies were: (1) 
vaccinating both species equally, thus pvc = pvs, (2) vaccinating all cattle with additional 
vaccination of sheep (pvc = 1 and pvs ≠ 0) and, (3) vaccinating all sheep with additional 
Table 2 Final outcome from the transmission experiments with vaccinated animals. 
Experiment
FMDV 
serotype Animals 
No. of 
animals/group S0 I0 St Rt Frequency Reference
a Asia-1 Calves 2 2 0 2 0 5 (Bravo de Rueda 
et al., in press)
b O Calves 4 2 2 2 2 4 (10)
b O Calves 4 2 2 1 3 1 (10)
b O Calves 4 3 1 3 1 1 (10)
c O Cows 10 7 3 7 3 1 (9)
c O Cows 10 10 0 10 0 1 (9)
d Asia-1 Lambs 4 2 2 2 2 4 (7)
d Asia-1 Lambs 4 3 1 3 1 2 (7)
e O Lambs 4 2 2 2 2 2 (11)
e O Lambs 4 3 1 2 2 1 (11)
e O Lambs 4 3 1 3 1 2 (11)
e O Lambs 4 4 0 4 0 1 (11)
S0 and St represent the number of susceptible animals at the start and at the end of the experiment; I0 
represents the number of infectious animals at the start of the experiment; and Rt represents the number 
of recovered animals at the end of the experiment. Frequency represents the number of experimental 
groups with the same outcome. Dashed lines separate the experimental groups of animals.
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vaccination of cattle (pvc ≠ 0 and pvs = 1). The obtained results were plotted for each strategy. 
Because R depends on pc, pvc and pvs, we calculated the proportion of animals that has to be 
vaccinated (or has to be present in a population) at which R reached the value of 1. 
Results
Quantification of (partial) R values by using experimental data 
In groups where no vaccination was applied, Rc–c was estimated as 5.3 (95% CI 3.0–42) and 
Rs–s was estimated as 1.1 (95% CI 0.44–2.4). The partial Rs–c was estimated as 0.87 (95% 
CI 0.20–2.9) (bold values in Table 3). Rc–c was found to be significantly higher than Rs–s 
(P = 0.002). Moreover, Rc–c was significantly higher than partial Rs–c (P = 0.005). Rs–s was not 
significantly different from partial Rs–c (P = 0.56) and therefore based on these results the 
susceptibility of cattle and sheep are considered similar. 
In groups where vaccination was applied, the Rvacc–c was estimated as 0.13 (95% CI 
0.0032–0.83) and Rvac s–s was estimated as 0.098 (95% CI 0.0026–0.65). The estimated relative 
infectivities (fi), relative susceptibilities (gi), and the (partial) R’s are shown in Table 3. 
Construction of the NGM 
Equation (1) shows the 4 × 4 NGM in which the proportions of cattle and sheep and the 
proportion of vaccinated animals are included. In our matrix, because of the assumption 
of separable mixing, the dominant eigenvalue equals the sum of the elements on the 
diagonal (from top left to bottom right) which is called the trace of the matrix [27]. This 
dominant eigenvalue is the R for the mixed population described by the NGM [20, 27]. 
Thus R(pc,pvc,pvs) = pc((1-pvc) fcgc+ pvcfvcgvc) + (1-pc)((1-pvs)fsgs + pvsfvsgvs).
Table 3 (Partial) R values as estimated from infected non-vaccinated (NV) or vaccinated (V) animals to 
non-vaccinated (NV) or vaccinated (V) contact animals 
From
NV cattle
(fnc =5.3)
NV sheep
(fns =0.87)
V cattle
(fvc =0.13)
V sheep
(fvs=0.075) 
To
NV cattle (gnc=1) 5.3 0.87 0.13 0.075
NV sheep (gns =1.3) 6.9 1.1 0.17 0.10
V cattle (gvc =1) 5.3 0.87 0.13 0.075
V sheep (gvs =1.3) 6.9 1.1 0.17 0.10
The values in bold were estimated from experimental data using the final size method. The other R values 
were based on the product of the relative infectivity (fi) and relative susceptibility (gj). We assumed that the 
relative susceptibility of both non-vaccinated and vaccinated cattle and sheep are equal. Without any loss of 
generality we took non-vaccinated cattle to have susceptibility equal to 1. Note: this table is not yet the NGM 
as the proportion of the different animal species and the proportion of vaccinated animals are still missing. 
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For example, for a population consisting of non-vaccinated cattle only, the dominant 
eigenvalue of that matrix is R(1, 0, 0) = fcgc = Rc–c and, for a population consisting of only 
vaccinated cattle, the dominant eigenvalue of that matrix is R(1, 1, 0) = fvcgvc = Rvacc–c.
Equation 1: NGM with non-vaccinated and vaccinated animals. fc and fs correspond to the 
infectivity of cattle and of sheep, respectively. gc and gs correspond to the susceptibility of 
cattle and of sheep, respectively. The proportion of the population of cattle pc and of sheep 
1 – pc depends on the characteristics of a mixed population. pvc represents the proportion 
of vaccinated cattle and pvs, the proportion of vaccinated sheep: 
evaluation of the influence of different proportions of cattle (pc)  
and sheep (1 – pc) 
In the different non-vaccinated mixed populations, for populations with 0%, 24%, 61%, 
78% and 100% cattle, R was estimated to be 1.1, 2.1, 3.7, 4.4 and 5.3, respectively. 
evaluation of the effect of different vaccination strategies 
Strategy 1: vaccination of both cattle and sheep 
In Figure 1a we show the effect of vaccination when we vaccinate (the same proportion of) 
both cattle and sheep (so when pv=pvc=pvs) for populations consisting of cattle or sheep in 
different proportions. The R for a fully vaccinated mixed population with 0%, 24%, 61%, 
78% and 100% cattle was 0.1, 0.11, 0.12, 0.12 and 0.13, respectively, i.e. always <1. 
The percentage of the population that has to be vaccinated to achieve R = 1 is: 14%, 56%, 
75%, 79% and 83% for populations with 0%, 24%, 61%, 78% and 100% cattle, respectively. 
Strategy 2: vaccination of all cattle with additional vaccination of sheep 
When in the populations no sheep, but only all cattle (thus 100% of the cattle) are vaccinated, 
R was 1.1, 0.90, 0.52, 0.35 and 0.13 for populations with 0%, 24%, 61%, 78% and 100% 
cattle, respectively (see Fig. 1b). The percentage of cattle in the population that has to be 
present to reach R = 1 (when all cattle are vaccinated) was 14%. 
Strategy 3: vaccination of all sheep with additional vaccination of cattle 
When in the populations no cattle, but only all sheep (thus 100% of the sheep) are vaccinated, 
R was 0.1, 1.4, 3.3, 4.1 and 5.3 for populations with 0%, 24%, 61%, 78% and 100% cattle, 
respectively (see Fig. 1c). 
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Fig. 1. The effect of different vaccination strategies on the reduction of R in mixed populations. (a) The 
effect of vaccination of both cattle and sheep (in equal proportions) on the reduction of R in different mixed 
populations with cattle and sheep. (b) The effect of vaccination of all cattle and additional vaccination of 
sheep on the reduction of R in different mixed populations with cattle and sheep. (c) The effect of vaccination 
of all sheep and additional vaccination of cattle on the reduction of R in different mixed populations with 
cattle and sheep. pc represents the proportion of cattle of the mixed population. The threshold value of R = 
1 is indicated by a grey line. The percentage of the population of (a) cattle and sheep, (b) sheep, or (c) cattle 
that needs to be (additionally) vaccinated to reach the threshold value of 1 is indicated. 
The additional percentage of the cattle population that has to be vaccinated to reach R 
= 1 was 0%, 29%, 72% and 78% and 83%, respectively, for populations with 0%, 24%, 61%, 
78%, and 100% cattle, respectively. 
disCussion
In the current study we quantified the transmission of FMDV in mixed cattle-sheep populations 
and evaluated the effect of different vaccination strategies. The evaluation of different vaccination 
strategies was based on the transmission estimates from experimental transmission studies. The 
higher the proportion of cattle in a mixed cattle-sheep population, the higher the R for the 
mixed population is. Thus, the impact of vaccination of the cattle is higher. When the whole 
population is vaccinated, R < 1 regardless of the population composition. In mixed cattle-sheep 
populations with at least 14% of cattle, vaccination of cattle only is sufficient to reduce R to 
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<1. The strategy of vaccinating cattle only for eradication purposes has been used in the past 
in continental Europe [15] and South America [16, 19] with success. Previous studies using 
mathematical modelling also predicted that for emergency vaccination, targeting cattle only is 
much more efficient than using other vaccination strategies [29]. Therefore, this strategy will be 
more cost-effective in countries with mixed populations of cattle and sheep where prophylactic 
vaccination is applied [30], as it would mean a reduction in the number of vaccine doses needed 
and in required manpower. Moreover, when using it as an emergency vaccination strategy, it 
would also mean a reduction in the time needed to immunize all the animals. 
While our conclusions are valid for mixed cattle- sheep populations, different results might 
be expected for mixed populations where other FMDV-susceptible species are present. For 
instance, in The Netherlands, where routine annual vaccination of cattle only was used from 
1953 to 1991, FMD outbreaks occurred be- tween 1961 and 1967 in mixed cattle and pig farms. 
At that time, additional vaccination of pig herds was used effectively to control the outbreaks 
[31]. Additionally, in Asian countries, where the Asian buffalo (Bubalus bubalis) is a host of 
epidemiological importance [32], a vaccination strategy that includes (additional) vaccination of 
the Asian buffalo is probably advisable. Thus depending on the different species and percentages of 
these species in a population, different vaccination strategies might be needed. When quantitative 
data of transmission of FMDV for other animal species are known, this could be included in the 
NGM and then similar analyses can be performed for other heterogeneous populations. 
In our analysis, we used data from transmission studies in which good quality vaccines, 
containing >6 PD50 per dose, were used. Experience in South America [33] shows that the 
strategy of vaccinating cattle only is only effective when good quality vaccines are used. The use 
of good quality vaccines is of course a prerequisite when using vaccination to control a disease. 
We used data from within-pen transmission studies in which cattle and/or sheep were mingling 
in one animal room, thus within-pen transmission occurred. However, in many situations, 
cattle and sheep within a population will have less intensive contact. Other studies show that 
transmission between pens is in general lower than within a pen [12, 34] and that between-herd 
transmission will be even lower [35]. Thus, the effect of targeting vaccination towards cattle will 
probably be even better under these circumstances than predicted in the current study. In the 
current study, we used a mathematical approach to calculate which vaccination strategies would 
be effective. In field situations, other aspects, e.g. vaccine quality, might influence the results. 
However, even if the quality of the vaccine batch is low, it is probably better to use it in cattle only 
than spread the available capacity over both species. Although we did use different serotypes in 
the current study, which produced similar results, there might be a different outcome for other 
virus strains. Moreover, our approach looks only at the scenario where eradication of FMDV is 
the goal, there may be an interest to consider scenarios where intermediate situations (FMDV 
still endemic) have also to be considered, but this has not been studied here. 
We developed an NGM that can be used to evaluate the transmission of FMDV for 
mixed populations of cattle and sheep and we analysed the effect of a targeted vaccination 
strategy. We conclude that vaccination of cattle only in mixed populations consisting of 
sheep and cattle will in most cases be sufficient for controlling FMDV epidemics. 
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Part i: the roLe oF inFeCtion routes  
in the transmission oF Fmdv
In part 1 of this thesis (chapters 2 and 3), we analysed the role of infectious secretions and 
excretions in the transmission of FMDV and correlated it to the indirect route of transmission 
of FMDV. First (in chapter 2), those factors that contribute to higher secretion and excretion 
of FMDV by the infected animals were identified. Various FMDV infected secretions and 
excretions contribute to the transmission of the virus between susceptible animals. It is 
therefore important to think how these infected secretions and excretions can reach non-
infected susceptible animals either within or between farms. Within a farm, it is likely that 
the infected secretions and excretions are deposited in the environment and the neighbor 
animals become infected by inhaling air shed by the infected animals, inhaling re-aerosolized 
infected material, or by getting infected secretions and excretions in abrasions or small 
wounds. Ruminants are known to be reasonably sensitive to airborne infection [1] but pigs are 
relatively resistant to airborne infection [2]. Therefore, it is likely that one of the natural routes 
of infection in ruminants is via aerosols that spread to the upper respiratory tract. However, 
in pigs, small wounds could comparatively be one of the most important routes of infection.
After infection, FMDV replicates in the epithelial tissues and in the internal organs of the 
animals and is shed in a variety of secretions and excretions. Consequently, it was of interest to 
quantify the role of the environment, contaminated with infected secretions and excretions, 
in the transmission of FMDV. As it was demonstrated in chapter 2 of this thesis, cattle 
contaminate the environment with large amounts of FMDV especially via the respiratory 
route (i.e. upper respiratory tract excretions). This can be linked with the fact that most of 
the replication of FMDV occurs in the respiratory tissues from this species [3]. And the fact 
that even larger amounts of FMDV can be found in these secretions and excretions during 
the clinical stage of the disease (as it was also demonstrated in chapter 2) can be associated 
to the excessive production of oral (saliva) and respiratory (nasal discharge) secretions and 
excretions during this stage of the disease, in proximity to the replication sites. But still, 
large amounts of FMDV can be found early after infection, before the appearance of clinical 
signs e.g. in saliva [4] or in milk [5]. Thus worryingly, the asymptomatic animals could pass 
undetected and contaminate the environment with their infectious secretions and excretions 
resulting in new FMD cases. Early detection of FMDV infected animals is essential for the 
control of the disease. In field conditions, early detection could be a challenge specially when 
small ruminants are involved because the lack of apparent clinical signs [6].
Certainly direct transmission of FMDV will occur when FMDV-susceptible animals 
e.g. cattle or sheep are in close vicinity to infectious animals; the infected animals will shed 
the virus onto the environment and the susceptible animals will pick it up [7] preceding 
virus replication and later virus secretions and excretion. As described in chapter 3, even 
when the livestock are removed from the premises, transmission of FMDV will occur. 
Accordingly, in the outbreak of 2001, Irish cattle became infected after being exposed to 
an environment contaminated previously by infected British sheep on their way to The 
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Netherlands [8] leading to outbreaks of FMDV in the Dutch territory. Thus then, the role 
of indirect routes (i.e. by contaminated environments with FMDV) was already notorious 
in the transmission of the infection. Transmission of the infection to other animals via 
contaminated environments with FMDV is feasible either inside the same premise (e.g. 
holding FMDV infected and susceptible animals in a same pen, feeding FMDV-susceptible 
animals with infectious milk from the same farm [9], or during artificial insemination of 
animals with infectious semen from the same farm [10]), or between-farms (e.g. when 
moving infected animals or objects from an infected farm to another farm or neighbour 
premises). Supportively, it has been suggested that movement of contaminated persons and 
objects were responsible for the between-farm transmission of FMDV in Denmark in 1982 
and in Italy in 1993 [11], in United Kingdom  in 2007 [12] and in Japan in 2010 [13]. Thus 
again physical interaction of infected animals (direct contact) is not a prerequisite for the 
occurrence of transmission of FMDV as shown in chapter 3 contradicting previous studies 
that suggest that direct contact transmission occurs only after 0.5 days post clinical detection 
in the animals [14]. Between-farm transmission of FMDV will depend on the amount of 
virus that is transported from location A to location B. The accumulation of virus in the 
environment will be determined by the amount of virus that is released in the environment, 
and as others have determined, also by the time needed to reach a location and the decay 
of the virus [15]. Indeed, in chapter 3, a decay of FMDV in the environment (depending on 
temperature) was taken into consideration for the quantification of the contribution of the 
environment in the transmission of FMDV. In this study an average temperature (20 °C) 
was considered in the 2 routes stochastic susceptible-infectious-recovered (or removed) 
(SIR) model but other temperatures can be used accordingly. Simple SIR models [16] have 
been employed for the quantification of transmission in between cattle [14, 17–20], between 
sheep [21–24], between pigs [25–29], and between buffaloes [30, 31] studies. The so far used 
SIR models enabled estimation of intraspecies transmission but no quantification of the 
contribution of the environment was performed. Knowing that SIR models can be updated 
by using extra routes [32], an SIR model for FMDV with the environment as an extra route 
was developed in chapter 3. Because it is of importance that models include an accurate 
set of transmission parameters to give better predictions [33], this model used a survival 
rate of FMDV for giving more precise transmission estimates. The results from using the 2 
routes SIR model demonstrate that approximately 44% of the transmission of FMDV occurs 
via the environment when temperatures are in average 20 °C. This contribution is relative 
high if we consider that it relates to the presence of infectious secretions and excretions 
in an environment without the presence of livestock. This and the fact that FMDV may 
survive [34] and persist in a contaminated environment for up to 1 month, depending on 
the temperature and pH conditions [35], raise awareness on the importance of biosecurity 
measures for the control of FMDV (see below “Targeting control measures”).
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Part ii:  the roLe oF sPeCies diFFerenCes  
in the transmission oF Fmdv and vaCCination 
strateGies towards the sPeCies
We have seen that cattle are shedders of high quantities of virus followed by swine and by 
small ruminants i.e. sheep and goats (in chapter 2). Although cattle are major producers of 
infected secretions and excretions (specially upper respiratory tract excretions as shown in 
chapter 2), swine are major producers of infected airborne excretions. Thus both animal 
species, when in close proximity, can together contaminate the environment enormously 
and have a major effect in the transmission of FMDV. Even though the airborne route has 
been considered to introduce FMDV in livestock populations [36–38], we have seen (in 
chapter 3) that approximately 44% of the transmission of FMDV occurs via other types of 
infectious secretions and excretions that are either on the floor or in air droplets inside an 
environment (e.g. saliva from cattle that contains high quantities of FMDV, in chapter 2). 
Furthermore, transmission of FMDV via the airborne route will depend on atmospheric 
conditions [36].  Because when in close proximity, cattle and pigs can together contaminate 
the environment enormously, high transmission of FMDV can be expected in mixed 
cattle-pigs populations. While in pigs the risk of infection with FMDV could rely on e.g. 
the ingestion of contaminated feedstuffs or ground [39] with infectious secretions and 
excretions from cattle, in cattle the inspiration of suspended viral particles could lead to 
infection with FMDV. Supportively, it has been shown that in populations where cattle and 
pigs are in close vicinity, transmission of FMDV is very high [40, 41].
On the other hand, small ruminants shed lower levels of FMDV in their secretions 
and excretions than cattle and swine do (in chapter 2). It was already known that small 
ruminants contaminate the environment with infected secretions and excretions limitedly 
[42] but their contribution in the transmission of FMDV in mixed populations was until 
now not clear. Even though cattle and sheep have been reported to be similarly susceptible 
to airborne infection [1], others claim that the small ruminants are the least susceptible 
animal species [43]. Additionally, a decline in the transmission of FMDV in this species 
(when the virus is passaged in a population composed of sheep only) has been previously 
observed [24]. Accordingly, others have observed a decline in the transmission of the virus 
via this species in field conditions [6]. However the role of sheep in the epidemiology of 
FMD has been noted as important as this species show clinical signs of the disease only 
vaguely and their infectious status could pass without notice [6, 44]. Because the latter and 
the need to understand more about the transmission of FMDV between different species, 
in chapter 4 the quantitative role of sheep in transmitting FMDV to susceptible cattle was 
investigated. In a study, using a statistical model, reducing the number of sheep in a mixed 
population with cattle did not have a significant effect on reducing transmission of FMDV 
and thus cattle were blamed to have driven the UK 2001 epidemic [45]. The results from 
chapters 4 and 5 confirm this observation; cattle are the most important epidemiological 
species as compared to sheep. Only 40% of the cattle in the transmission experiment with 
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infected sheep in chapter 4 got infected with the virus and only 10% of it became clinically 
infected and shed virus to the environment (partial R0= 0.9). In chapter 4, it is shown that 
cattle and sheep are similarly susceptible to FMDV but that the relative infectivity of cattle is 
higher than that of sheep. In chapter 4, by using a SIR model, only a part of the transmission 
of FMDV in mixed sheep-cattle populations could be quantified. Thus, to determine total 
transmission of FMDV for a mixed population consisting of cattle and sheep, in chapter 
5 another technique was employed: a next generation matrix (NGM). The NGM has been 
previously used for other diseases [46] and used limitedly to determine transmission of 
FMDV in mixed populations [47, 48]. In chapter 5 this method was useful for assessing 
transmission of FMDV in different mixed populations (with different animal proportions) 
and for evaluating targeted vaccination. In accordance with chapters 2, 3 and 4 of the thesis, 
chapter 5 shows the importance of cattle in the epidemiology of FMDV. In chapter 5, it is 
shown that mixed cattle-sheep populations containing a larger proportion of cattle might 
run a higher risk of transmission of FMDV (i.e. higher transmission rates will be expected). 
In the same chapter, it is indicated that vaccination of cattle only is sufficient to reduce 
transmission of FMDV (see below “Targeting control measures”).
tarGetinG ControL measures to reduCe  
the transmission oF the inFeCtion 
According to this thesis, control measures to reduce transmission of FMDV should be 
focused on early detection of new infections, prevention of physical interaction between 
infected and susceptible animals, biosecurity (e.g. disinfection) and targeted vaccination.
early detection and the reduction of the transmission of Fmdv
Efforts to control FMD should be directed at early detection of infection and rapid 
intervention e.g. by emergency vaccination of the animals and by applying movement 
restrictions. As seen in chapter 2 of the thesis, as early as 0-3 dpi, large amounts of the 
virus can be found in secretions and excretions from cattle 4.8 10log TCID50/ml (1.0, 8.5) 
and swine 5.6 10log TCID50/ml (4.4, 8.6). This indicates that high contamination of the 
environment can occur fast after the infection of animals and thus transmission of FMDV 
will occur.  For the purpose of early detection of FMDV, there are highly specific tests 
for detecting NSPs to differentiate non-infected from infected vaccinated animals and to 
even detect silent infections in populations of either cattle or sheep. The latter might be of 
consideration in populations of sheep where sometimes the detection of clinical signs is 
impossible. Early detection of FMDV infected animals aids to the prompt use of control 
interventions which will result in the reduction of the transmission parameter β, of the 
number of new infections caused by a typical infected individual per unit of time. As early 
the detection of infections, as early the biosecurity measures can be applied as well as the 
emergency vaccinations can be started.
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Prevention of physical interaction between infected and susceptible 
animals
By reducing the amount of FMDV that is left in the environment (e.g. by virus inactivation), 
contact to infectious surfaces and thus new infections can be avoided. But also, it is 
necessary to avoid contact of the animals to contaminated environments and to restrict 
movement between farms.
During an outbreak, transmission of FMDV can be controlled by stamping-out of all 
susceptible affected animals [49–52] reducing the average number of infections caused by a 
single typical infectious individual during its entire infectious period (R0). One other control 
strategy to reduce transmission of FMDV is movement restriction of the animals and/or of 
farm related equipment [51].  If during an outbreak no movement restriction is applied, 
modelers predict that transmission of FMDV may persist [53, 54] and especially when large 
number of cattle are involved [55]. This is supported by the findings in chapter 2, where 
cattle are shown to be the major contributors of contamination of the environment with 
FMDV. Previously, it has been observed that even when movement restriction of animals is 
applied outbreaks still occur [49]. Movement of machinery, agriculture equipment, or, milk 
bulk tanks between farms can be responsible for the transmission of the disease between 
farms [49, 56]. This thesis shows that aside of reducing contact of animals to contaminated 
environments, restricting transport and/or disinfecting all materials that enter the farms 
(see below for details on disinfection) should be taken as a basic rule to avoid new infections. 
Biosecurity and the reduction of the transmission of Fmdv
Due to that most of the secretions and excretions from animals infected with FMDV 
contain virus [42] as corroborated in the chapter 2 of this thesis, there exist concerns about 
the role of infectious secretions and excretions, and infectious animal products (e.g. milk 
and meat) in the transmission of FMDV [49, 50]. Thus import restrictions are implemented 
as a strategy to prevent introductions of FMDV in free areas. 
In chapter 3, transmission of FMDV after the exposure of calves to a contaminated 
environment occurred in time intervals from 0-3 days and from 4-6 days post infection 
of the donors. This showed that the virus might be transmitted to other animals even after 
3 days post infection of animals that were housed in the same environment. Hence in 
order to control transmission of FMDV via a contaminated environment with infectious 
secretions and excretions, disinfection of the premises should be applied as soon as possible. 
Thorough cleaning and disinfection of the environment will prevent indirect transmission 
of FMDV and thus R0 will be reduced. Disinfection of the environment can be performed 
using thermal and chemical inactivation methods. Thermal inactivation of FMDV has been 
studied extensively [57–60], especially for the control of transmission via contaminated 
animal products [35, 61–63]. FMDV is progressively inactivated by temperatures above 
50°C [64] with effective inactivating temperature at approximately 60°C [65]. Thus in most 
open-air conditions, the virus is not inactivated very quickly.
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FMDV is reported to be resistant to inactivation between pH 7 and 7.5 but rapid 
inactivation is seen in more acid or more basic conditions [59]. Several scientists have 
evaluated the effect of different chemicals on the inactivation of FMDV [57, 66, 67]. And 
the OIE recommends the use of sodium hydroxide (2%), sodium carbonate (4%), citric 
acid (0.2%), acetic acid (2%), sodium hypochlorite (3%), potassium peroxymonosulfate/
sodium chloride (1%), or chlorine dioxide for the disinfection of premises and all infected 
material, such as implements, cars, and clothes [64]. In this thesis it is shown that if no 
proper disinfection of the environment is performed, transmission of FMDV will occur.
vaccination of the animals as a tool for Fmd control
In chapter 5, it is shown that vaccinating cattle only in mixed populations with sheep is in a 
lot of cases (when at least 14% of the population is cattle) sufficient to control transmission 
of FMDV (R0<1).
Vaccination is used as a tool to reduce the number of susceptible animals and to 
reduce infectivity and thus virus shedding [68], and consequently contamination of the 
environment. Unlikely to conventional vaccines, emergency vaccines are sometimes of 
higher quality (≥6 PD50) [69]. Conventional vaccines are used during annual vaccination 
campaigns in countries where FMD is still endemic [70] e.g. in Israel [71]. And emergency 
vaccines are used during outbreaks for control [51, 72]. 
Previously, it has been shown that the average number of new infections caused by one 
typical infectious individual (the reproduction ratio, R) can be reduced after vaccination 
of the susceptible animals [18, 21, 26, 27, 45, 73, 74]. And in field conditions, eradication 
of FMD has been achieved after vaccination of susceptible animals (mostly cattle only) in 
different regions [49, 75, 76]. In mixed populations, vaccination of all susceptible animal 
species is impractical and very uneconomical. Models have predicted that vaccination 
of a heterogeneous population composed by cattle, sheep and pigs reduce transmission 
of FMDV [77]. In that study [52], excluding pigs from vaccination increased slightly the 
transmission rates but halved the number of animals that needed to be vaccinated. Even 
though vaccination targeted towards cattle in a heterogeneous population composed by 
cattle and sheep reduces transmission of FMDV significantly [49],  vaccinating cattle only 
either in annual vaccination campaigns or during outbreaks is not globally practiced. In 
this thesis, it is shown that targeted vaccination is a good alternative to reduce transmission 
of FMDV in mixed cattle-sheep populations and thus it should be considered during the 
planning of control strategies against FMD.
ConCLudinG remarks
During the past years, an effort to understand the epidemiology of FMDV and its transmission 
dynamics has been performed. Quantification of transmission parameters have been performed 
by using animal experiments and by using data from published animal experiments. And 
mathematical models have been used to understand and predict the transmission dynamic of the 
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virus. In this work, efforts have been made to understand a little bit more on how the virus can 
be transmitted through the environment and which animal species should be targeted primarily 
during the control of an outbreak. We showed that cattle infected with FMDV contaminate the 
environment with huge amounts of infected secretions and excretions than other species (in 
chapter 2). And thus the risk of transmission of FMDV, via the environment (in chapter 3), by 
this animal species is high (except when vaccination is applied). Thus according to chapters 2 
and 3, transmission of FMDV depends on several determinants: the amount of secretions and 
excretions that are in a determined environment, the affected animal species which determines 
higher or lower contamination of the environment, the clinical status of the animal which 
determines higher contaminations, the vaccination status of the animals, and the temperature 
in which the virus is exposed in the environment. 
In mixed populations consisting of cattle and sheep, cattle are of higher risk for 
transmission of FMDV as compared to sheep (in chapter 4). In these mixed populations, 
transmission of FMDV can be controlled after vaccination of cattle only when at least 14% 
of cattle are present in these populations (in chapter 5). Thus according to chapters 4 and 5, 
transmission of FMDV depends as well on the type of animal population and its proportion 
inside a population, and on the vaccination status of the animals. And in general when 
observing the results from chapters 2, 3, 4 and 5, the presence of cattle inside a population 
contributes to a higher transmission of the infection, being even higher when pigs are present.
In order to develop global strategies for FMDV transmission control, a multidisciplinary 
effort of virologists, modelers, veterinarians and authorities will be necessary in order to update 
contingency plans. Efforts should be made on strengthen biosecurity measures (i.e. disinfection 
of premises and equipment, and controlling in and outs), segregating animal species or using 
physical barriers when possible, and targeting cattle to vaccination during an epidemic.
imPLiCations and Further researCh
The results from this thesis could be used to improve the control of FMDV by e.g improving 
contingency plans and update vaccination strategies. This thesis raises the importance of 
possible silent transmission of FMDV within and between farms. The conclusions of this 
study highlight the importance of a contaminated environment in the transmission of the 
disease even when the infected animals are not present anymore. 
There is still little known on how much infectious virus could be transported from 
farm to farm and which is the route of infection that determines major transmission of 
the virus when animal transport is not allowed i.e. illegal transport of infectious milk 
or of contaminated feedstuff. Quantification studies on the amounts of virus that can be 
transported between farms and its contribution in the transmission of FMDV (by the 
estimation of infection rates from this contaminated material) are recommended. 
Additionally, this work identifies cattle as the species that can infect larger number 
of animals during an outbreak. Therefore cattle should be targeted primarily during 
vaccination campaigns. However, in populations where pigs coexist with cattle and sheep, 
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summary 
Foot-and-mouth disease (FMD) continues to be a major worldwide veterinary problem 
causing serious disease resulting in production losses and trade restrictions, therefore FMD 
is an OIE-Listed disease [1]. Control strategies for FMD are available [2] however the disease 
is until now not globally controlled. Because there were still gaps in the understanding of 
the transmission of FMDV this thesis aimed to gain more knowledge about underlying 
mechanisms in the transmission of FMDV, which might contribute to improved control of 
the infection. The thesis is divided in two parts: Part 1: The role of infection routes in the 
transmission of FMDV (Chapters 2 and 3), and Part 2: The role of species differences in 
the transmission of FMDV and the effect of targeted vaccination strategies (Chapters 4 and 
5). It is generally accepted that the most common route of transmission of FMDV is via 
contact exposure to an infectious individual (the direct route) [3]. However, transmission of 
FMDV occurs even when the animals are not exposed to infectious individuals (the indirect 
route) [4–6]. Some of the current control strategies against FMDV involve movement 
restrictions [2] but even when this control measure is applied,  transmission between farms 
still occurs (e.g. during the UK epidemic and Dutch epidemic in 2001). For understanding 
how transmission could occur via the indirect route, chapters 2 and 3 aimed to analyse the 
role of infected secretions and excretions in the transmission of FMDV. For this purpose, 
in chapter 2 the factors that are associated with the amount of virus shed by the infected 
animals were identified. Information from 32 published scientific articles in which FMDV 
infection experiments were described, were recorded in a database and analysed using 
multivariate regression models with and without random effects. The identified factors 
were: type of secretions and excretions (se-excretions), animal species, stage of the disease 
(clinical or non-clinical) and days post infection. Cattle were shown to contribute mainly in 
the contamination of the environment via their respiratory se-excretions early after infection 
when they showed clinical signs. In chapter 3, the contribution of an environment that 
was contaminated with se-excretions of infected cattle to the transmission of FMDV, was 
quantified. For this purpose, calves that were not vaccinated and calves that were vaccinated 
(1 week prior to inoculation with FMDV) were used in direct and indirect transmission 
experiments. By using the results from both experiments, FMDV transmission was quantified 
using a generalized linear model based on a 2 route (2R, i.e. direct contact and environment) 
SIR model that included information on FMDV survival in the environment. Roughly 44% 
of the transmission of FMDV occurred via environmental contamination with infectious 
se-excretions from the affected animals. Vaccination of the calves 1 week prior to inoculation 
with the virus, completely prevented transmission of FMDV in both direct and indirect 
transmission experiments and therefore no transmission parameters could be estimated.
It has been described that cattle can contaminate the environment with larger quantities 
of FMDV than sheep can do [5, 7] and that they are more infectious than sheep [8]. However, 
because the difficulties of detecting FMD clinical signs in sheep [9], the epidemiological 
role of sheep in the transmission of FMDV is sometimes considered important [10]. 
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Even though transmission of FMDV occurs in mixed cattle-sheep populations [11], there 
were until now no quantified transmission parameter for this type of population. For 
understanding how species differences could have an effect on the transmission of FMDV, 
chapters 4 and 5 aimed to quantify transmission of FMDV between cattle and sheep and to 
evaluate which vaccination strategies could stop an epidemic in mixed populations of cattle 
and sheep. In chapter 4, an animal experiment is described using infected sheep, which 
were kept in contact to cattle to quantify the interspecies sheep-to-cattle transmission 
parameter (a partial reproduction ratio, R0p). Limited transmission of FMDV from infected 
sheep to in-contact cattle was observed (R0p = 0.87). R0p was compared to the R0’s obtained 
in previous transmission studies with sheep or cattle only allowing the determination 
of the relative infectivity and relative susceptibility of both species. Cattle were found to 
be more infectious than sheep but similarly susceptible. Due to that R0p is not sufficient 
to quantify the transmission of FMDV in populations consisting of cattle and sheep, we 
implemented in chapter 5 a method to estimate total transmission of FMDV in mixed cattle-
sheep populations. Using this method, transmission of FMDV (R0) in mixed cattle-sheep 
populations (having different proportions of cattle and different proportions of vaccinated) 
was estimated and the effects of the different (targeted) vaccination strategies against 
FMDV were analysed. The method consisted of a 4 by 4 next generation matrix (NGM) that 
included infectivity and susceptibility of cattle and sheep, population proportions of cattle 
and sheep, and their vaccination status. In mixed populations of cattle and sheep where 
cattle are predominant, transmission of FMDV is higher and targeting vaccination for cattle 
only can be sufficient to control FMDV (R0 < 1).
This thesis covers some gaps regarding the dynamics of the transmission of FMDV. The 
results of this thesis can be used to improve the measures to prevent and control FMDV by e.g. 
implementing better biosecurity measures based on the material that is most likely infected 
(e.g. extra effort in the disinfection of premises and farm equipment that have had contact 
with se- and excretions of cattle) or updating vaccination plans (i.e. vaccinating cattle only).
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Mond-en-klauwzeer (MKZ) is nog steeds een belangrijk veterinair probleem in grote delen 
van de wereld. MKZ veroorzaakt ernstige ziekteverschijnselen hetgeen resulteert in verlies 
van productiviteit (melkgift, verminderde groei) en handelsbeperkingen en MKZ staat dan 
ook op de OIE lijst met aangifteplichtige dierziektes [1]. Ondanks de beschikbaarheid van 
bestrijdingsmaatregelen voor MKZ [2] is de ziekte nog steeds niet uitgeroeid. Ook zijn er nog 
steeds lacunes in de kennis over transmissie van het mond-en-klauwzeer virus (MKZV). In het 
onderzoek dat wordt beschreven in dit proefschrift werd geprobeerd meer kennis te verkrijgen 
over onderliggende mechanismes die belangrijk zijn voor de transmissie van MKZV. Deze 
kennis kan gebruikt worden om verbeterde bestrijdingsmaatregelen te ontwikkelen voor MKZ. 
Het proefschrift is verdeeld in twee delen. In het eerste deel werd onderzoek gedaan naar 
de rol die verschillende infectieroutes spelen in de transmissie van MKZV (Hoofdstukken 
2 en 3). In het tweede deel werd onderzoek gedaan naar verschillen tussen MKZ gevoelige 
diersoorten die een rol kunnen spelen bij transmissie van MKZV en het effect van zgn. 
gerichte vaccinatie, dat wil zeggen een vaccinatie strategie waarbij niet alle dieren maar 
alleen een bepaalde doelgroep wordt gevaccineerd (Hoofdstukken 4 en 5). In het algemeen 
wordt aangenomen dat contact met een MKZ geïnfecteerd dier de meest gangbare route is 
voor transmissie van MKZV (de directe route) [3]. Maar ook dieren die geen direct contact 
hebben gehad met geïnfecteerde dieren kunnen besmet worden met MKZV (indirecte route) 
[4–6]. In huidige bestrijdingsmaatregelen worden vervoersverboden toegepast [2] maar zelfs 
in periodes met een vervoersverbod treedt transmissie tussen bedrijven op (b.v. tijdens de 
MKZ epidemieën in Groot-Brittannië en in Nederland in 2001). Om inzicht te krijgen in 
hoe transmissie via de indirecte route plaatsvindt, werd in hoofdstuk 2 en 3 geprobeerd om 
te analyseren welke rol verschillende se- en excreta (van MKZV geïnfecteerde dieren) spelen 
in de transmissie van MKZV. In hoofdstuk 2 werden factoren geïdentificeerd die gerelateerd 
zijn aan de hoeveelheid virus die wordt uitgescheiden door geïnfecteerde dieren. 
Hiervoor werd gebruik gemaakt van informatie uit 32 gepubliceerde wetenschappelijke 
artikelen waarin gegevens van experimentele MKZV infecties werden gerapporteerd. De 
gegevens van deze experimenten werden verzameld in een database. Vervolgens werd met 
behulp van statistisch analyse ( multivariaat regressie model; met en zonder random effect) 
bepaald welke factoren de virusuitscheiding beïnvloedden. Factoren die invloed hadden op 
de virusuitscheiding waren: het type se- / excreta, de diersoort, het ziektestadium (klinisch 
ziek versus niet klinisch ziek) en het aantal dagen na infectie. Runderen scheidden het meeste 
virus uit in de omgeving, vooral via respiratoire se- /excreta, kort na infectie en wanneer ze 
klinisch ziek waren. In hoofdstuk 3 werd gekwantificeerd welke rol een besmette (met se- / 
excreta van geïnfecteerde dieren) omgeving speelt in de transmissie van MKZV. Voor dit doel 
werden eerst niet gevaccineerde en later gevaccineerde (1 week voor inoculatie met MKZV) 
kalveren gebruikt, beiden in zowel directe als indirecte transmissie experimenten. Met behulp 
van de gecombineerde resultaten van de directe en indirecte transmissie experimenten, kon 
het deel van de MKZV transmissie dat plaatsvond via de omgeving worden gekwantificeerd. 
127
Su
m
m
a
ry &
 Sa
m
e
n
va
ttin
g
 
VII
Hiervoor werd gebruik gemaakt van een gegeneraliseerd lineair model (GLM), dat was 
gebaseerd op een zgn. 2-route (2R, d.w.z. direct contact en omgeving) SIR model. Informatie 
over overleving van MKZV in de omgeving (zgn. ‘survival’) werd in het model gebruikt. Bij 
de niet-gevaccineerde dieren, vond ruwweg 44% van de transmissie van MKZV plaats via 
een omgeving die besmet was met infectieuze se- / excreta van besmette dieren. Vaccinatie 
van kalveren een week voor inoculatie met MKZ virus, voorkwam dat er transmissie van 
MKZV plaatsvond, zowel in de directe als de indirecte transmissie experimenten en daardoor 
konden geen transmissie parameters worden geschat.
Er is al eerder beschreven dat runderen de omgeving met grotere hoeveelheden MKZV 
kunnen contamineren dan schapen [5, 7] en dat ze infectieuzer zijn dan schapen [8]. Maar 
omdat het soms erg moeilijk is om klinische MKZ verschijnselen bij schapen te detecteren 
[9] wordt de epidemiologische rol van schapen in de transmissie van MKZV toch belangrijk 
geacht [10]. Ondanks dat er transmissie van MKZV plaatsvindt in gemengde populaties 
van runderen en schapen [11], waren er tot nu toe geen gekwantificeerde transmissie 
parameters bekend voor dit type populaties. 
Om inzicht te krijgen in hoe verschillende diersoorten de transmissie van MKZV 
beïnvloeden, werd in hoofdstukken 4 en 5  beoogd om de transmissie van MKZV tussen 
runderen en schapen te kwantificeren en werd geëvalueerd welke vaccinatie strategieën 
een epidemie in gemengde populaties van runderen en schapen tot staan kunnen brengen. 
In hoofdstuk 4 wordt een dierexperiment beschreven waarin geïnfecteerde schapen samen 
werden gehuisvest met contact runderen, om zo de interspecies (tussen diersoort) schaap-naar-
rund transmissie parameter te kwantificeren (deze transmissie parameter is een zgn. partiële 
reproductie ratio, R0p). Er werd slechts beperkte transmissie van de geïnfecteerde schapen 
naar de contact runderen waargenomen (R0p = 0.87). Deze R0p werd vergeleken met de R0’s 
die in eerder uitgevoerde transmissie experimenten met of alleen schapen of alleen runderen 
waren verkregen. Op deze manier kon de relatieve infectiviteit (besmettelijkheid) en relatieve 
vatbaarheid van beide diersoorten worden bepaald. Runderen bleken infectieuzer te zijn dan 
schapen, maar de vatbaarheid van runderen en schapen was vergelijkbaar. Met alleen de partiële 
transmissieparameter  die transmissie van schaap naar rund beschrijft, kan de transmissie in 
een gemengde schaap-rund populatie niet worden beschreven. Daarom werd in hoofdstuk 5 
een techniek geïmplementeerd waarmee de transmissie in gemengde populaties (in dit geval 
runderen en schapen) kan worden geschat. Met deze methode werd de transmissie van MKZV in 
gemengde schaap-rund populaties (met verschillende verhoudingen van runderen en schapen) 
geschat (R0 waardes) en werd bovendien  het effect van verschillende vaccinatie strategieën, 
(met verschillende verhoudingen niet-gevaccineerde en gevaccineerde dieren, waaronder zgn. 
gerichte vaccinatie) geanalyseerd. Voor deze analyses werd gebruik gemaakt van een zgn. 4x4 
volgende generatie matrix (next generation matrix, NGM), waarin de infectiviteit en vatbaarheid 
van runderen en schapen, proportie van runderen en schapen in een populatie en de vaccinatie 
status waren opgenomen. Hoe meer runderen er aanwezig zijn in een gemengde schaap-rund 
populatie, des te hoger is R0. In populaties met minstens 14%  runderen kan vaccinatie van 
alleen de runderen voldoende zijn om een uitbraak van MKZ te stoppen (R0 < 1).  
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In dit proefschrift wordt onderzoek beschreven dat antwoord geeft op sommige leemtes in 
kennis over de transmissie van MKZV. De resultaten die beschreven worden in dit proefschrift, 
kunnen worden gebruikt om maatregelen die ingesteld worden om uitbraken van MKZ te 
voorkomen of onder controle te brengen of te verbeteren, zoals bijvoorbeeld implementatie 
van nog betere biosecurity maatregelen (hygiëne en afscherming), die gebaseerd zijn op kennis 
over met MKZV geïnfecteerd materiaal (bv extra aandacht voor desinfectie van bedrijven en 
materialen die contact hebben gehad met se- / excreta van runderen) of het updaten van 
vaccinatie-strategieën (onder bepaalde omstandigheden toepassen van gerichte vaccinatie).
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